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Chapter I 
INTRODUCTION AND 
BACKGROUND 
 
 
 
 
 
 
 
 
 
 
 
“On current trends, AIDS will kill tens of millions of people over the next 20 years. 
But this need not happen. We know prevention works. We know that HIV treatment 
and care work. The global AIDS response is poised to enter a new era: where 
leadership and commitment are at long last matched with the resources needed to 
get on with the job.” 
 
 
--- Dr. Peter Piot 
(UNAIDS Executive Director and Under Secretary-General of the United Nations) 
 
 
Chapter I: Introduction and Background 
 
After more than 20 years since HIV/AIDS was first recognized in 1981, it seems 
unnecessary to introduce HIVAIDS here again, however, an overview of HIV/AIDS 
global trend will provide a snapshot to understand the epidemic more easily. 
  
 
1.1 HIV/AIDS Global Trend 
 
Acquired immunodeficiency syndrome (AIDS) is caused by human 
immunodeficiency virus (HIV) and was first recognized as a new and distinct 
clinical emerge in 1981 in USA (Rushing, 1995; UNAIDS, 2005). The HIV/AIDS 
epidemic spreads across the globe at an appalling rate, since AIDS was first 
described. When the epidemic was first described in North America, and soon after 
in Western Europe, HIV infection was high among gay men and injecting drug 
users. Heterosexual transmission later becomes dominant in general population in 
sub-Saharan Africa. Even within continents and countries, different epidemics 
demonstrate at different rates in different population groups. Another feature of the 
HIV/AIDS epidemic is the enormous diversity of strains of the virus due to its 
ability to rapidly mutate. There are two main types of HIV, HIV-1 and HIV-2 
(Curtis, 1992). HIV-2 infection is predominantly found in Africa. Both HIV-1 and 
HIV-2 have the same modes of transmission and are associated with similar 
opportunistic infections and AIDS. 
 
As of today, few diseases have emphasized the interaction between human behavior, 
community, health and disease as AIDS has done. HIV/AIDS, just with other two 
major infectious diseases - tuberculosis (TB) and malaria, cause approximately half 
of infectious disease mortality. These three diseases result in over 300 million 
illnesses and more than 5 million deaths each year (WHO, 2000-a). HIV/AIDS 
demonstrates an increasing challenge to countries all over the world, both directly as 
a health issue and indirectly through the challenges they pose for development. 
AIDS is a critical problem for development because of the number of people and 
sectors affected. By killing large numbers of productive and reproductive adults, It 
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also increases the total number of children orphaned by death of one or both parents 
(Fan et al, 1995). 
 
The epidemic is not homogeneous within regions and within some countries. Even 
at the country level there are wide variations in infection levels between different 
areas, sexes and socioeconomic level, such as in China and India. The number of 
people living with HIV/AIDS continues to rise, but in several countries it is 
declining. Evidence shows that changes in sexual behavior, such as increased use of 
condoms, fewer sexual partners and delay of sexual experience, play key parts in 
these declines. The more current increases have occurred in Eastern Europe and 
Central Asia (25% increase to 1.6 million) and East Asia (UNAIDS, 2005). 
 
By the end of 2005, 25 million people around the world have already died of AIDS, 
4.3 million of them children. Nearly twice that many – 40.3 million - are now living 
with HIV, and most of these are likely to die over the next decade or so. The Joint 
United Nations Programme on HIV/AIDS (UNAIDS) and World Health 
Organisation (WHO) recent estimates showed that, in 2005 alone, 4.9 million people 
were newly infected with HIV, 3.2 million were in Sub-Saharan Africa and 
1,138,200 in Asia and the Pacific (See Table.1.1) (UNAIDS, 2005). 
 
Table 1.1 The number of adults and children infected with HIV during 2005 
 
Region Total of people living with 
HIV to the end of 2005
Total of newly infected 
Adults & Children with HIV 
in 2005
Sub Saharan Africa 25.8 million 3.2 million
Asia and the Pacific 8,344,000 1,138,200
Eastern Europe & Central 
Asia 
1.6 million 270, 000
Latin America and the 
Caribbean 
2.1 million 230, 000 
The Middle East and 
North Africa 
510,000 67, 000
High-income countries 1,920,000 65, 500
Total 40.3 million 4.9 million
Source: UNAIDS 2005 
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Today, more than two decades after the first case of AIDS was reported, five people 
worldwide die of AIDS every minute of every day. HIV has hit every corner of the 
world, infected more than 40 million men, women and children, 4 million of them in 
2005 alone. Ninety-five percent of its victims are residents of the developing world 
(UNAIDS, 2002-b).The need to characterize the complex interaction of 
psychological and cultural factors that place individuals, families and communities 
at risk of HIV and AIDS has become urgent. 
 
Africa is the global epicentre of the HIV epidemic, the current data show that 25.8 
million adults and children are living with HIV. In 2005 alone, AIDS have caused 
an estimated 2.4 million African deaths. In addition, at least 95 percent of all AIDS 
orphans have been Africans (WHO, 2005).  
 
Sub-Saharan Africa is the hardest hit region of the world. Sub-Saharan Africa's 
epidemic is best analyzed under three sub-regions: eastern, southern and western 
Africa. In East Africa, which has Africa's oldest epidemic, with 15 percent of sub-
Saharan Africa's population, this sub region has 38 percent of its HIV infections 
(World Bank, 1996; FHI, 2006). Yet the epidemic has slowed in East Africa. It is 
spreading much faster in southern Africa, where it was first observed in the early 
1980s. In fact, in 1993, WHO stated that the global HIV epicenter had moved from 
eastern to southern Africa. The turning point was a 1993 survey showed that 37 
percent of pregnant women in Francistown, Botswana, were infected with HIV. 
Southern Africa now has over 40 percent of sub-Saharan Africa's HIV infections 
and the world's seven most-affected countries: Swaziland, Zimbabwe, Botswana, 
Zambia, Malawi, South Africa and Namibia. HIV entered West Africa in the early 
1980s, but fortunately has spread more slowly there. Fewer than 18 percent of HIV 
infections are in West Africa, Africa's most populous region （UN, 2003;  WHO, 
2000-b）. 
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In 2001, 70 percent of all people who became infected with HIV, and 80 percent of 
those who died of AIDS, came from sub-Sahara Africa, even though only a tenth of 
the world's population lives there. However, the African countries south of the 
Sahara have some of the best HIV surveillance systems in the world (UN, 2003). It 
showed that the estimated number of newly infected adults and children in Africa 
reached 3.5 million by the end of 2002 (UNAIDS, 2003). While adult HIV 
prevalence has apparently fallen in Kenya, Uganda and Zimbabwe, the epidemic has 
yet to peak in several other nations. Women are disproportionately affected. 
 
A few countries have seen recent declines in prevalence, probably in part due to 
effective prevention campaigns, but elsewhere epidemics are still increasing. The 
number of Africans living with HIV continues to rise due to general population 
growth, even though prevalence remains stable. Stabilisation of HIV prevalence 
occurs when the rate of new infections is equalled by the death rate among the 
infected population. This means that a country with a stable but very high 
prevalence must be suffering a very high number of AIDS deaths each year. 
 
To tackle HIV/AIDS in Africa is not an easy work. Many efforts are and will be 
needed. The long-term planning to slow the epidemic and reduce its impact needs be 
emphasized. One of the best and easy ways to cope with HIV/AIDS is prevention. 
Those prevention efforts that work in Africa and individual countries need to be 
identified and sustained. This also means enabling African people to protect 
themselves against infection.  
 
The difference of the AIDS epidemic in Asia is even greater than in Africa. Until the 
late 1980s, no Asian country had experienced a major AIDS epidemic, but by the 
late 1990s, the disease was well established across the region. The Asia Pacific 
region is vast and diverse. In addition to countries with varied epidemiological 
patterns of HIV and AIDS – high versus low HIV prevalence countries and different 
predominant HIV risk behaviours – countries in the region also have extremely 
diverse capabilities to develop and support public health prevention and control 
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programmes. Many Asian countries lack accurate systems to surveillance the spread 
of HIV. This means that the estimates of HIV infection in Asia are often based on 
less information than in other regions. The lack of research and information on the 
nature and linkages between sexual networks in Asian countries also makes it 
difficult to predict the future course of the HIV epidemic (UNAIDS, 2002-c).  
 
In Western countries, AIDS cases have fallen to levels not seen since the original 
outbreak; many attribute this trend to aggressive educational campaigns, screening 
of blood transfusion and increased use of condoms. Also, the death rate from AIDS 
in Western Europe and North America has fallen sharply, as new AIDS therapies 
have proven to be an effective means of suppressing HIV.  
 
The routes of transmission of HIV are different in Western countries, including 
commercial sex, MSM, IDU, mother to child and heterosexual sex. However, many 
new infections in this region occur through contact with HIV-infected individuals 
from other regions. The adult (15-49) prevalence in this region was 0.3% with 
between 570,000 and 890,000 people currently living with HIV (UNAIDS, 2005). 
Due to the availability of antiretroviral therapy, AIDS deaths have stayed low. 
 
  
Latest estimates showed some 8.3 million people were living with HIV in Asia and 
the Pacific region in 2005, including the 1.1 million people who became newly 
infected in the past year. AIDS claimed some 520,000 lives in 2005 (UNAIDS, 
2005). Combinations of risky sexual and drug-use behaviors are speeding the 
epidemic; authorities worry that current prevention strategies may not take this into 
account. Half of the world's population lives in Asia, so even small differences in 
the absolute numbers of people infected, can make huge differences in the infection 
rates. 
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1.2 HIV/AIDS Epidemic in China 
 
In 1985, a foreign tourist visiting southeast China became the first person in the 
country to be diagnosed with AIDS (Yuan & Li; 1997). Since the first detected case 
in 1985, the epidemic has been expanding continuously (See Table.1.2). By March 
1999, the cumulative reported number of people living with HIV/AIDS reached 
13,051, with a total of 419 AIDS cases and 226 AIDS-related deaths. As of 30 
September 2001, MOH reported a total of 28,133 people infected with HIV, of 
whom 1,208 had developed AIDS and 641 died (MOH, 2002). Up to the end of 
2005, the cumulative HIV-1 positive reported number was 141,241, with a total of 
32,244 AIDS cases and 7,933 AIDS deaths (MOH, 2006).  
 
 
 
 
Table 1.2 HIV/AIDS Epidemiological 
Situation in China 
Cases Year 
Year AIDS first reported:   1985 
Reported cumulative AIDS 
cases:  32,244 2005 
Reported cumulative AIDS 
deaths: 7,933 2005 
Reported cumulative HIV+: 141,241 2005 
Official estimates of current 
HIV +:  650,000 2005 
Source: MOH, China 
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China's HIV/AIDS epidemic is associated with illiteracy, poverty, population 
mobility, and gender inequality. Both prostitution and drug abuse boomed in the 
mid-1990s accompanying with the economic reform. The sharing of contaminated 
needles among injecting drug users is the most frequent mode of transmission of 
reported HIV-1 infections in China. The worst affected provinces tend to be along 
drug trafficking routes, especially the areas bordering the Golden Triangle. Both 
heterosexual and homosexual transmissions of HIV are also increasing. A vast 
migrant population of between 80 and 120 million people are moving away from 
home in search of better jobs and income, providing fertile ground for HIV's spread 
(Anderson et al, 2003). Migration, economic disparity, and poor knowledge of 
AIDS are important factors driving the epidemic, particularly among commercial 
sex workers. There are an estimated four to six million commercial sex workers in 
China, and condom use is relative low (Abrams, 2001). China's illegal blood trade 
has fuelled HIV/AIDS among the country’s rural populations (Beach, 2001).  
 
The HIV/AIDS pandemic continues to spread around the world at an alarming rate, 
and the number of people living with HIV will grow significantly by the end of the 
decade, as it becomes more geographically diverse. HIV/AIDS have also been 
spreading at an alarming rate in China, though the estimated adult prevalence rate of 
HIV/AIDS is still low (<0.1%) (MOH, 2006). However, considering only the overall 
national HIV prevalence can give misleading impressions, especially in countries 
with very large populations - like China and India - China is a country with an 
overall low HIV prevalence and concentrated epidemic in focused areas and focused 
groups of people, where millions of people can be affected while the prevalence in 
some groups is very high despite low national prevalence rate. While national 
scientifically valid data on current estimates and future trends remain incomplete, 
many national and international experts estimate that there were over one million 
HIV infections in China in 2001 (WHO, 2002). The overall figure of reported HIV 
infections remains relatively low, and is concentrated in particular regions, the 
majority of them is in rural area. However, the routes of transmission now cover 
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broad areas of the country.  
 
HIV/AIDS epidemic in China can be divided into four phases. The first phase, in 
1985~8, the first diagnosed case of AIDS was reported in 1985, included a small 
number of imported cases in east coast cities - mostly foreigners and overseas 
Chinese. Four haemophiliacs from Zhejiang province also got infected with HIV-1 
after using imported factor VIII. In 1987, China reported its first AIDS-related death 
of a Chinese person contracting AIDS in China. The victim was a 13-year-old 
haemophiliac boy who contracted AIDS from imported blood products (Xinhua, 
1987). In the same year, China reported its third AIDS-related death, a resident of 
Fujian province who had lived in Hong Kong and New York (Southerland, 1987).  
 
The second phase, from 1989 to 1993, began with finding HIV-1 infection in 146 
drug users among minority communities in Yunnan province in the south west, 
bordering to the “Golden Triangle”. In  November 1990, China announced the death 
of two Chinese men from AIDS. One of these men was a drug addict from Yunnan, 
and the other was a Beijing resident who contracted HIV-1 through sexual 
intercourse while traveling abroad (Toronto Star, 1990). Since 1985, China has 
confirmed that 446 people have contracted the HIV virus, of which 378 were 
Chinese. Some 368 of the Chinese carriers were from Yunnan. 
 
The HIV/AIDS case rate in China increased 117% over the period 1990-1992, from 
446 to 957 HIV infections. While the majority of cases in 1990 were localized in 
Yunnan among minority farmers, infection was found in 19 provinces, counties, and 
urban areas over a wider spectrum of society in 1992 (Gil, 1993). By the end of 
1993, Chinese health officials has reported that 1,159 people have tested positive for 
HIV, and at least 19 now have full-blown AIDS (14 AIDS patients have died) 
(MOH, 1995). 
 
The third phase was from 1994 to 1998, when a number of infections was reported 
among drug users and commercial plasma donors. Later, the virus spread beyond 
Yunnan and moved into Sichuan, Xinjiang and Guangxi. At the same time, the 
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number of reported cases for the whole country rose by 30%. Up to May of 1994, 
China reported 1,361 HIV carriers (of whom 255 were foreigners or foreign citizens 
of Chinese origin and 1,106 were Chinese), and 40 AIDS patients. These HIV 
positives and AIDS patients were found in 22 provinces and cities, including 
Yunnan, Guangdong, Beijing, Shanghai, Fujian and Zhejiang, with more than 85 per 
cent of the HIV positives in Yunnan Province (MOH, 1995). Before 1989, the 
persons infected with the HIV virus had been mainly people from abroad, but 
thereafter the incidence of mainland HIV carriers rose at a rapid speed. 
 
By 1998, HIV-1 infection had been reported from all 31 provinces, autonomous 
regions, and municipalities (Zhang & Ma; 2002). Underreporting was probably 
high; the estimated actual number of HIV-infection cases throughout the country 
may exceed 300,000 in 1998. A survey (Zhu, 1998) indicated that 89% of HIV-
infection cases were men; 11% were women. The age distribution was as follows: 
51% were 23 or younger; 40% were between the ages of 24 and 32; and 8.4% were 
age 33 or older. 70% living in large cities; 21% living in medium size cities; and 9% 
living in towns (MOH, 1998). 
 
From 1999 to the present is the fourth phase of HIV epidemic in China, during this 
period, the number of reported cases for 2000 was 37.3% higher than the numbers 
for 1999.This indicates that the virus spreads more quickly and in some regions of 
China, e.g.  Yunnan, the epidemic has moved into a critical phase.  
 
HIV/AIDS in China began as a highly localized and largely rural problem in Yunnan 
Province. From 1985 through 1994, However, HIV-1 infection and AIDS have 
become an emerging urban problem (Yu et al, 1996). Since 1997, China has moved 
from predominantly HIV epidemic among IDUs to a country facing a massive 
explosion of HIV.  It has spread along the various trafficking routes and has now 
transmitted into areas that were previously unaffected. In 2000, 70% of all HIV 
cases are due to IDU (MOH, 2001-b).  
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The highest prevalence rates have been reported in Yunnan, Xinjiang, Guangxi, and 
Sichuan, all western and southern provinces that locate on the drug route. UNAIDS 
reported “prevalence rates higher than 70 percent among injecting drug users in 
areas such as Yili Prefecture in Xinjiang and Ruili County in Yunnan.” (UNAIDS, 
2002-a). These statistics show the seriousness of the epidemic in these areas. 
 
An estimated 400,000 persons were living with HIV in 1998. The prevalence rate 
among people aged 15 to 49 years was less than 0.1%. However, only about 5% of 
estimated HIV/AIDS were reported (WHO, 1999). By March 1999, the cumulative 
reported number of people with HIV/AIDS reached 13,051, with a total of 419 
AIDS cases and 226 AIDS-related deaths. As of 30 September 2001, MOH reported 
a total of 28,133 people infected with HIV, of whom 1,208 had developed AIDS and 
641 died (MOH, 2002).  
 
In 2002, HIV/AIDS epidemic increased continuously, the national report on 
HIV/AIDS were 9,824, compared in 2001 a rise 19.5 %. Full-blown AIDS cases 
were 1,045, compared in 2001 an increase of  46.4%, 363 died. By the end of 2002, 
the national accumulative reported HIV/AIDS were 40,560 (MOH, 2003). HIV and 
AIDS have been spreading at an alarming rate in China, and it shows a big different 
geographic distribution of the accumulative number of HIV infection .  (Figure 1.1) 
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Figure 1.1 The geographic distribution of cumulative reported HIV cases in China 
1985- 2004 
source: WHO: A Joint Assessment of HIV/AIDS Prevention, Treatment and Care in China 
(2004) 
 
 
By the end of 2005, MOH reported accumulative total number of 141,241 people 
infected with HIV, of whom 32,244 had developed AIDS and 7,933 died (Figure 
1.2). The Chinese government currently estimates up to 650,000 Chinese citizens 
may be infected with HIV (MOH, 2006).   
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Figure 1.2 Annual Report HIV/AIDS in China (1985~2005) 
Source: MOH, China 
 
 
 
 
In August 2001, the Chinese Government finally admitted that the country was 
facing a serious AIDS crisis. Previously,  the Chinese Government did not like 
recognizing this problem because of the social value and ideology, and the extent of 
the Chinese epidemic had been unknown. Now government officials estimate that 
the total number of people infected with HIV is around 650,000 (MOH, 2006). The 
ratio of male to female HIV prevalence was 9/1 between 1991 and 1995, and 4/1 in 
2001, the number of female HIV prevalence has been increasing continuously (See 
table 1.3).  
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Table 1.3 Adult HIV data and estimates for China (1990~2005) 
 
 1990- 
1995 
1996- 
1997 
1998- 
1999 
2001 2003 2005 
Estimate total adult HIV 
(thousand) 
10 100 500 800- 
1,500 
840 650 
Adult HIV prevalence <0.002% <0.02% <0.1% <0.2% <0.1% 0.05% 
Male/Female ratio 9:1 7:1 5:1 4:1 1.5:1 1.5:1 
Male HIV prevalence <0.01% <0.05% <0.2% <0.5% / / 
Female HIV prevalence <0.001% <0.01% <0.02% <0.01% / / 
Source: MOH, China, State Council 
 
Unlike in other developing countries, centralism is the major characteristics of 
Chinese politics, in the field of economy, the major challenges are associated with a 
transition from a centrally planned economy to a market economy and from a rural 
to an urban economy and with social changing (UNDP, 1999). These changes have 
also been associated with changes in social values and HIV-risk behaviours; social, 
cultural factors have influence on the behaviour that is at the central point of HIV 
transmission. These factors explain why there are significant differences among 
different population groups at the level of HIV prevalence and the rate of its 
transmission. The emergence and wide spread of HIV in China can be well 
understood in the context of the country’s socio-economical changes, which have 
played a role on behaviours such as the use of injectable drugs and prostitution, 
STDs are exponentially increasing throughout the country as well.  
Especially, a growing floating population is also a main factor in the increase and 
spread of socially changing and epidemiological high-risk behaviour in China 
(Thomas, 1998). A number of factors make migrant workers particularly more 
vulnerable to HIV infection. Migrant workers are often young, lower educated,  and 
living for a long period away from their families and communities. They are often 
unmarried or live apart from their spouses and children. They tend to have more 
available cash money than they were used to having in rural areas. All these factors 
make them likely to have sexual interaction with casual partners, in some cases with 
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commercial sex workers. 
 
HIV has always been associated with the movement of people. Migration makes 
personal contact more easily and mixes different population groups together, which 
provides a loose environment for viral transmission. Through the movement of 
infected persons, migration can also offer a easy way to transport diseases to places 
where they are previously virgin. Population mobility is not only a transporter of 
HIV; it also causes broader social and behavioural changes that make transient 
migrants particularly susceptible to HIV infections (Yang, 2001).  
 
Injecting drug use is the major mode of HIV infection in China. It accounts for 
about 70% of total reported cumulative HIV infections. Transmission of HIV 
through blood and blood products and plasma donation was also a severe problem in 
China in a special period in 1990s. In recent years, the number of HIV infections 
caused by heterosexual contact is increasing. In general, the infection rate through 
sexual transmission is still low, but the rate of increase for annual reported STD was 
about 30%. In 1999, 837,357 STD cases were reported (Gong et al, 2000). The 
actual number of new STD cases was estimated at about six millions people and it is 
estimated that sexual transmission will become the major mode of HIV transmission 
among the general population in the future. 
 
The HIV/AIDS epidemic in China has the following characteristics. 
¾  The spread of the epidemic is fast. Since 1995, the spread of the HIV/AIDS 
has speeded and the newly discovered HIV positives increased by 30 per 
cent per year in 1995-2000 (MOH, 2001-a).  
¾ The HIV/AIDS epidemic is more serious in the rural regions. The HIV/AIDS 
epidemic has spread to all provinces, autonomous regions and municipalities 
of China and the worst cases are found in the west and south-west areas 
where socio-economical level is very low in comparison to other regions in 
China. Among the 10 provinces and regions where the HIV/AIDS 
prevalence rates are the highest, 7 are in the economically underdeveloped 
regions in the middle and western parts of China. It is estimated that 80 per 
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cent of the infections are in the rural areas (MOH, 2006).  
¾ People at young ages are threatened by this epidemic most severely. Among 
the HIV/ AIDS cases in China, more than half of them (51.9%) are aged 20-
29; the next is the age group 30-39, 30.6 per cent. These two age groups 
together comprise of 82.5 per cent of all HIV/AIDS infections (SFPC, 2002).   
¾ The main channel of infection is the intravenous drug injection, but 
infections through sexual transmission are also on the rise. In 2000, the 
proportion of infection through intravenous drug injection was 66.5 per cent 
of the total reported cases, slightly lower than that in 1999 (MOH, 2001-b). 
In 2005, the epidemic data showed, 44.3% of HIV infection was through 
IDU, and 43.6% was through sexual transmission (MOH, 2006). Infections 
through sexual transmission are clearly rising.  
 
China has made remarkable achievements in improving the health status of its 
population since 1949 (Abrams, 2001). These achievements were made much faster 
than the rate of economic growth and with far less resources than most 
countries.  However, there is good evidence that this progress has slowed since early 
1980s, despite accelerating growth of the economy and personal income levels. 
Furthermore, the discrepancy in health status between the richer coastal areas and 
the poorer inland provinces has become worse. At the same time, the country is now 
facing newer health problems including those associated with economic growth and 
breakup of former national social insurance system. 
 
It is extremely difficult to project the future trend of the HIV/AIDS epidemic in 
China which has such a huge population, as well as the big difference between the 
rural areas and the urban cities and reliable statistic data on HIV/AIDS are difficult 
or impossible to get.  UNAIDS maintains the most comprehensive databases of 
information in the world on AIDS, but the UN organization relies on official 
government statistics from every single country—which experts believe sometimes 
understate the number of infected people (UN, 2003). Whatever the number of 
people with HIV finally reached in China, it can be expected that there will be a 
corresponding explosion in the number of people with AIDS in future years, since 
 16
Dissertatation: national  HIV/AIDS second generation surveillance on drug users in China, 2005 
AIDS cases are actually corresponding to the number of HIV infections of five to 
ten years earlier. Similar epidemic increases can be expected in the diseases closely 
associated with HIV infection and AIDS, such as TB and other opportunistic 
infections.  
 
Increasing rate of HIV infections among commercial sex workers in several 
provinces, many of whom inject drugs, is beginning to form a bridge to the general 
population, added by low condom use and little knowledge of  HIV/AIDS. The 
rapid rise of commercial sexual behaviour and sexual transmitted diseases not only 
negatively impacts the physical and mental health of young women, but also helps 
the transmission of HIV. Simultaneously, after a quasi-absence during some 20 
years since 1960s, STDs are recognized again as a growing public health issue in 
China. In fact, STDs are increasing rapidly throughout the whole country. 
Gonorrhea remains the most prevalent STD, but syphilis, condyloma acuminatum, 
and nongenital urethritis are also on the increase. STDs today constitute a major 
public health problem in China. This resurgence accompanies by the marketing 
economy, the breakdown of the national health insurance system, the return of 
prostitution, and other factors (Abrams, 2001).  
 
The current rapidly increase in STD numbers is clearly an indicator for the 
increasing risk of sexual transmission of HIV. Of particular importance is the 
seriousness of the STD epidemic in a number of provinces in southern China. In 
Fujian, Guangdong and Hainan, syphilis is spreading fast, with reported numbers 
quadrupling yearly since 1994. For instance, in Guangdong, reported STDs have 
increased from 77,728 to 90,066 from 1994 to 1996. The reported syphilis increased 
from 286 in 1994 to 4,179 in 1996 and to 7,001 in 1997 (MOH, 1996, 1998). 
According to surveys of customers of prostitutes done in Yunnan, no HIV infected 
patient was found between 1995 and 1997. A cohort study showed that HIV 
prevalence among spouses of HIV infected persons increased from 3.1% in 1990 to 
12.3% in 1997 (MOH, 2000-a). Increasing rate of HIV infections among 
commercial sex workers in several provinces, many of whom inject drugs, is 
beginning to form a bridge to the general population, accompanied by low condom 
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use and lack knowledge of  AIDS. 
 
Due to widespread drug use and commercial sex, China is still facing an increasing 
danger of HIV/AIDS epidemic (UNAIDS, 2002a). China needs to spend more 
money and effort in HIV/AIDS prevention and control in order to avoid heavy 
economic losses due to a widespread epidemic. The spread of AIDS will not only 
cause the increasing of medical fees, expenditure on preventive campaigns and the 
cost of labour loss, but also slowdown of the national economy. Now China must 
consider the AIDS issue from the perspective of the whole national development. 
 
It is clear China now faces a large, rapidly growing and more complex HIV/AIDS 
problem that carries potential risks for the country’s future development. HIV/AIDS 
has spread from China’s borders to inland areas, and from rural to urban, and again 
from urban to rural areas. The majority of HIV infected persons and people around 
them, however, does not know their HIV status. It is urgent to take action now; 
otherwise this opportunity to control the AIDS epidemic in China will be lost. 
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1.3 HIV/AIDS Surveillance 
 
Surveillance refers to a number of different systems used to track the incidence (new 
occurrences) and prevalence (total existing cases) of a particular disease. Incidence 
and prevalence are two basic epidemiological definitions used to explain the extent 
of particular disease. HIV surveillance is the systematic collection of information on 
the occurrence, distribution and trends of HIV infection among specific population 
groups on an ongoing basis. Policies and programs concerning the accessibility and 
requirements for HIV testing are also a part of surveillance. Continual HIV 
surveillance data provide useful information to estimate HIV prevalence in select 
populations, to monitor trends in HIV prevalence in these populations, and to guide 
and evaluate the planning and implementation of HIV/AIDS prevention and 
intervention programmes (UNAIDS/WHO, 2000). 
 
Since the first emerge of HIV/AIDS, HIV/AIDS surveillance has branded with 
complexity, with advocates, public health officials, and government agencies often 
differ on such issues such as reporting for HIV infection, contact tracing, and testing 
of pregnant women. Now, HIV surveillance becomes a core function of national 
HIV/AIDS programmes. Surveillance data on HIV infection are important for 
various reasons, but most importantly to trace the spread of HIV both within 
different populations in countries as well as across different geographic regions 
(WHO, 1988). Accurate data are not needed for most purposes, as long as the 
general trends and the extent of magnitude of the existing infection can be 
measured; and sometimes, it is really hard to get precise data. However, for some 
purposes, such as measuring the impact of specific interventions, or for testing the 
efficacy of vaccines and treatments, precise data must be obtained. 
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AIDS cases reporting has been used as the primary AIDS surveillance tool since the 
epidemic was identified in 1981 in USA. WHO has requested countries to submit 
regular reports on cases of AIDS since then (WHO, 1988). Updates on aggregated 
information by sex, age and presumed mode of transmission are collected in a yearly 
round. The reported AIDS figures give a useful general overview but cannot be 
assumed to give an accurate or strictly comparable picture of the epidemic in 
different countries, because the method used to detect, diagnose, and report of AIDS 
is not universal even in the same country. Almost all countries have set AIDS case-
reporting systems now, but the quality of the AIDS case reports varies significantly. 
The considerable variation in the percentage of AIDS cases that are reported to 
WHO from different countries reflects differences in the quality and extent of 
available services and testing facilities and the extent to which the population has 
access to and uses the facilities, it is also co-related with local socio-economic 
status. 
 
HIV sentinel surveillance is the main epidemiological tool used to monitor trends in 
HIV infection prevalence in various population groups. This is HIV screening of 
selected population groups in the population, including those who are easily 
accessible, such as pregnant women (whose blood is routinely taken for other 
reasons ) and people thought to be at high risk of HIV infection. This may include 
men who have sex with men (MSM), injecting drug users (IDUs), sex workers and 
people attending sexually transmitted infections (STI) clinics. Surveillance is 
usually conducted repeatedly at the same sites at regular intervals (serial 
surveillance) to indicate how levels of infection are changing over time in specific 
areas and certain population groups. HIV prevalence in the general population and 
among those at lower risk is also important indicator of the parameters of the 
epidemic. HIV sentinel surveillance can provide more accurate indications of trends 
of HIV infection in the selected population groups and sites, particularly when 
conducted regularly at yearly intervals. HIV sentinel surveillance is a relatively 
simple and cheap epidemiological tool. Its flexibility and low cost make it feasible 
and sustainable even in resource poor areas. 
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The UNAIDS/WHO Working Group on Global HIV/AIDS and STI Surveillance 
has developed coding schemes to represent four dimensions related to the quality of 
surveillance systems (Walker et al, 2001; Garcia-Calleja et al, 2004):” 
• Frequency and timeliness of data collection; 
• Appropriateness of populations under surveillance; 
• Consistency of the sites/locations and groups measured over time; and 
• Coverage/representativeness of the groups for the adult populations.” 
 
The coding schemes depend on the different level of the HIV epidemic in a country. 
The levels are defined as generalized, concentrated and low according to the HIV 
prevalence in general population and in defined risk population groups. 
 
Case report, contact tracing and testing of pregnant women and infants comprise of 
American HIV surveillance system (Collins, 2001). States report the names and 
demographic information of people diagnosed with AIDS to the federal Centers for 
Disease Control and Prevention (CDC) since the beginning of epidemic, where 
national figures on the AIDS epidemic are tracked. Though AIDS surveillance is 
often referred to as the "gold standard" for HIV/AIDS surveillance, it is nonetheless 
also recognized as an incomplete representation of the epidemic in America. Newly 
diagnosed cases of AIDS can only state when people are transitioning from 
asymptomatic HIV positive to full-blown AIDS. Information about the incidence of 
new infections could not be obtained by AIDS case reports.   
 
HIV incidence information could greatly help prevention planners to allocate 
prevention resources and target risk population groups. Contact tracing is a 
traditional public health tool used to identify and contact individuals who may have 
been exposed to an infectious agent, such as HIV or other STDs. In 1998, CDC 
issued guideline on HIV partner counseling and referral services (PCRS). It defined 
the goals of PCRS as providing services to HIV-infected persons and their sex and 
needle-sharing partners so they can avoid infection, or, if already infected, 
preventing transmission to others, and helping partners gain earlier access to 
counseling, testing, medical evaluation, and treatment. Test of pregnant women and 
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infants is a routine component of prenatal care. Women are informed that a HIV test 
is being conducted and they would retain the right to refuse to be tested.  
 
HIV infection is also an important public health issue in Europe, though HIV 
prevalence in most west European countries is very low, evidence shows that sexual 
transmission of HIV is  increasing in many western and eastern European countries. 
AIDS reporting has been the principal means of monitoring the HIV/AIDS situation 
in Europe since 1989 (EuroHIV, 2004,2005). HIV reporting was set up at the 
European level in 1999, although it has existed in most west European countries 
since 1980s. Anonymous individual data on AIDS and, if available, new HIV 
diagnoses, and data on HIV prevalence in various populations are reported from the 
51 countries of the WHO European Region to EuroHIV. EuroHIV Data are 
presented after grouping the 51 countries into three geographic areas: the West, 
Center, and East. At middle of 2005 (EuroHIV, 2005), in the West, AIDS incidence 
continued to decline except among those infected heterosexually; numbers of newly 
diagnosed HIV infections are relatively stable, but rising among heterosexually 
infected persons, many of whom originate from countries with generalized HIV 
epidemics. In the East, numbers of newly diagnosed HIV cases (mostly IDUs) 
continue to rise steeply, particularly in the Russian Federation, Latvia, and Estonia 
(EuroHIV, 2005). In the Center, levels of HIV and AIDS remain low.  
 
HIV/AIDS case reporting is becoming a core element of HIV/AIDS surveillance in 
Europe. However, at the European level, data standardization is still a challenge 
because various health care systems between European countries and different HIV 
testing and surveillance systems. Efforts should be made to use surveillance data for 
evaluating the effectiveness of HIV/AIDS prevention and intervention programmes. 
 
Globally, sub-Saharan Africa is the hardest hit region. In the fact, all countries in the 
WHO African Region have generalized epidemics, which are defined as HIV 
prevalence is equal or over 1% of pregnant women attending antenatal clinics in the 
urban areas. Ironically, sub-Saharan Africa has some of the best HIV surveillance 
systems in the world. HIV sentinel surveillance systems have been built in the early 
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1980s (WHO, 2001-b). About 70% of the countries in the region are implementing 
HIV sentinel surveillance systems with pregnant women attending antenatal care 
clinics (ANC attendees) being the main sentinel population, because HIV epidemic 
is already generalized there and the major mode of HIV transmission is heterosexual 
contact. Pregnant women are set as reference group, because pregnant women are 
sexually active, constitute an easily definable, accessible and stable population, and 
are fairly likely to represent the general population. Other sentinel populations that 
have been used are STI clinic attendees and TB patients. Surveys are conducted 
once a year or once every two years. 
 
HIV sentinel surveillance data have used to map the epidemic and monitor HIV 
infection trends in countries in the region as well as serving as an advocacy tool. To 
some extent, countries have evaluated sentinel data for planning and evaluating HIV 
interventions. While sentinel surveillance may help to map and determine levels of 
infection, it does little to explain the current trends, so that second generation 
surveillance was recommended by UNAIDS and implemented (UNAIDS, 2002-d). 
Compare to previous sentinel surveillance that only focus on HIV sero-prevalence, 
HIV/AIDS second generation surveillance combines HIV sero-surveillance and 
behavior surveillance. 
 
Countries are being encouraged to strengthen the existing HIV sentinel surveillance 
systems and linking the system with behavioral surveillance, using population based 
HIV prevalence surveys to calibrate and complement the systems. 
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1.4 HIV Surveillance in China 
 
HIV surveillance system in China  mainly  includes HIV/AIDS case reporting 
system and HIV sentinel surveillance system, there are also a number of special 
studies focusing on HIV infection related behaviours as supplement (CDC, 
China/CDC; 2002). HIV/AIDS reporting was set up at the national level since 1985.  
In 1985, a foreign tourist visiting southeast China became the first person in the 
country to be diagnosed with AIDS (Yuan & Li; 1997). The official notification of 
HIV/AIDS cases became a legal requirement in 1989 (NCAIDS, 2004). HIV/AIDS 
case reproting is a passive HIV surveillance tool, the reported AIDS figures give a 
useful general overview but cannot be expected to give an accurate picture of the 
epidemic in different regions and in different population groups. With the advent of 
powerful new AIDS treatments, called highly active anti-retroviral therapy 
(HAART), the limits of AIDS reporting became even more significant. With 
increasing numbers of people receiving early treatment for HIV and slow the 
progression to AIDS, reporting of AIDS cases became an increasingly inaccurate 
representation of the current epidemic.  
 
 
Comparatively, HIV sentinel surveillance could provide more accurate information 
of trends of HIV infection in the selected population groups and sites, particularly 
when conducted regularly at yearly intervals. HIV sentinel surveillance is a 
relatively simple and cheap epidemiological tool. Its flexibility and low cost make it 
feasible and sustainable even in resource poor regions. China launched HIV sentinel 
surveillance system in 1995 (Xinhua News Agency, 2003). In 1999, in response to 
these expanded needs for data collection, WHO and UNAIDS in collaboration with 
other international partners were promoting the improvement of surveillance 
systems based on the “second-generation” approach. This approach integrated 
biological surveillance — i.e. HIV sentinel surveillance, reporting of AIDS cases, 
and surveillance of sexually transmitted infections (STIs) — and behavioural 
surveillance, it is comprised the core component of current surveillance systems 
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(UNAIDS/WHO, 2000). The core of second-generation systems is to strengthen and 
improve the existing surveillance systems. Surveillance efforts are targeted at the 
population groups in which most new infections occurr, which might change 
depending on the stage and level of the epidemic. Second-generation systems enable 
HIV sero-surveillance and behavioural data to be used and compared concurrently, 
allowing national programme managers not only to better understand and explain 
the observed trends in the HIV epidemic but also to better assess the impact of 
national AIDS control programmes. 
 
WHO and UNAIDS published „practical guidelines: initiating second generation 
HIV surveillance systems“ in 2002 (UNAIDS, 2002-d). The guidelines particularly 
emphasized that the first step is to implement second generation surveillance 
systems based on the existing surveillance systems. These include assessment, 
consensus, plan and protocol development, implementation, and monitoring and 
evaluation. Second generation surveillance systems monitor risk behaviours, using 
them to warn of or explain changes in levels of infection. Therefore, second 
generation surveillance uses data from behavioural surveillance to explain the HIV 
sero-prevalence data. 
 
 
The guidelines also emphasized the importance of effective coordination between 
surveillance and prevention programmes, since second generation surveillance is 
designed to provide essential data for the development of intervention and 
prevention strategy. They also recommend a range of surveillance strategies 
according to different types of HIV epidemic. In generalised epidemics, surveillance 
should concentrate on monitoring HIV infection and high-risk behaviour in the 
general population, such as antenatal pregnant women, and also include in-risk 
groups such as sex workers. In concentrated epidemics, surveillance should focus on 
monitoring infection and behaviour in higher risk groups, paying particular attention 
to behavioral links between members of those groups and the general population, so 
called bridge population such as sex worker clients, drug users who engage in 
unprotected sex. In low-level epidemics, surveillance should focus largely on 
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behaviours and HIV infection in groups at high risk, looking for changes in 
behaviour that may lead to an increase in the rate of infection. 
 
 
China set national sentinel surveillance system in place since 1995,  as a part of the 
campaign to fight against HIV/AIDS epidemic， the system has recorded large 
geographical differences in the distribution of infections in China, with some 
provinces recording very high prevalence rates in at-risk populations, while others 
report virtually no infections (China CDC/CDC, 2002). Surveillance systems are an 
integral part of an overall national framework in dealing with HIV/AIDS. 
HIV/AIDS surveillance systems collect important data of HIV prevalence and risk 
behaviors related to HIV infection, which are used to evaluate HIV/AIDS epidemic. 
Data help government and health partners to plan prevention and intervention 
strategies and target various approaches. Data collected are used not only at the 
national level in planning policy, but also at the local level as well. The better the 
quality of data, the better the ability of authorities and health partners to identify and 
target behavioral changes. Traditional surveillance systems tracked HIV infection or 
other biological markers of risk such as STIs. Since HIV infection among adults is 
closely related to a limited number of behaviors, such as unprotected sex with an 
infected partner or injection with contaminated needles, we know that if these 
behaviours change, there will be a change in the spread of HIV.  
 
 
Since 1999, China began conducting behavioral surveillance (second generation 
surveillance) that targeted high-risk groups, vulnerable groups and the general 
public (NCAIDS, 2001). This was followed by epidemiological surveys among the 
high-risk groups. China now has in place a surveillance network that covers all 31 
provinces, autonomous regions and municipalities. Much more information than in 
the past is now available on epidemiological trend and risk behaviour. 
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In 2004, 42 national-level HIV surveillance sites among 6 population groups have 
been established in 19 provinces, on-site survey was accomplished from September 
through November 2004, surveillance data were reported through national net-based 
directly reporting system. China CDC and provincial CDC organize national and 
provincial sentinel surveillance respectively. Up to the end of 2005, there were 
totally 105 comprehensive (second generation surveillance) national sentinel sites 
focusing on drug user, FSW, STD clinic clients, MSM, male long distance truck 
drivers and students (China CDC, 2005). 
 
Since 2006, HIV/AIDS net direct reporting system was initiated in China, all 
identified HIV infections and AIDS cases are reported directly to China CDC 
through a net-based online system, an electrical form including demographic 
information such as gender, age, nation, resident place, and HIV/AIDS related co-
infection and symptoms/syndrome was used (China CDC, 2006).  
 
Although HIV and AIDS case reporting has many limitations, it should be 
continued, because: 
♦ it is a good advocate instrument; 
♦ for emerging epidemics, it could provide an early warning; 
♦ it also helps to monitor trends and draw estimates and projections in some 
extent; 
♦ it helps to calculate the burden of AIDS on the health care system. 
 
According to the different HIV/AIDS surveillance activities that are implemented in 
China, HIV/AIDS surveillance could be divided into three phases: 
• Passive surveillance  (1985-1994) : HIV/AIDS cases were reported through 
the National AIDS Case Reporting System as well as the National Case 
Reporting System for Infectious Diseases. 
• Active surveillance (1995-1998): HIV sero-prevalence surveillance, 100 
national sentinel sites were established nationwide to monitor the DU  
population, STD patients, FSWs, and long-distance truck drivers. 
 27
Chapter I: Introduction and Background 
• Second generation surveillance (1999-Now): Second generation surveillance 
systems include HIV and STI surveillance and monitor risk behaviours, 
using them to explain the correlation between HIV infection and risk 
behaviours.  Target Groups for second generation surveillance include 
(China CDC,  2005): 
• High Risk Groups – Underground CSWs,  DUs, MSM, and STDs 
Clinics Attendees 
• Vulnerable Groups – LD Truck Drivers 
• General Groups – College students 
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1.5 Drug Users in China 
 
 Drug use continues to have a major impact on the global HIV/AIDS pandemic, both 
through injecting drug use, and through unsafe sexual contact. HIV is transmitted 
very efficiently through blood transfer, thus, needle sharing among injecting drug 
users (IDUs) is extremely risky. HIV can be easily transmitted by sharing infected 
injecting equipment, so IDUs are a group who are disproportionately affected. It is 
not only IDUs however, at risk of exposure to HIV; non-IDUs are also susceptible 
through unprotected sexual contact (UNAIDS; 2000).  
 
There are many different type of drugs that used in the world and the popularity of 
each varies around of the world. It is estimated that in 2004, 4% of the worldwide 
population used cannabis, 1% used amphetamine type stimulants, cocaine, or 
opiates (Heimer/Kaplan, 1992). It is estimated that one tenth of HIV infections are a 
result of needle sharing and it is estimated that there are 13.2 million IDUs 
worldwide (Aceijas et al, 2004), with around 80% living in developing countries 
(Riley et al, 2005). In a number of countries, HIV infection through needle sharing 
is the dominant transmission route. In Russia for example 80% of HIV positive 
people were infected by needle-sharing (Coalition ARVS4IDU, 2004). Besides HIV 
virus, sharing needles among IDUs is also a very efficient and direct way of 
spreading other blood-borne viruses such as hepatitis B and C. Injecting drug users 
have been accounted as the groups that most affected by HIV/AIDS since the 
epidemic began.  
 
Around 10% of HIV infections globally are directly a result of transmission through 
injection; this was about 4 million at the end of 2005 (Riley et al, 2005). The worst 
affected areas for infection through contaminated needles are Eastern Europe, 
Central Asia, most of Southern Asia, North Africa (Coalition ARVS4IDU, 2004). 
Around 25% of all injecting drug users live in South and South-east Asia, and a 
further 18% in East Asia. Each of China and India is home to more than a million 
IDUs. The world's highest rates of HIV infection among IDUs are found in Asia. By 
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1999, IDU comprised about 77% of HIV infections in Malaysia and 69% in China, 
and 66% of AIDS cases in Viet Nam (UNAIDS, 2000; Coalition ARVS4IDU, 2004).. 
 
HIV transmission in China has been mainly due to misuse of injectable drugs and 
unprotected sexual contact. Moreover the current epidemic of STD in China is 
fuelling the AIDS epidemic. IDU is the major mode of HIV transmission in China. 
Historically, the term 'drug abuse' referred to the smoking of opium in China. Heroin 
abuse first emerged as a problem in China’s southern border province Yunnan in the 
late 1980s, which is adjacent to the opium-growing “Golden Triangle” regions of 
Myanmar, Thailand, and Laos (Zhang & Ma, 2002; UNAIDS, 2000).  
 
Now,  the practise from non-injecting to injecting drug-use is increasingly common, 
because injecting drug is a more cost- effective way to experience the effects of the 
drug (UNAIDS, 2000). Incomplete statistics showed the number of registered users 
to be 148,000 in 1991, 250,000 in 1992. The National Narcotics Control 
Commission reports in June 1994 that China has 250,000 registered drug users; 
1,361 persons were exposed to the AIDS virus, among them over 80 percent were 
drug addicts. In 2003, the number of registered drug users was 1.05 million of which 
643,000 used heroin; in which 74 percent of drug users were under the age of 35 and 
80 percent of detained female drug users were also engaged in commercial sex (Luo, 
2004). By the end of 2004, there were totally 1.14 million registered drug users in 
China (NNCC, 2002, 2005; Liu et al, 2006-a; Chu & Levy, 2005) (See Figure 1.3). 
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Figure 1.3 Registered drug users in China (1990-2004) 
Source: NNCC, Liu et al, 2006-a; Chu & Levy, 2005 
 
Widespread IDU was an early source of HIV infection in China especially in the 
southern provinces that border the opium-growing “Golden Triangle” regions. The 
geographic environment and the large market for drugs make it very difficult to 
eliminate and control drug use effectively.  
 
An explosive HIV epidemic among IDUs in southwest China was mainly due to  
rapid increase in heroin injecting in this population. The proportion of injecting drug 
among all drug users is relative higher in China, a study in central China found 
45%-92% of all drug users in 4 cities once injected drug (Cheng et al, 2003). The 
rapid increase in heroin injecting in this population appears to have triggered an 
explosive HIV epidemic among IDUs in southwest China (Xiao et al, 2007).  
 
Risk behaviours among IDUs are mainly due to needle-sharing, and unprotected sex 
among drug users and their partners (Zheng et al, 1994). And with respect to the 
rapid spread of HIV among drug users, the really risky behaviour is needle sharing. 
Most drug users in China tend to be young, less educated, unmarried, and without a 
stable occupation; these factors lead this population group to engage most likely in 
risk behaviours, such as injecting drug and unprotected sex. Although typically 
male, the proportion of female drug abusers has increased rapidly in the last decade 
(Tucker et al, 2005; Qian et al, 2005). Concurrently, drug abuse also has moved 
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from being concentrated almost exclusively in the low-income and less educated 
level of Chinese society to all of its social levels. 
 
MOH reported that by the end of 1989, HIV/AIDS has been reported in 10 
provinces and regions, the number of HIV cases in China has risen to 194, of which 
three foreigners had developed AIDS. The sharp increase was due to HIV testing 
among drug users in Yunnan province.  These tests revealed 146 cases of HIV 
infection in Yunnan (Zheng et al, 1994).  This was the first time China has traced 
HIV/AIDS cases among drug users in remote areas. From 1985 to 1990, a total of 
446 cases have been confirmed HIV positive and five (two Chinese citizens and 
three from outside China) have progressed to AIDS. Of the 446 cases, 378 were 
Chinese citizens and 68 were from outside China.  Of the 378 Chinese citizens, 368 
were from Yunnan and all were related to the sharing of needles (MOH, 1995). 
 
The sharing of needles is a highly effective mode of HIV transmission, and HIV 
prevalence among IDUs was found to range between 44% and 85% in selected 
communities of drug users in Yunnan and Xinjiang provinces. In 1995, survey 
results found no HIV infection among drug users in 8 sentinel surveillance sites. In 
February 1996, MOH reported China's drug user population was increasing rapidly. 
In 1998 however, HIV infection had been found in 17 of 19 sentinel surveillance 
sites. HIV infection prevalence rates among drug users in Urumqi had increased 
from 0% in 1995 to 28.8% in 1998; in Guangxi and Guangdong, from 1% in 1997 to 
12.8% and 10.4% respectively, and 17% in Jiangxi in 2000. The highest HIV 
prevalence rate was 82.2% among drug users in Yining city (MOH et al, 2000-a). 
 
Up to June 1998, two thirds of reported HIV infection cases lived in rural China, 
and nearly one third of the 301 people diagnosed as having AIDS have died. About 
10% of all HIV infections occurred among teenagers under age 19 years old, with 
most infected through intravenous drug use (Zha, 1998). There have been reports of 
an increase in the sharing of equipment by drug users, increasing from 32% in 1999, 
to 34% in 2000, and to 45% in 2001 (MOH, 2001-b). Nine provinces are now on the 
edge of IDU-related HIV epidemics due to very high rates of needle sharing. 
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Increasing rate of HIV infections among commercial sex workers in several 
provinces, many of whom inject drugs, is forming a bridge to the general 
population, speeded by low condom use and little knowledge of  AIDS. Yunnan 
suffered first HIV epidemic in China, and accounted the biggest number of HIV 
infection in China. There are a number of sentinel sites that HIV prevalence among 
IDU is relative higher, for example, Xinjiang Yining 84%, Yunnan Ruili >80%, 
Sentinel sites in Guangdong 21%, Guangxi Baise over 30% (MOH, 2000-b)  (See 
Table 1.4). 
 
Table 1.4  Provinces and sites with highest HIV infections rates among IDU (2000)
Provinces Sites/Rates 
Xinjiang Yining 84% Urumqi 39% 
Yunnan Ruili > 80% Wenshan 75% Kaiyuan 58% Yingjiang 70% 
Guangdong Sentinel Site: 21% 
Guangxi Baise 30%~40% Pingxiang 12% Liuzhou 12% 
Jiangxi Sentinel Site: 17% 
Source: MOH, China CDC 
 
By the end of 2003, it was estimated totally 840,000 people were living with 
HIV/AIDS, IDU accounted for about 70% of total reported cumulative HIV 
infections. The number of provinces that have reported HIV infections among IDUs 
increased from one province in 1994 to 21 provinces in 1999 (China CDC, 2003). 
Outbreaks of HIV infections have been reported among IDUs in Yunnan, Xinjiang, 
Guangxi, Sichuan, and Guangdong provinces and autonomous regions.  HIV 
infection rate among IDUs has reached 20%--30% in some areas in these provinces, 
and about 60%--80% in Ruili, Yunnan Province and Yining, Xinjiang Autonomous 
Region. Large numbers of drug users continue to share equipment (73% in Hunan, 
81% in Jiangxi and 100% in Xinjiang) (China CDC, 2004/MAP, 2005). By the end 
of 2005, there were approximately 650,000 people living with HIV/AIDS in China; 
in which 288,000 were  drug users living with HIV/AIDS, accounting for 44.3% of 
the total number of estimated HIV cases (MOH, 2006). 
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1.6 HIV/AIDS Epidemic in Yunnan  
 
Yunnan is one of the areas of China with alarmingly high rates of drug use. Yunnan 
province experienced the first HIV/AIDS epidemic in China, among mainly 
injecting drug users in rural communities close to the borders with Myanmar, Lao 
PDR and Viet Nam. The south-eastern region of Yunnan is a key site for durg 
trafficking and HIV-1 infection spread from the west of Yunnan to other regions of 
inner province and outer province. HIV/AIDS is spreading rapidly across the 
province and from minority national groups into the Han majority population (Xiao 
et al, 2007). 
 
Yunnan also has one of the highest prevalence rates of HIV/AIDS infection. 
Intravenous drug use and sharing of needles are the primary causes of HIV/AIDS 
transmission in the region. It is estimated that 70% of the HIV infections in Yunnan 
are due to injecting drug use (Pan et al, 1997). Drug use negatively impacts not only 
to the users themselves, but also their families, their communities and society. The 
continued high prevalence of drug use also causes additional health problems, not 
only the acceleration of the spread of HIV/AIDS, but also increase the financial 
burden on limited health resources. 
 
From 1985 to 1990, a total of 446 cases have been confirmed HIV positive and five 
(two Chinese citizens and three from outside China) have progressed to AIDS. Of 
the 446 cases, 378 were Chinese citizens and 68 were from outside China.  Of the 
378 Chinese citizens, 368 were from Yunnan and all were related to the sharing of 
needles (MOH, 1995). In 1993, China opened its first AIDS hospital in Ruili City, 
Yunnan.  The Chinese government decided to place the hospital in Yunnan province 
because Yunnan has had the largest number of HIV cases in China, and Ruili City 
had the largest number of HIV cases in Yunnan at that time. Up to 1993, China has 
had 1,106 confirmed HIV cases, 850 of whom were located in Yunnan, and Ruili 
City has had 425 confirmed HIV carriers. Yunnan province has had four confirmed 
AIDS patients, three of which have already died (MOH, 1995).  
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Up to 1994, MOH reported that 1,453 have tested positive for HIV since the first 
case was detected in 1985. 22 of China’s 31 provinces, autonomous regions and 
municipalities have reported cases of HIV infection. Of all China’s registered HIV 
infections 1,174 were Chinese, of which 70 percent where infected through 
intravenous drug use (MOH, 1995). However, only high-risk groups were being 
tested.  
 
In Yunnan, HIV has spread beyond the initial IDU epidemic in Dehong Prefecture 
to resident populations throughout much of the Province. People living with 
HIV/AIDS were found in all 16 prefectures and in 111 counties by the end of 1999 
(MOH, 2001-a). HIV infection rates were very high in resident IDU populations of 
an increasing number of cities in Yunnan, above 50% and even as high as 80%. A 
total of 5,678 HIV infections have been reported from 1987 through September 
1998 accounting for 51% of the total reported HIV infections in China. Remarkable 
changes have started to occur over the last couple of years with respect to the 
descriptive epidemiological characteristics of HIV transmission in Yunnan. Indeed, 
while the predominant route of transmission remains sharing of needles among 
injecting drug users, the overall rate of IDU among total HIV has decreased from 
87% in 1997 to 75% in 1998. Surveillance data in 2000 reported HIV prevalence 
rates among IDU up to 69.4%, with an average rate of 26.5%. The prefectures with 
HIV infection rates above 40% were Dehong, Wenshan, Lincang, Honghe, Dali and 
Kunming (MOH, 2001). 
 
Sexual transmission has started to increase since mid-1997 and the overall 
percentage of HIV infection transmitted by sexual contact in 1998 reached nearly 
14%. Provincial sentinel surveillance among STD patients has produced evidence in 
1998 that sexual HIV epidemics have started in a number of sites including Ruili, 
Dali and Lijiang in Yunnan province (MOH, 1998). There were 4 recorded cases of 
mother-to-child HIV transmission. The highest prevalence of HIV/AIDS (78%) was 
in young people between 15 and 30 years. More women were becoming infected as 
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evidenced by a shift of the male to female ratio from 4:1 in 1997 to 3:1 in 1998 
(SFPC, 2002). The last couple of years also saw the shift of HIV infection from 
mainly among national minorities to an equal distribution among minority 
populations and the majority Han population.  
 
Up to 1997, Yunnan has had 4,421 HIV/AIDS cases, of which 91 percent contracted 
AIDS through intravenous drug use. Of the HIV cases, 98 have developed AIDS 
and 84 have died.  Some 70 percent of counties in Yunnan have reported HIV/AIDS 
cases. Up to 1998, Yunnan has tested more than 457,000 for HIV/AIDS (MOH, 
1998).  
 
In 1999, there were significant increases in HIV infection among male STI patients 
in Baoshan, and among sex clients in Kunming City. In 2000, the HIV prevalence 
among male STI patients reached up to 8% with an average of 2.7%. HIV infections 
among male STI patients rapidly increased in Binchuan, Gengma, Chuxiong and 
Kunming. Among female STI patients the rates reached up to 13% with an average 
of 1.9% (MOH, 2001-a). HIV infections are also shifting from rural to urban areas 
and from border communities to interior populations. In 1989, Yunnan officials 
reported 149 HIV carriers. In 1999, the number of HIV carriers accounted for 43.6 
percent of the national total.  In September of 2001, Yunnan had 70,000 estimated 
cases of HIV infections, with 11,957 registered cases of HIV, which represented 32 
percent of the national total (MOH, 2001-b); in September of 2003, 13,948 HIV 
positives and 841 AIDS patients had been reported in Yunnan (Xinhua Agency, 
2004). In 2004, the HIV-1 prevalence among IDUs in Yunnan was between 21.2%-
27.8%. By the end of 2004, Yunnan had cumulatively reported 28,391 HIV 
infections (MOH, China/WHO; 2004).  
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Zhang et al. studied HIV-1 patients in Yunnan using immunoassays found  HIV-1 
subtype C/CRF07_BC/CRF08_BC and CRF01_AE were codominant among IDUs, 
the discovery of many sexually transmitted CRF01_AE cases was new and 
suggested that HIV-1 could be transmitted through “bridge population” into general 
population, this subtype may lead to a new epidemic in the general Chinese 
population (Zhang et al., 2006). The same phenomena  also found in another HIV-1 
molecular epidemiological study by Zhang et al. in 2004 in Xinjiang found HIV-1 
infected by homo- or heterosexual transmission multiple subtypes of HIV-1 which 
were related to strains dominated among IDU suggested HIV-1 has spread into 
general population (Zhang et al., 2004).  Yu et al. found unprotected sex continued 
to occur at high rates among IDU and their sex partners in Yunnan (Yu et al., 2003).  
 
Some studies have found drug users were more  likely to engage in high-risk sexual 
behaviors, and most female drug users engaged in commercial sex (Zhang et al., 
2002; Yang et al., 2005; Qian et al., 2005; Tucker et al., 2005; Chu & Levy, 2005).  
A number of studies suggest that HIV infection spread from high risk groups into 
the general population mainly due to sexual transmission (Zhang et al., 1999; Zhang 
et al., 2001; Huang et al., 2004; MOH, China/WHO, 2004; Hesketh et al., 2005; 
Zhu et al., 2005, Shao, 2006; Lonn et al, 2007). A study by Liu et al found HIV-1 
prevalence among IDUs in rural Guangxi was 25% (172/702) (Liu et al., 2006-b), a 
study in Xinjiang showed HIV prevalence among drug users was 24.5%, and among 
IDUs was significantly higher (56.1%) (Ni et al, 2006).  
 
Unfortunately, the HIV epidemic continues to spread among and from IDUs in 
China. By the end of 2005, there were approximately 650,000 people currently 
living with HIV/AIDS in China, in which there were approximately 288,000 drug 
users living with HIV/AIDS, accounting for 44.3% of the total number of estimated 
HIV cases. Seven provinces – Yunnan, Xinjiang, Guangxi, Guangdong, Guizhou, 
Sichuan, and Hunan – each have more than 10,000 drug users infected with HIV, 
and these 7 provinces account for 89.5% of the HIV/AIDS cases among drug users 
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(WHO, UNAIDS; 2006). Today, Yunnan still has the most HIV-1 infected number 
than any other provinces in China, accounting for one-fourth of the reported cases.  
 
Chinese government has made efforts to improve HIV/AIDS surveillance systems 
since the emergence of HIV epidemic,  policy and strategy focus on HIV education, 
prevention, and care have been implemented through the country.  
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“We can not deal with AIDS by making moral judgements or refusing to face 
unpleasant facts - and still less by stigmatising those who are infected and making 
out that it is all their fault.” 
 
--- Kofi Annan, 
(former Secretary General, United Nations) 
 
 
 
Chapter II: Objectives and Methodology 
 
2.1 Objectives 
 
HIV surveillance is the systematic collection of information on the occurrence, 
distribution and trends of HIV infection among specific populations on an ongoing 
basis. Data from HIV surveillance are used to estimate HIV prevalence in selected 
populations, to monitor trends of HIV epidemic in these populations, and to guide 
and evaluate the planning and implementation of HIV/AIDS prevention and control 
program activities (UNAIDS/WHO, 2000), as well as to provide useful information 
for policy maker. 
 
Through sentinel site surveillance,  it is expected to obtain the AIDS-related 
behavioral information and its time trends among target population in order to 
provide early warning of AIDS epidemic; to provide information and basis for 
evaluation of HIV/AIDS intervention strategies and their effectiveness and to 
determine the point prevalence of HIV infection by serological examination which, 
performed consistently over years, serves to monitor the distribution and trend of the 
HIV epidemic in China.  
 
This study concentrates on 2005 HIV second generation surveillance on drug users 
in China, it helps to determine prevalence of HIV-1, risk behaviours and 
demographic characteristics associated with HIV-1 infection among drug users in 
China based on the national second-generation surveillance on drug users in 2005. 
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2.2 Methodology 
 
HIV surveillance system in China  mainly  includes HIV/AIDS case reporting 
system and HIV sentinel surveillance system, there are also a number of special 
studies focusing on HIV behaviours as supplement (CDC, China/CDC; 2002). 
 
HIV/AIDS second generation surveillance is an annual routine work in monitoring 
specified groups in China (i.e. DU, FSW, STD clients, MSM, long distance truck 
drivers and young students), cross-sectional survey is conducted with standardized 
questionnaire, it helps to trace the behaviour change over time, to describe the 
HIV/AIDS epidemic, but every year, the sentinel sites are not always the same. 
 
For the drug users in Chinese surveillance system, there is no specific target group 
for IDU, but as drug user group, it includes IDU and Non-IDU drug user).  
 
 
Principals  of implementation of surveillance 
• Sentinel sites should be established according to the epidemic level and 
resource availability in different regions, to implement targeted technical 
support and guidance;  
• Multi-sectoral cooperation should be fostered in defining respective 
responsibility and co-operation; 
• Ethical requirements and professional moral should be followed in 
surveillance work, to keep informed consent and confidentiality. 
 
 
Target population groups: 
• High Risk Groups – Underground CSWs,  DUs, MSM, and STDs 
Clinics Attendees 
• Vulnerable Groups – LD Truck Drivers 
• General Groups – College students 
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This paper only focused on drug users. 
 
Definition and source of target population 
 
Drug users 
 
Definition: people who smoke, intravenously or intramuscularly use heroin, cocaine, 
opium, marijuana, morphine, methamphetamine hydrochloride, pethidine, K powder 
(ketamine), and dancing outreach. 
 
Sample Source: drug users from communities and detoxification centers. Drug users 
from communities provide better representativeness but recruitments of participants 
are considerably difficult because of their hidden behaviours. Each sentinel site 
should try the community-based surveillance according to local situation, e.g. the 
snow-ball method could be used. During the defined timeframe, if in the case that 
the subjects could not be adequately recruited from the community to meet 
requirement of sample size, the recruitments could be made from drug users who 
have been recently admitted in the detoxification centers in supplementing the 
sample size. Principally, the number of drug users recruited from detoxification 
centers could not exceed 50% of total sample size, and the duration of the drug users 
at detoxification center should be less than three months. 
 
 
Principals of selection of surveillance sites for drug users 
• National HIV surveillance sites are designed on the basis of administrative 
area, city (city at prefecture level) or county (city at county level) is 
considered the basic unit to set surveillance site. Sustainability of the sites 
will be the priority consideration. The number of sites collecting data each 
year is selected based on local HIV epidemic level and resource availability. 
According to the local HIV/AIDS epidemic situation and prevention and 
control needs at provincial level, the National Surveillance System will 
gradually increase or adjust the number of sentinel sites in different areas. 
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• According to the provincial epidemic trend, every province should set high-
risk population surveillance sites for drug users. Provinces that HIV 
prevalence among drug users over 5% should set at least 1 surveillance site, 
sites in provinces that HIV prevalence among drug users below 5%  or HIV 
positive was found could also be selected to compare the differences of 
demographic characteristics and risk behaviors in different sites.  
• Factors such as the local economic development, number of floating 
population as well as available local medical resources should be considered 
when the sentinel sites are established. 
 
Surveillance methods 
Surveillance frequency and timeframe 
Annual surveillance is implemented among drug users. 
 
Surveillance period of second generation surveillance sites in each year is from July 
to September. In some special cases or if there is an urgent event, the surveillance 
period could be appropriately adjusted after discussion with National Center for 
AIDS Prevention and Control. 
 
During each surveillance period, questionnaire survey will be conducted among the 
surveillance subjects and the sentinel sites should try their bests to collect serum 
specimen from all subjects. Detection of both HIV antibody and syphilis antibody 
should be conducted for all subjects.  
 
Behavioral surveillance 
Quantitative surveys are carried out through questionnaire, i.e. a face-to-face 
interview is conducted by trained investigators with a standardized designed 
questionnaire in order to collect information on demographic characteristics, risk 
behaviours, knowledge and attitudes towards HIV/AIDS among drug users.  
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Serological detection of HIV and interpretation of results 
• Two ELISA assays will be used for testing HIV antibodies. If blood 
specimens is positive from the first ELISA assay, the second ELISA assay 
with different principle (or with different antigen, or at least from different 
manufacturer) will be used for re-testing. Those specimens with positive 
results for both ELISA assays are considered positive for HIV antibody. 
Antigen should be distributed by National Center for AIDS Prevention and 
Control, no allowance for self exchange. 
• Laboratory methods for detection of HIV antibodies refer to the National 
Working Guidelines for HIV Detection, and manufacturer’s instructions of 
testing kits. 
• Laboratories to provide HIV antibody detection: the detection of HIV 
antibody could be done by the HIV screening laboratories officially 
approved by the provincial HIV confirming laboratories or by the institutions 
responsible for the national HIV comprehensive surveillance sites at the 
provincial level. Provincial HIV confirming laboratories should conduct 
quality control for the HIV screening laboratories regularly. 
• In order to ensure the laboratory testing quality and avoid the waste of 
testing kits, the lab detection should be conducted after completion of all 
specimen collection. 
• National Center for AIDS Prevention and Control conducts a non-scheduled 
quality control and evaluation of the provincial institution responsible for the 
national HIV sentinel sites in its jurisdictions and to the relevant units 
assigned by the provincial institution for HIV surveillance and testing. 
• For all serum specimens, the leftover sera after testing for HIV antibody and 
STD (syphilis antibody) should be stored appropriately at -20°C for eventual 
check. 
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Serologic tests for syphilis and interpretation of results 
• Rapid plasma reagin test (RPR) is used to detect syphilis antibodies in serum 
specimens. 
• Serological assays for detection of syphilis antibodies refer to Standard 
Operating Procedure for Laboratory Detection of STDs, and manufacturer’s 
instructions of reagents. 
• Laboratories to provide syphilis antibody testing: the tests should be 
conducted by the screening laboratories approved by the provincial HIV 
confirmed laboratories or the provincial authorities. 
 
Reagent used in 2005 national HIV surveillance on drug users: 
First HIV ELISA  test: ELISA reagent: (Wantai Biotech, Beijing, China) 
Second HIV ELISA test: ELISA reagent: (Vironostika HIV Uniform II Ag/Ab. 
Akzo Organon Teknika, Netherlands) 
Syphilis RPR reagent: (Kehua Biotech, Shanghai, China; Lizhu Biotech, Zhuhai, 
China) 
 
 
Sample size and sampling methods 
 
Sample size  
 ( ) ( ) ( )[ ]
( )212
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D = Design efficiency: the efficiency of complete randomized sampling is 1; in 
order to ensure the accuracy in estimation of sample size from multi-stage cluster 
sampling to be the same as that in simple randomized sampling, a coefficient of 
sample size has to be used, and the design efficiency is usually to be D =1.5 or D 
=2; 
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P1 = proportion of a given behavioral indicator estimated from the first round of 
survey; 
P2 = proportion of a given behavioral indicator estimated from the consequent 
rounds of surveys, making (P2-P1) be equal to the value (difference) you expect to 
find; 
=(P1+P2)/2； 
Z1-α= Z value in accordance with the expected significant level; 
Z1-β= Z value in accordance with the expected confidence level;  
 
In compliance with a standardized protocols in the sentinel sites, based on the 
calculation of sample size using the mathematic formula, and taking the 
characteristics of the surveillance populations, the sample size for each sentinel site 
and each round of surveillance survey requires 300-400 subjects for each target 
population.  
 
Sample method for drug users 
Drug users in the community 
Drug users are mainly from the community. However, drug users in the community 
have characteristics of sporadic distribution, concealment, and sensitivity, thereby 
leading to difficulties for mapping and randomized sampling, the convenience 
sampling and snowball sampling methods, therefore, could be used.  
 
Convenience sampling method 
Through interviewing key informants, local government department, police and 
community members to know about distribution of locations where drug users 
reside and use drugs, the drug users could be found will conduct the survey. If the 
drug user found by this way rejects to be investigated, next drug user could be 
recruited and so on until the expected sample size is reached. 
 
Snowball method 
Investigator should find a key informant or a drug user recognized by surveillance 
department and this informant or drug user gives the names, address, and other 
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contact information of second drug user (or second group of drug users) for 
investigation, who provides the names, address, and other contact information of 
third drug user (or third group of drug users) in the same way, and so on to increase 
samples through snowballing process until the expected number of sample size is 
reached. 
 
It is apt to result in selection bias if snowball method is used because informants 
tend to provide their familiar or close drug users and some of these drug users can 
influence each other in behavioral practice, resulting in similar behaviors (e.g. 
syringe and condom use) among them. Therefore, it is better to objective select 
target population with several different behaviors for initial surveys in order to avoid 
or reduce selection bias.  
 
If there are many drug users in the local community and it is more likely to access 
these drug users through interviewing local government department, police and 
community members to know about the distribution of the locations where drug 
users engage drug-use practice; therefore, sampling frame and mapping can be 
developed.  
 
Drug users in detoxification center 
If enough number of subjects could not be obtained in community, the inadequate 
part could be recruited from detoxification center to supplement the sample size. In 
principal, the number of drug users recruited from detoxification center could not 
exceed 50% of expected sample size and the duration of the recruited drug users to 
admit to the center should be less than three months. In detoxification center, 
randomized sampling should be used – i.e. listing all drug users in the center and 
coding them for randomized sampling. 
 
Survey procedure 
 
National standardized questionnaire for drug users is used in sentinel sites by 
interview, the questionnaire consists of information of demographic characteristics, 
HIV related behaviours and knowledge, and test results of HIV and syphilis.  Local 
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CDC investigators who are trained according to the surveillance protocol conduct 
the interview, in addition, verbal informed consent should be obtained before the 
investigation to emphasize the anonymity and confidentiality of the survey. 
 
 Data cleaning and analyse 
 
there were totally 6539 samples in 21 surveillance sites which conducted survey 
included HIV and STI surveillance and risk behaviours, one site in Kunming, 
Yunnan province was excluded due to lack of key information about risk behaviour. 
At first, data cleaning was conducted, 649 samples were dropped according to one 
of the following reasons; i.e. no blood taking, no HIV and syphilis test results, logic 
errors that could not be revised even after the consultation with local CDC charge 
person, in which in 621 cases no blood test was performed (blood samples were 
either insufficient for conducting HIV test, blood taking was not successful or the 
patients rejected). In one case first HIV test was negative and the second positive, 
but second test should be performed only if the first test was positive. In 26 cases 
age of the first drug use was below 10 and additionally in one case the age was 
reported as 13 years. All other participants reported first age use starting from 14 to 
60, we therefore decided to consider the 27 cases as coding errors. Other missing 
values and logic errors were revised under the suggestion of local CDC charge 
person. 
 
After data cleaning, a total of 5890 records were included in the analysis. SPSS 
software (version 14.0 for Windows; SPSS Inc., Chicago, IL) was used to analyse 
the dataset, χ2 statistics with P-values were used to compare HIV-1 and syphilis 
prevalence associated with demographics, drug use and sexual risk behaviours. 
Logistic regression was used to analyse independent association between HIV-1 
status and risk behaviours, syphilis status and risk behaviours. 
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“It is a big challenge to understand HIV/AIDS from the limited data available.“ 
 
 
--- Mary A. Foulkes 
(NIH) 
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3.1 Sample Characteristics 
3.1.1 General information 
There were totally 6539 samples in 21 surveillance sites which conducted survey 
included HIV and STI surveillance and risk behaviours, one site in Kunming, Yunnan 
province was excluded for lack of key information about risk behaviour – first 
generation surveillance was conducted there. However, the HIV-1 sero-prevalence in 
Kunming, Yunnan was significantly higher than other sites, 54% (54/100).  
 
After data cleaning,  649 samples were deleted for any one reason of which not taking 
blood, and no HIV and syphilis test results, logic errors that could not be revised even 
after the consultation with local CDC charge person. Other missing values and logic 
errors were revised under the suggestion of local CDC charge person. Some variables 
were re-categorized or merged for further bi-variable and logistic regression analyse 
or there was too few cases in such category. 
 
Demographic and socio-economic information 
There were totally 21 surveillance sites , sample size was 5890. 21 surveillance sites 
were selected from 13 provinces, there was geographical and socio-economical 
difference between province, provinces from higher GDP east coast and provinces 
from lower GDP west and south-west were selected, they were Anhui (Huainan, 
Maanshan), Gansu (Dingxi, Wuwei), Guangxi (Nanning), Guangdong (dongguan), 
Guizhou (Qianxinan, Tongren), Hebei (shijiazhuang), Hubei (jingzhou, Xiaogan), 
Liaoning (Fushun), Qinghai (Haidong, Haixi), Sichuan (Dazhou, Leshan, Liangshan), 
Xinjiang (Yili, Kashi), Zhejiang (Hangzhou), and Chongqing. Among the 21 survey 
sites, there were 14 sites with more than 200 records available (Sichuan Dazhou, 
Zhejiang Hangzhou, Guangxi Nanning, Xinjiang Kashi, Hubei Xiaogan, Gansu 
Wuwei, Hebei Shijiazhuang, Guizhou Qianxinan, Chongqing, Guizhou Tongren, 
Guangdong Dongguan, Hubei Jingzhou, Sichuan Liangshan, and Qinghai Haixi), for 
5 other sites there were 100-200 records (Anhui Huainan, Anhui Maanshan, Qinghai 
Haidong, Sichuan Leshan, and Gansu Dingxi) and for two sites (Liaoning Fushun and 
Xinjiang Yili) were less than 100 records. 10 sentinel sites reached the needed sample 
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size (300-400), they were Gansu Wuwei, Guangdong Dongguan, Guizhou Qianxinan, 
Guizhou Tongren, Hebei Shijiazhuang, Hubei Xiaogan, Hubei Jingzhou, Qinghai 
Haixi, Sichuan Liangshan, and Chongqing. The rest sentinel sites did not recruit the 
needed samples.  
 
See the following figure about HIV reported cases in every single province. See 
Figure 3.1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1 The geographic distribution of cumulative reported HIV-1 cases in China 
1985- 2004 and sentinel sites among drug users in 2005* 
source: WHO: A Joint Assessment of HIV/AIDS Prevention, Treatment and Cwere in China 
(2004) 
*sentinel sites (HIV-1 prevalence): 1 Liaoning Fushun (0%), 2 Hebei Shijiazhuang (0%), 3 
Zhejiang Hangzhou (0%), 4 Guangdong Dongguan (5.9%), 5 Anhui Huainan (0%), 6 Anhui 
Maanshan (0.7%), 7 Hubei Xiaogan (0.9%), 8 Hubei Jingzhou (0.5%), 9 Chongqing (7.3%), 
10 Guizhou Qianxinan (0.4%), 11 Guizhou Tongren (4.5%), 12 Sichuan Dazhou (0.4%), 13 
Sichuan Leshan (2.6%), 14 Sichuan Liangshan (29.4%), 15 Gansu Dingxi (0%), 16 Gansu 
Wuwei (0%), 17 Qinghai Haidong (0.6%), 18 Qinghai Haixi (0%), 19 Xinjiang Yili (0%), 20 
Xinjiang Kashi (10.8%), 21 Guangxi nanning (21.0%) 
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Sample source  
55.8% from detoxification centre, 30.9% from community,  others 12.7%。 
Gender   
Male accounted a major part, 84.4%. male female ratio was 5.6:1. 
Age  
Age rank was between 14-78, median was 30.0, mean was 31.6, in which 51.9% were 
equal or younger than 30, 48.0% were elder than 30. 
 
Marital status  
Married was 6.1%, single 40.7%, cohabited 38.7%, divorced or widowed 13.5%. In 
order for further bi-variable and logistic regression analyse, the variable was re-
categorized into two groups: live alone (includes single, divorced and widowed) 
54.2%, and live with partner (includes married and cohabited) 44.8%. 
 
Resident place 
84.4% drug users were local residents (have local permanent resident permission), 
14.9% were transient (have temporary local resident permission). 
 
Nation 
Most were Han Chinese, were 72.9%, 25.9% were minorities. There were totally 55 
minorities in China, there was no detailed information about single minorities in this 
study, thus, minority was used to refer non-Han. 
 
Education 
Education refers the highest diploma that subject received inland and overseas, or 
similar with his/her current knowledge.   
• Illiteracy (never in school)： character is can not read newspaper, can not 
write informal note.  
• Primary school： the highest education is primary school graduate, drop-out, 
and in-school; and any one has similar diploma. It also includes who never 
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was in primary school but can read newspaper and write informal note. (in 
general 6 years education).   
• Middle school：the highest education is middle school graduate, drop-out, and 
in-school; and any one has similar diploma. (in general 9 years education).  
• High school or professional high school：the highest education is high school 
graduate, drop-out, and in-school; and any one has similar diploma. (in general 
12 years education).  
• College or above：the highest education is college or above graduate, drop-
out, and in-school; and any one has similar diploma. (in general over 15 years 
education).  
In china, the compulsory education is 9 years to graduate from middle school.  
 
In this study, the most were middle school 48.4%, primary school 23.7%, high school 
or above  17.0%, illiterate 8.7%. In order for further bi-variable and logistic regression 
analyse, the variable was re-categorized into two groups: education equal or less than 
9 years (includes illiteracy, primary school and middle school) accounted for 32.4%, 
and education more than 9 years (includes high school and college or above) 
accounted for 65.4%. 
 
Profession 
There were 15 profession categories, 1 student, 2 teacher, 3 home maid, 4 service 
industry personnel, 5 shop assistant, 6 medical staff, 7 worker, 8 migrant worker, 9 
peasant, 10 farmer, 11 fisher, 12 officer, 13 pensioner, 14 home worker, 15 other. In 
for further bi-variable and logistic regression analyse, the variable were re-categorized 
into two groups: white collar (includes student, teacher, medical staff, officer and 
pensioner) 32.7%, and blue collar (other rest categories) 64.1%.  
 
Monthly income 
40.7% samples monthly income equal or less than 600 RMB, 20.9% earned 601-2000 
RMB per month, 5.8% earned more than 2000 RMB. The missing values were 32.5%. 
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3.1.2 HIV-1 and syphilis infection 
HIV-1 infection 
HIV-1 positives were 297, HIV-1 positive rate was 5.0%. 13 sentinel sites found HIV-
1 positive, 5 sentinel sites HIV-1 positive rate were over 5%, in which Guangdong 
Dongguan (5.9%), Chongqing (7.3%), Guangxi nanning (21.0%), Sichuan Liangshan 
(29.4%), and Xinjiang Kashi (10.8%), respectively. Detailed information see table 
below (Table 3.1). 
 
 
Table 3.1 HIV-1 prevalence in surveillance sites 
Sites Number of HIV+ Total 
HIV prevalence 
% (95% CI) 
Anhui Huainan 0 113 0.0 (0.0-3.2) 
Anhui Maanshan 1 141 0.7 (0.1-3.9) 
Gansu Dingxi 0 193 0.0 (0.0-2.0) 
Gansu Wuwei 0 357 0.0 (0.0-1.1) 
Guangxi Nanning 61 291 21.0 (16.7-26.0) 
Guangdong Dongguan 24 407 5.9 (4.0-8.6) 
Guizhou Qianxinan 1 363 0.3 (0.1-1.6) 
Guizhou Tongren 17 376 4.5 (2.8-7.1) 
Hebei Shijiazhuang 0 361 0.0 (0.0-1.1) 
Hubei Jingzhou 2 409 0.5 (0.1-1.8) 
Hubei Xiaogan 3 352 0.9 (0.3-2.5) 
Liaoning Fushun 0 28 0.0 (0.0-12.1) 
Qinghai Haidong 1 163 0.6 (0.1-3.4) 
Qinghai Haixi 0 478 0.0 (0.0-0.8) 
Sichuan Dazhou 1 223 0.4 (0.1-2.5) 
Sichuan Leshan 5 189 2.6 (1.1-6.1) 
Sichuan Liangshan 122 415 29.4 (25.2-34.0) 
Xinjiang Yili 0 99 0.0 (0.0-3.7) 
Xinjiang Kashi 32 297 10.8 (7.7-14.8) 
Zhejiang Hangzhou 0 267 0.0 (0.0-1.4) 
Chongqing 27 368 7.3 (5.1-10.5) 
Total 297 5890 5.0 (4.5-5.6) 
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Syphilis infection 
There were 162 syphilis positive, positive rate is 2.8%, 11 sites found syphilis 
positive. Guangxi Nanning (17.5%), Guangdong Dongguan (9.6%), and Xinjiang 
Kashi (10.4%) were the three highest sites, all over 5%.  See Table 3.2  
 
Table 3.2 HIV prevalence in surveillance sites 
Sites Number of syphilis+ Total
syphilis prevalence 
% (95% CI) 
Anhui Huainan 3 113 2.7 (0.9-7.5) 
Anhui Maanshan 5 141 3.6 (1.5-8.0) 
Gansu Dingxi 5 193 2.6 (1.1-5.9) 
Gansu Wuwei 0 357 0.0 (0.0-1.1) 
Guangxi Nanning 51 291 17.5 (13.6-22.3) 
Guangdong Dongguan 39 407 9.6 (7.1-12.8) 
Guizhou Qianxinan 1 363 0.3 (0.1-1.6) 
Guizhou Tongren 0 376 0.0 (0.0-1.0) 
Hebei Shijiazhuang 0 361 0.0 (0.0-1.1) 
Hubei Jingzhou 0 409 0.0 (0.0-0.9) 
Hubei Xiaogan 0 352 0.0 (0.0-1.1) 
Liaoning Fushun 0 28 0.0 (0.0-12.1) 
Qinghai Haidong 0 163 0.0 (0.0-2.3) 
Qinghai Haixi 4 478 0.8 (0.3-2.1) 
Sichuan Dazhou 5 223 2.2 (1.0-5.1) 
Sichuan Leshan 3 189 1.6 (0.5-4.6) 
Sichuan Liangshan 15 415 3.6 (2.2-5.9) 
Xinjiang Yili 0 99 0.0 (0.0-3.7) 
Xinjiang Kashi 31 297 10.4 (7.5-14.4) 
Zhejiang Hangzhou 0 267 0.0 (0.0-1.4) 
Chongqing 0 368 0.0 (0.0-1.0) 
Total 162 5890 2.8 (2.4-3.2) 
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All 21 drug use sites were categorized into three groups according to geographical and 
economical difference. See table 3.3. 
 
Geographic region: 
 
1. East coast: Liaoning (Fushan), Hebei (shijiazhaung), Zhejiang (Hangzhou), 
Guangdong (Dongguan) 
2. Central region: Anhui (Huainan, Maanshan), Hubei (Xiaogan, Jingzhou), 
Chongqing 
3. West and South-West: Guangxi (Nanning), Guizhou (Tongren, Qianxinan), 
Sichuan (Dazhou, Leshan, Liangshan), Gansu (Dingxi, Wuwei), Qinghai 
(Haidong, Haixi), Xingjiang (Kashi, Yili)  
 
Table 3.3  Regional GDP per capita 2004 
Region Provinces  HIV prevalence GDP per capita 
(RMB) 
East  Liaoning, Hebei, Zhejiang, Guangdong 2.1% 18,216 
Central Anhui, Hubei, Chongqing 2.4% 9,292 
West and South-
West 
Guangxi, Guizhou, Sichuan, Gansu, 
Qinghai, Xingjiang  
6.1% 7,550 
Source: national statistical annual report 2005. National Bureau of Statistics, China. 
http://www.stats.gov.cn/tjsj/ndsj/2005/indexch.htm 
 
Then, every single region was categorized into two groups according to the HIV-1 
prevalence tested in target populations, low HIV-1 sub-region when HIV-1 prevalence 
below 5%; and high HIV-1 sub-region when HIV-1 prevalence over 5%. See table 3.4. 
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Table 3.4 HIV-1 prevalence and surveillance sites in sub-region 
 
Region (HIV 
prevalence) 
Sub-
region Surveillance sites (HIV prevalence) 
HIV prevalence 
in sub-region
Low 
Liaoning Fushun (0%), Hebei Shijiazhuang (0%), 
Zhejiang Hangzhou (0%) 
0%
East (2.3%) 
High Guangdong Dongguan (5.9%) 5.9%
Low 
Anhui Huainan (0%), Anhui Maanshan (0.7%), 
Hubei Xiaogan (0.9%), Hubei Jingzhou (0.5%) 
0.6%
Central (2.4%) 
High Chongqing (7.3%) 7.3%
Low 
Guizhou Qianxinan (0.4%), Sichuan Dazhou 
(0.4%), Gansu Dingxi (0%), Gansu Wuwei (0%), 
Qinghai Haidong (0.6%), Qinghai Haixi (0%), 
Guizhou Tongren (4.5%), Xinjiang Yili (0%), 
Sichuan Leshan (2.6%), 
1.0%
West and South-
West (7.0%) 
High 
Guangxi nanning (21.0%), Sichuan Liangshan 
(29.4%), Xinjiang Kashi (10.8%) 
21.4%
 
 
 
 
Sites which HIV-1 prevalence lower than 5% were categorized into HIV-1 lower 
region, and sites which HIV-1 prevalence equal or higher than 5% were categorized 
into HIV-1 higher region. after the categorization, there were much few HIV-1 
positives in low regions, totally 31 (0.8%); all sites which HIV-1 prevalence over 5% 
were reordered to higher prevalence regions, it included Guangxi nanning (21.0%), 
Sichuan Liangshan (29.4%), Xinjiang Kashi (10.8%), Chongqing (7.3%), Guangdong 
Dongguan (5.9%). HIV-1 prevalence in higher regions was 15.0% (266/1778). 
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Table 3.5  Prevalence of HIV-1 and syphilis in target populations 
Variables 
Total  (5890) 
(%) 
East coast 
(n=1063) 
(%) 
Central 
(n=1383) 
(%) 
west and 
South-West 
(n=3444) (%) 
P* 
HIV+ 5.0 2.3 2.4 7.0 <0.001 
Syphilis+ 2.8 3.7 0.6 3.3 <0.001 
HIV+ and syphilis+ 0.6 0.1 0.0 1.0 <0.001 
HIV- and syphilis+ 2.1 3.6 0.6 2.3 <0.001 
HIV+ and syphilis- 4.4 2.2 2.4 6.0 <0.001 
 
There were totally 36 samples who both HIV-1 and syphilis tests were positive, 261 
samples were HIV-1 positive and syphilis negative, and 126 samples were syphilis 
positive and HIV-1 negative. (Table 3.5) 
 
 
3.1.3 Behaviour 
 
Drug use behaviour 
79.4% samples first used drug at younger than 30, 13.3% first used drug at elder than 
30. 51.5% samples once injected drug. 25.2% samples once injected in last one month.  
40.9% samples first injecting age were equal or younger than 30, 8.8% elder than 30. 
22.7% samples once shared needles,  7.2% samples shared needles by latest injecting, 
6.5% samples shared needles by latest one month. 16.0% samples ever shared needles 
in last 6 months.  
 
 
Sex behaviour 
 
45.8% samples have had sex in last month, 41.5% samples used condom by latest sex,  
12,7% samples have had any commercial sex (paying or offer) in last one year, 4.7% 
samples used condom by latest commercial sex, 13.1% samples have had  STD 
symptoms in last 1 year (emiction ache/burn, urethra/vagina secretion abnormal, 
genitals derma trauma/hyperplasia).  
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3.1.4 Other information 
 
Knowledge about HIV transmission 
Knowledge about HIV transmission means object knew the three transmission ways 
of HIV, e.g. blood transmission, sexual transmission and mother to child transmission. 
It includes five questions: 
• can a person be infected with HIV through transfusion HIV infected blood or 
blood product?  
• can a person be infected HIV if he/she shares needles with HIV infected 
person? 
• can the risk of transmission HIV decrease if condom is used properly by sex at 
every time? 
• can the risk of transmission HIV decrease if you have a non-infected fix sex 
partner? 
• can a HIV infected pregnant woman transmit HIV virus to her unborn child? 
57.6% samples knew all HIV transmission ways, 7.6% samples did not know any 
HIV transmission way.  
 
Information about receive HIV test 
22.0% samples reported once tested HIV and knew results. 
 
Information about intervention program 
25.6% samples reported once got any intervention services in different way. 
Intervention services include needle exchange/clean needle distribution, methadone 
replacement treatment, partner education, condom distribution, HIV counselling and 
test, and AIDS/STD brochures. 
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3.2 Sample Characteristics in Different Geographic Regions  
 
All 21 drug use sites were categorized into three groups according to geographical and 
economical difference, i.e. east coast, central, west and south-west regions. 
1. East coast: Liaoning (Fushan), Hebei (shijiazhaung), Zhejiang (Hangzhou), 
Guangdong (Dongguan) 
2. Central region: Anhui (Huainan, Maanshan), Hubei (Xiaogan, Jingzhou), 
Chongqing 
3. West and South-West: Guangxi (Nanning), Guizhou (Tongren, Qianxinan), 
Sichuan (Dazhou, Leshan, Liangshan), Gansu (Dingxi, Wuwei), Qinghai 
(Haidong, Haixi), Xingjiang (Kashi, Yili) 
 
The most samples (87.5%) in east region were from detoxification center, in central 
and west and south-west regions were a bit more or less than 50%. Male accounted a 
big part of samples, the proportion of male in all three regions was over 80%; more 
dug users in east and west and south-west regions were younger than 30, on the 
contrary, most drug users in central region were elder than 30; most drug users lived 
without partner in all three regions. Over 90% of drug users in central and west and 
south-west regions were local resident, however, the proportion of transient residents 
in east coast is over 50%, it is also coincident with the regional economics, most 
floating workers migrate into east coast regions. Over 90% of drug users in east coast 
and central regions were Han-Chinese, however, the proportion of minorities in west 
and south-west was over 50%, it is also coincident with the geographic distribution of 
Chinese nations, there were 55 minorities in China, most populous minorities locate in 
west and south-west regions, e.g. Urgur, Zhuang, Tibetan, etc (National Bureau of 
Statistics, China; 2005). Over 50% samples got more than 9 years education in all 
three regions, the proportion of samples that got education more than 9 years was 
even more than 80% in central regions.  Over 50% samples were blue-collar worker in 
all three regions, the proportion of samples that blue collar worker was more than 
80% in central regions. Almost 50% samples in central and west and south-west 
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regions earned equal or less than 600 RMB, whereas, only 14.4% samples in east 
coast earned equal or less than 600 RMB. See table 3.6. 
 
 
Table 3.6 Demographic characteristics of the surveillance samples in different 
geographic regions 
 
Variables Total  (5890) (%)
East coast 
(n=1063) 
(%) 
Central 
(n=1383) 
(%) 
west and 
South-
West 
(n=3444) 
(%) 
P* 
detoxification center 55.8 87.5 41.9 51.7 
community 30.9 8.9 27.9 38.9 Sample source 
others 12.7 2.6 29.9 8.9 
<0.001
male 84.4 81.8 82.9 85.8 Gender 
female 15.2 17.6 16.9 13.9 
0.005
<30 51.9 58.2 45.8 52.4 Age 
>30 48.0 41.7 54.1 47.5 
<0.001
live without partner 54.2 60.1 57.3 51.2 Marital 
status live with partner 44.8 38.5 41.8 47.9 
<0.001
local 84.4 46.8 93.9 92.1 Resident 
place transient 14.8 52.4 5.4 7.1 
<0.001
Han 72.9 91.0 97.2 57.6 Nation 
minority 25.2 6.7 1.4 40.5 
<0.001
<= 9 years 32.4 28.2 13.7 41.2 Education 
> 9 yeas 65.4 69.6 84.8 56.3 
<0.001
white collar 32.7 28.4 14.8 41.2 
blue collar 64.1 64.3 81.9 56.9 Profession 
missing 3.2 7.2 3.3 1.9 
<0.001
<600 40.7 14.4 46.2 46.7 
601-2000 20.9 21.5 16.3 22.6 
>2000 5.8 19.2 4.2 2.3 
monthly 
income 
missing1 32.5 44.9 33.3 28.4 
<0.001
*Pearson Chi-Square 
1 32.5% were missing values in this category 
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The most dug users used drug at younger than 30, 76.2%, 80.2%, and 80.1% in east 
coast, central, and west and south-west regions, respectively. The proportion of IDU 
was 72.0% in central regions, 62.6% in east coast, and 39.8% in west and south-west. 
The proportion of needle sharing among IDU was 34.4% in central regions, 42.5% in 
east coast, and 49.9% in west and south-west. The proportion of IDU among drug 
users was quite lower in west and south-west regions in comparison  to other two 
regions, however, needle sharing rate was the highest in west and south-west regions, 
and most HIV infections were found there. See table 3.7. 
 
Table 3.7 Drug using behavioral characteristics of the surveillance samples in 
different geographic regions 
 
Variables Total  (5890) (%)
East coast 
(n=1063) 
(%) 
Central 
(n=1383) 
(%) 
west and 
South-
West 
(n=3444) 
(%) 
P* 
<30 79.4 76.2 80.2 80.1 
>30 13.3 11.6 13.7 13.7 first drug use age 
missing 7.3 12.2 6.1 6.2 
<0.001 
No 46.1 35.0 27.4 57.1 Ever injected 
Yes 51.5 62.6 72.0 39.8 
<0.001 
Number of IDU  3033 665 996 1372  
<30 78.3 75.5 75.9 81.4 
>30 16.8 13.5 21.0 15.4 age first inject 
not 
remember 3.1 7.4 1.9 1.9 
<0.001 
No 51.1 54.3 61.9 41.8 injected in last 
month Yes 48.9 45.7 38.1 58.2 
<0.001 
No 55.9 65.6 57.5 50.1 
IDU 
ever shared 
needles Yes 44.1 34.4 42.5 49.9 
<0.001 
Number of sharing needles in 
IDU  1337 229 423 685  
No 68.4 65.5 66.9 70.4 share needles by 
latest injecting Yes 31.6 34.5 33.1 29.6 
0.279 
No 71.2 68.1 69.7 73.1 share needles by 
latest one month Yes 28.8 31.9 30.3 26.9 
0.252 
No 30.7 38.4 31.4 27.6 
IDU share 
needles 
share needles in 
last 6 months Yes 69.3 61.6 68.6 72.4 
0.008 
*Pearson Chi-Square 
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46.5% samples in east coast have had sex in last month, and 47.4% and 44.9% in 
central and west and south-west regions, respectively. The proportion of who engaged 
commercial sex in last year was 12.8%, 16.6%, and 11.1% in east coast, central, and 
west and south-west region, respectively. The rate of condom use by last commercial 
sex was over 50% in east coast (52.9%), whereas, significantly lower in central and 
west and south-west regions, 37.0% and 31.1% respectively. The proportion of who 
have had STD symptoms (emiction ache/burn, urethra/vagina secretion abnormal, 
genitals derma trauma/hyperplasia) in last one year was 15.2%, 14.7%, and 11.8% in 
east coast, central, and west and south-west regions, respectively. See Table 3.8. 
 
Table 3.8 Sexual behavioral characteristics of the surveillance samples in different 
geographic regions 
 
Variables 
Total  
(5890) 
(%) 
East 
coast 
(n=1063) 
(%) 
Central 
(n=1383) 
(%) 
west and 
South-
West 
(n=3444) 
(%) 
P* 
No 52.5 48.0 51.8 54.2 have had sex in last month 
Yes 45.8 46.5 47.4 44.9 
<0.001
Number who had sex in last month 2695 494 655 1546  
No 9.2 15.6 4.9 9.0 have had sex in last 
month 
used condom 
by latest sex Yes 90.8 84.4 95.1 91.0 
0.001
No 87.3 87.2 83.4 88.9 any commercial sex in last one year 
Yes 12.7 12.8 16.6 11.1 
<0.001
Number who had commercial sex in last one 
year 749 136 230 383  
No 63.2 47.1 63.0 68.9 
any commercial sex in 
last one year 
Use condom 
by latest 
commercial 
sex 
Yes 36.8 52.9 37.0 31.1 
<0.001
No 84.3 77.3 84.0 86.6 STD symptoms in last 1 year 
Yes 13.1 15.2 14.7 11.8 
<0.001
 
*Pearson Chi-Square 
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The proportion of samples who knew all three transmission ways of HIV infection 
was all over 50% in three regions, 55.0%, 72.7%, and 52.3% in east coast, central, and 
west and south-west regions, respectively. 22.2% samples in east coast once tested 
HIV and knew the result, 20.2% and 22.6% in central and west and south-west 
regions, respectively. The proportion of samples who received any intervention 
service in last one year was lower than 35% in all three regions. See table 3.9.  
 
Table 3.9 Other characteristics of the surveillance samples in different geographic 
regions 
 
Variables 
Total  
(5890) 
(%) 
East coast 
(n=1063) 
(%) 
Central 
(n=1383) 
(%) 
west and 
South-
West 
(n=3444) 
(%) 
P* 
No 78.0 77.8 79.8 77.4 once tested HIV and 
knew result Yes 22.0 22.2 20.2 22.6 0.175 
Not know 7.6 5.7 2.8 10.0 
Know 20% 2.6 2.3 0.6 3.6 
Know 40% 4.2 3.5 1.9 5.3 
Know 60% 8.7 7.7 4.8 10.5 
Know 80% 19.4 25.8 17.2 18.3 
Knowledge about all 
HIV transmission 
Know all 57.6 55.0 72.7 52.3 
<0.001
No 74.4 79.0 66.8 76.0 Once received any 
intervention service Yes 25.6 21.0 33.2 24.0 <0.001
*Pearson Chi-Square 
 
HIV infection in different geographic regions 
The prevalence of HIV in east coast, central and west and south-west regions was 2.3% 
(24/1063), 2.4% (33/1383), and 7.0% (240/3444), respectively. The prevalence of HIV 
in west and south-west regions was over 5%, and most higher HIV prevalence regions 
were located in west and south-west in China (China CDC, 2005).  
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3.3 Sample Characteristics in Different HIV Prevalence Regions  
 
Every single site was categorized into two groups according to the HIV prevalence 
tested in target populations, low HIV region when HIV prevalence below 5%; and 
high HIV region when HIV prevalence over 5%. After the categorization, there were 
much few HIV positives in low regions, totally 31 (0.8%); all sites which HIV 
prevalence over 5% were reordered to higher prevalence regions, it included Guangxi 
nanning (21.0%), Sichuan Liangshan (29.4%), Xinjiang Kashi (10.6%), Chongqing 
(7.3%), Guangdong Dongguan (5.8%). HIV prevalence in higher regions was 15.0% 
(266/1778). 
 
The samples from detoxification center were over 50% in HIV lower and higher 
regions, 52.4% and 64.9% respectively; 38.5% samples in lower regions were from 
community, whereas, the proportion of samples from community in higher regions 
was quite lower, only 14%. Male accounted a big part of samples, the proportion of 
male in both regions was over 80%; more dug users in higher regions were younger 
than 30 (57.3%), on the contrary, drug users in lower regions that elder or younger 
than 30 almost the same proportion. Over 50% drug users lived without partner in 
both regions. Over 80% of drug users in both regions were local resident. Over 80% 
of drug users in lower regions were Han-Chinese, however, the proportion of 
minorities in higher regions is 44.5%. 72.7% samples got more than 9 years education 
in lower regions, it was only 53.5% in higher regions. The most samples were blue-
collar worker, 69.1% and 59.7% in lower and higher regions respectively. Over 50% 
samples in higher regions earned equal or less than 600 RMB, whereas, only 36.7% 
samples in east coast earned equal or less than 600 RMB. See table 3.10. 
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Table 3.10 Demographic characteristics of the samples in different HIV prevalence 
regions 
 
Varaibles 
lower 
regions 
(4112) 
Higher 
regions 
(1778) 
total 
(5890) p* 
detoxification 
center 52.4 64.9 55.8 
community 38.5 14.0 30.9 
Sample 
source 
others 9.1 21.1 12.7 
<0.001 
male 83.5 87.5 84.4 Gender 
female 16.5 12.5 15.2 
<0.001 
<30 49.6 57.3 51.9 Age 
>30 50.4 42.7 48.0 
<0.001 
live alone 52.9 59.0 54.2 Marital 
status live with partner 47.1 41.0 44.8 
<0.001 
local 85.9 83.1 84.4 Resident 
place transient 14.1 16.9 14.8 
0.007 
Han 82.5 55.5 72.9 Nation 
minority 17.5 44.5 25.2 
<0.001 
<= 9 years 27.3 46.5 32.4 Education 
> 9 years 72.7 53.5 65.4 
<0.001 
white collar 30.9 40.3 32.7 Profession 
blue collar 69.1 59.7 64.1 
<0.001 
<600 36.7 50.1 40.7 
601-2000 22.2 18.0 20.9 
>2000 4.7 8.3 5.8 
monthly 
income 
missing1 36.4 23.6 32.5 
<0.001 
*Pearson Chi-Square 
1 32.5% were missing values in this category 
 
The most dug users used drug at younger than 30, 77.6% and 83.6% in lower and 
higher regions, respectively. The proportion of IDU was 48.9% in lower regions, 
61.5% in higher regions. The proportion of IDU and needle sharing was 20.1% in 
lower regions and 30.3% in higher regions. 45.1% samples in lower regions have had 
sex in last month, and 49.9% in higher regions, respectively. The proportion of who 
engaged commercial sex in last year was 11.8% and 14.7% in lower and higher 
regions, respectively. The proportion of who have had STD symptoms (emiction 
ache/burn, urethra/vagina secretion abnormal, genitals derma trauma/hyperplasia) in 
last one year was 12.1% and 16.4% in lower and higher regions, respectively.  See 
table 3.11. 
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Table 3.11 Risk behavioral characteristics of the samples in HIV prevalence regions 
 
Varaibles 
lower 
regions 
(4112) 
Higher 
regions 
(1778) 
total (5890) p* 
<30 77.6 83.6 79.4 
>30 13.0 14.1 13.3 first drug use age 
misssing1 9.4 2.3 7.3 
<0.001
No 51.1 38.5 47.3 IDU 
Yes 48.9 61.5 52.7 
<0.001
No IDU 51.1 38.5 47.3 
IDU no share needles 28.7 31.2 29.5 IDU and share needles 
IDU shwere needles 20.1 30.3 23.2 
<0.001
No IDU 51.1 38.5 47.3 
IDU no share needles 28.7 31.2 29.5 
share needles but not in 
last 6 months 6.8 8.0 7.1 
IDU share needles 
in last 6 months 
share needles in last 6 
months 13.4 22.3 16.1 
<0.001
No 54.9 50.1 53.4 have had sex in 
last month Yes 45.1 49.9 46.6 
0.001 
no sex 54.9 50.1 53.4 
had sex with condom 40.9 45.4 42.3 had sex and condom use 
had sex no condom 4.2 4.5 4.3 
0.003 
No 88.2 85.3 87.3 commercial sex in 
last one year Yes 11.8 14.7 12.7 
0.002 
No 87.9 83.6 86.5 STD symptoms in 
last 1 year Yes 12.1 16.4 13.5 
<0.001
*Pearson Chi-Square 
1 7.3% were missing values in this category 
 
 
The proportion of samples who knew all three transmission ways of HIV infection 
was all over 50% in both regions, 60.2%and 51.6% in lower and higher regions, 
respectively. 22.5% samples in lower regions once tested HIV and knew the result, 
20.6% in higher regions. The proportion of samples who received any intervention 
service in last one year was lower, 25.5% and 26.0% in lower and higher regions 
respectively. See table 3.12.  
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Table 3.12 Other characteristics of the samples in different HIV prevalence regions 
 
Varaibles 
lower 
regions 
(4112) 
Higher 
regions 
(1778) 
total 
(5890) p* 
No 77.5 79.4 78.0 once tested HIV and 
knew result Yes 22.5 20.6 22.0 
0.105 
Not know 4.7 14.1 7.6 
Know 20% 3.0 1.7 2.6 
Know 40% 4.2 4.2 4.2 
Know 60% 9.3 7.3 8.7 
Know 80% 18.6 21.1 19.4 
Knowledge about all 
HIV transmission 
Know all 60.2 51.6 57.6 
<0.001
No 74.5 74.0 74.4 any intervention service 
in last one year any 25.5 26.0 25.6 
0.641 
*Pearson Chi-Square 
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3.4 Bivariate Analysis of Sample Characteristics and HIV and Syphilis Infection 
 
Bivariate analysis (χ2 statistics with P-values) was used to compwere HIV and 
syphilis prevalence associated with demographics, drug use and sexual risk 
behaviours. 
 
X² analysis for demographic and socio-economic factors showed that HIV prevalence 
was significant associated with sample source (p<0.01), age (p<0.05), resident place 
(p<0.001), nation (p<0.001), education (p<0.001), profession (p<0.001), monthly 
income (p<0.001). Risk factors among demographic and socio-economic characters 
were sample from detoxification center or other sources, male drug users, age younger 
than 30, local resident, minority, education equal or less than 9 years, white collar, 
and monthly income equal or less than 600 RMB. See table 3.13.  
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Table 3.13 Bivariate analyse of demographic and socio-economic characteristics of 
the samples in relation to HIV infection 
Variables HIV
+ 297 
(5.0%) p* 
detoxification centre 5.5 
community 3.7 
Sample 
source 
others 6.6 
0.004 
male 5.1 Gender 
female 4.9 
0.541 
<30 5.8 Age 
>30 4.3 
0.030 
live without partner 4.8 Marital status 
live with partner 5.3 
0.566 
local 5.6 Resident 
place transient 2.3 
<0.001 
Han 2.8 Nation 
minority 11.9 
<0.001 
<= 9 years 8.4 Education 
> 9 years 3.3 
<0.001 
white collar 8.1 Profession 
blue collar 3.6 
<0.001 
<600 6.4 
601-2000 4.5 
>2000 2.1 
Monthly 
income 
Missing1 4.2 
<0.001 
*Pearson Chi-Square 
1 32.5% were missing values in this category 
 
 
X² analysis for behavioral factors showed that HIV prevalence was significant 
associated with first drug use age (p=0.001), IDU and share needles (p<0.001). risk 
factors among behavioral characters were first drug use age younger than 30, IDU 
share needles. See table 3.14.  
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Table 3.14 Bivariate analyse of behavioral characteristics of the samples in relation to 
HIV infection 
 
Variables HIV
+ 297 
(5.0%) p* 
<30 5.5 first drug use 
age >30 4.1 
0.001 
No IDU 3.5 
IDU no share needles 4.6 IDU and share needles 
IDU share needles 9.2 
<0.001 
no commercial sex 5.1 
<=10 8.8 
Number of 
commercial 
sex partner in 
last 1 year >10 8.3 
0.285 
No 5.1 commercial 
sex in last one 
year Yes 4.7 
0.621 
No 5.0 STD 
symptoms in 
last 1 year Yes 6.1 
0.253 
*Pearson Chi-Square 
 
 
 
 
X² analysis for demographic and socio-economic factors, drug use behaviours and 
sexual behaviours showed that syphilis prevalence was significant associated with 
sample source (p<0.001), gender (p<0.001), marital status (p<0.05), resident place 
(p<0.05), nation (p=0.001), education (p=0.001), IDU (p<0.001), number of 
commercial sex partner in last 1 year (p<0.001), STD symptoms in last 1 year 
(p<0.001). Risk factors among demographic and behavioral characters were sample 
from detoxification center, female drug users, live with partner, transient resident, 
minority, education equal or less than 9 years, IDU, have had commercial sex partner 
in last 12months, and have had STS symptoms in last 12 months. See table 3.15.  
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Table 3.15 Bivariate analyse of demographic and behavioral characteristics of the 
samples in relation to syphilis infection 
Variables syphilis
+ 
162 (2.8%) p* 
detoxification center 4.0 
community 1.3 
Sample 
source 
others 0.9 
<0.001 
male 1.8 Gender 
female 8.0 
<0.001 
<30 3.2 Age 
>30 2.2 
0.056 
live without partner 2.3 Marital status 
live with partner 3.3 
0.038 
local 2.5 Resident 
place transient 4.0 
0.048 
Han 2.4 Nation 
minority 4.0 
0.001 
<= 9 years 3.9 Education 
> 9 years 2.2 
0.001 
white collar 2.9 Profession 
blue collar 2.8 
0.062 
<600 2.9 
601-2000 2.4 
>2000 4.1 
Monthly 
income 
missing1 2.6 
0.340 
No 1.9 IDU 
Yes 3.7 
<0.001 
no commercial sex 2.6 
<=10 10.0 
Number of 
commercial 
sex partner in 
last 1 year >10 41.7 
<0.001 
No 2.6 commercial 
sex in last one 
year Yes 3.7 
0.077 
No 2.6 STD 
symptoms in 
last 1 year Yes 4.1 
0.017 
*Pearson Chi-Square 
1 32.5% were missing values in this category 
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3.5 Logistic Regression of Sample Characteristics and HIV and Syphilis 
Infection 
 
Logistic regression was used to analyse independent association between HIV and 
syphilis status and demographic factors and risk behaviours. 
 
At first, logistic regression was used to analyse independent association between HIV 
and syphilis infection,  and demographic and socio-economic characters.  
 
Based on logistic regression analysis, demographic factors significantly associated 
with HIV prevalence were shown in Table 3.16: minority versus Han-Chinese (OR 
3.38; 95% CI 2.53-4.52; p<0.001), education <=9 years versus >9 years (OR 1.47; 
95% CI 1.11-1.95; p<0.01), profession white collar versus blue collar (OR 1.42; 95% 
CI 1.07-1.88; p<0.05), resident place local vs. transient (OR 1.96; 95% CI 1.19-3.24; 
p<0.01). See Table 3.16. 
 
Table 3.16 Logistic regression analysis of the socio-demographic factors associated 
with HIV+ 
95.0% C.I.  OR 
Lower Upper p 
community vs. detoxification 
center 0.78 0.58 1.05 0.105 Sample source 
others vs. detoxification 
center 1.05 0.74 1.49 0.777 
Gender female vs. male 1.35 0.95 1.93 0.097 
Age <30 vs. >30 1.11 0.85 1.45 0.433 
Marital status live alone vs. live with partner 1.09 0.84 1.42 0.504 
Resident place local vs. transient 1.96 1.19 3.24 0.009 
Nation Minority vs. Han 3.38 2.53 4.52 <0.001 
601-2000 vs. <600 0.89 0.63 1.24 0.484 
>2000 vs. <600 0.48 0.20 1.12 0.088 Monthly income 
Missing1 vs. <600 1.04 0.77 1.41 0.796 
Profession white collar vs. blue collar 1.42 1.07 1.88 0.014 
Education <= 9 years vs. > 9 years 1.47 1.11 1.95 0.007 
 
132.5% were missing values in this category 
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Based on logistic regression analysis, demographic factors significantly associated 
with syphilis prevalence were shown in Table 3.17: sample source detoxification 
center versus others (OR 3.78; 95% CI 1.73-8.24; p=0.001), gender female versus 
male (OR 6.06; 95% CI 4.25-8.65; p<0.001), marital status live with partner versus 
live alone (OR 1.46; 95% CI 1.03-2.07; p<0.05), minority versus Han-Chinese (OR 
1.87; 95% CI 1.27-2.75; p<0.01), education <=9 years versus >9 years (OR 2.09; 95% 
CI 1.45-3.02; p<0.001), profession blue collar versus white collar (OR 1.47; 95% CI 
1.01-2.15; p<0.05), resident place local vs. transient. See Table 3.17. 
 
Table 3.17 Logistic regression analysis of the socio-demographic factors associated 
with syphilis 
95.0% C.I.  OR 
Lower Upper p 
detoxification center vs. Other 3.78 1.73 8.24 0.001 Sample source
community vs. Other 1.41 0.60 3.33 0.427 
Gender female vs. male 6.06 4.25 8.65 <0.001 
Age <30 vs. >30 1.11 0.78 1.59 0.558 
Marital status live with partner vs. live alone 1.46 1.03 2.07 0.032 
Resident place local vs. transient 0.80 0.52 1.24 0.321 
Nation Minority vs. Han 1.87 1.27 2.75 0.002 
601-2000 vs. <600 0.78 0.48 1.26 0.305 
>2000 vs. <600 1.40 0.73 2.67 0.307 Monthly income 
 
Missing1 vs. <600 0.82 0.55 1.23 0.335 
Profession blue collar vs. white collar 1.47 1.01 2.15 0.043 
Education <= 9 years vs. > 9 years 2.09 1.45 3.02 <0.001 
1 32.5% were missing values in this category 
 
 
Based on logistic regression analysis, demographic and behavioral factors 
significantly associated with HIV prevalence were shown in Table 3.18: minority 
versus Han-Chinese (OR 4.10; 95% CI 3.03-5.55; p<0.001), education <=9 years 
versus >9 years (OR 1.61; 95% CI 1.20-2.15; p=0.001), profession white collar versus 
blue collar (OR 1.69; 95% CI 1.25-2.27; p=0.001), injecting drugs without needle-
sharing versus not injecting (OR 2.49; 95% CI 1.77-3.52; p<0.001), injecting drugs 
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with needle-sharing versus not injecting (OR 4.44; 95% CI 3.19-6.19; p<0.001). See 
table 3.18. 
 
 
 
Table 3.18 Logistic regression analysis of all factors associated with HIV+ 
95% C.I.  p OR 
Lower Upper
community vs. detoxification 
center 0.105 0.77 0.56 1.06 Sample source 
others vs. detoxification center 0.806 0.96 0.66 1.38 
Gender female vs. male 0.335 1.21 0.82 1.78 
Age >30 vs. <30 0.706 0.94 0.70 1.28 
Marital status live with partner vs. live alone 0.913 0.98 0.75 1.29 
Resident place local vs. transient 0.061 1.64 0.98 2.76 
Nation Minority vs. Han <0.001 4.10 3.03 5.55 
Education <=9 years vs. >9 years 0.001 1.61 1.20 2.15 
Profession white collar vs. blue collar 0.001 1.69 1.25 2.27 
601-2000 vs. <600 0.494 0.89 0.62 1.25 
>2000 vs. <600 0.044 0.41 0.17 0.98 Monthly income 
missing1 vs. <600 0.527 1.11 0.81 1.52 
First drug use age >30 vs. <30 0.474 0.85 0.54 1.33 
IDU no share needles vs. Non-
IDU <0.001 2.49 1.77 3.52 IDU and share needles IDU share needles vs. Non-IDU <0.001 4.44 3.19 6.19 
never use vs. no commercial sex 0.533 1.62 0.36 7.36 
occasionally vs. no commercial 
sex 0.659 1.32 0.38 4.59 
frequency of use 
condom by 
commercial sex in 
last 1 year every time vs. no commercial sex 0.991 0.99 0.17 5.71 
STD symptoms in 
last 1 year Yes vs. No 0.231 0.80 0.55 1.16 
1 32.5% were missing values in this category 
 
 
Based on logistic regression analysis, demographic and behavioral factors 
significantly associated with syphilis prevalence were shown in Table 3.19: sample 
source detoxification center versus others (OR 3.49; 95% CI 1.59-7.66; p<0.01), 
gender female versus male (OR 5.14; 95% CI 3.49-7.56; p<0.001), minority versus 
Han-Chinese (OR 1.89; 95% CI 1.26-2.83; p<0.01), education <=9 years versus >9 
years (OR 2.27; 95% CI 1.55-3.32; p<0.001), injecting drugs without needle-sharing 
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versus not injecting (OR 1.70; 95% CI 1.10-2.64; p<0.05), injecting drugs with 
needle-sharing versus not injecting (OR 2.17; 95% CI 1.39-3.39; p=0.001). See table 
3.19. 
 
 
 
Table 3.19 Logistic regression analysis of all factors associated with syphilis 
95.0% C.I.  OR 
Lower Upper 
p 
detoxification center vs. Other 3.49 1.59 7.66 0.002 sample source 
 community vs. Other 1.27 0.53 3.02 0.590 
Gender female vs. male 5.14 3.49 7.56 <0.001
Age <30 vs. >30 0.93 0.62 1.38 0.705 
marital status live with partner vs. live alone 1.42 0.99 2.03 0.058 
Resident place local vs. transient 0.72 0.46 1.13 0.154 
Nation Minority vs. Han 1.89 1.26 2.83 0.002 
601-2000 vs. <600 0.71 0.43 1.18 0.183 
>2000 vs. <600 1.07 0.53 2.16 0.853 Monthly income 
Missing1 vs. <600 0.97 0.64 1.47 0.893 
Profession blue vs. white 1.24 0.84 1.85 0.280 
Education <= 9 years vs. > 9 years 2.27 1.55 3.32 <0.001
first drug use age >30 vs. <30 0.60 0.31 1.17 0.134 
IDU no share needles vs. Non-
IDU 1.70 1.10 2.64 0.017 IDU and share 
needles IDU share needles vs. Non-
IDU 2.17 1.39 3.39 0.001 
never use vs. No sex 0.60 0.11 3.36 0.563 
occasionally vs. No sex 1.34 0.37 4.86 0.658 
frequency of use 
condom by 
commercial sex in 
last 1 year every time vs. No sex 2.47 0.65 9.36 0.185 
STD symptoms in 
last 1 year Yes vs. No 1.14 0.72 1.81 0.570 
1 32.5% were missing values in this category 
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3.6 Sample Characters of Higher HIV-1 Prevalence Sites in Higher HIV-1 
Prevalence  Regions 
 
The major mode of HIV infection in the four provinces with the highest reported 
cases of HIV/AIDS, including Yunnan, Xinjiang, Guangxi and Sichuan, is attributed 
to injection drug use (MOH, China/WHO, 2004 & China CDC, 2003). In this study, 
the characteristics of the sentinel sites located in abovementioned provinces which 
HIV-1 prevalence was higher than 5% were listed below.  See Table 3.20 
 
In this study, the sentinel sites which the HIV-1 prevalence was over 5% in 
abovementioned higher  prevalence regions were Guangxi Nanning 21.0%, Xinjiang 
Kashi 10.8%, Sichuan Liangshan 29.4%, respectively; in which HIV-1 prevalence 
among IDU in these sites were 20.9% in Guangxi Nanning, 38.0% in Sichuan 
Liangshan, and 32.7% in Xinjiang Kashi, respectively. 
 
The most samples (99.3%) in Xinjiang Kashi were from detoxification center, in 
Guangxi Nanning over half of samples were from community (60.8%),  and in 
Sichuan Liangshan  over half of samples were from detoxification center (57.0%). 
Male accounted a enormously big part of samples in Sichuan Liangshan and Xinjiang 
Kashi, 93.2% and 96.6% respectively; whereas in Guangxi Nanning, male to female 
ratio was almost 1:1. More dug users in Sichuan Liangshan and Xinjiang Kashi were 
younger than 30, on the contrary, most drug users in Guangxi Nanning were elder 
than 30. Over 98% of drug users in Guangxi Nanning and Sichuan Liangshan were 
local resident, in Xinjiang Kashi all samples were local resident. Over 90% of drug 
users in Sichuan Liangshan and Xinjiang Kashi were minorities, however, the 
proportion of Han-Chinese in Guangxi Nanning was over 80%. Over 70% samples 
got more than 9 years education in Guangxi Nanning, whereas, Over 80% samples got 
less than 9 years education in Sichuan Liangshan. Most drug users use drug at 
younger than 30, 97.6% drug users in Guangxi Nanning were IDUs, only 36.2% and 
17.6% samples were IDUs in Sichuan Laingshan and Xinjiang Kashi respectively. 
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Most samples have had no commercial sex in last 12 months, and have had no STD 
symptoms in last 12 months. See Table  3.20. 
 
Table 3.20 Characteristics of samples in Guangxi Nanning, Sichuan Liangshan, and 
Xinjiang Kashi 
Variables 
Guangxi 
Nanning 
(N=291) %
Sichuan 
Liangshan 
(N=415) % 
Xinjiang 
Kashi 
(N=297) %
detoxification center 39.2 57.0 99.3 
community 60.8 16.9 0.7 Sample source 
others 0.0 26.1 0.0 
male 50.9 93.2 96.6 Gender 
female 49.1 6.8 3.4 
<30 43.6 66.0 71.7 Age 
>30 56.4 34.0 28.3 
live alone 63.6 34.4 52.2 Marital status 
live with partner 36.4 65.6 47.8 
local 98.6 99.8 100 Resident place 
transient 1.4 0.2 0.0 
Han 82.7 5.1 1.7 Nation 
Minority 17.3 94.9 98.3 
<= 9 years 25.1 84.7 55.4 Education 
> 9 years 74.9 15.3 44.6 
<600 40.5 63.1 85.2 
601-2000 9.6 10.1 9.1 
>2000 3.4 1.4 1.3 
Monthly income 
missing 46.4 25.3 4.4 
<30 90.6 82.4 83.7 First drug use age 
>30 9.4 17.6 16.3 
No 2.4 63.8 82.4 IDU 
Yes 97.6 36.2 17.6 
No 90.0 90.1 94.9 commercial sex in last 
12 months Yes 10.0 9.9 5.1 
No 86.6 80.9 93.5 STD symptoms in last 
12 months Yes 13.4 19.1 6.5 
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Based on logistic regression analysis, no demographic and behavioral factors 
significantly associated with HIV-1 prevalence in Guangxi Nanning. See table 3.21. 
 
 
Table 3.21 Logistic regression analysis of sample characteristics associated with HIV+ 
in Guangxi Nanning (HIV-1 prevalence 21.0%) 
95% C.I.  P OR 
Lower Upper
Sample source detoxification center vs. community 0.357 1.77 0.53 5.95 
Gender male vs. female 0.530 1.46 0.45 4.72 
Age <30 vs. >30 0.643 0.86 0.46 1.62 
Marital status live alone vs. live with partner 0.226 1.54 0.77 3.08 
Resident place local vs. transient 0.412 0.32 0.02 4.87 
Nation Han vs. Minority 0.599 1.26 0.54 2.93 
Education >9 years vs. <9 years 0.816 1.09 0.53 2.22 
601-2000 vs. <600 0.587 1.34 0.46 3.90 
>2000 vs. <600 0.366 0.35 0.04 3.39 Monthly income 
Missing1 vs. <600 0.830 0.93 0.47 1.83 
First drug use age <30 vs. >30 0.270 2.09 0.57 7.74 
IDU yes vs. no 0.558 2.08 0.18 24.18
Commercial sex in last 
12 months yes vs. no 0.277 1.67 0.66 4.18 
STD symptoms in last 
12 months yes vs. no 0.933 0.96 0.38 2.41 
1 46.4% were missing values in this category 
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Based on logistic regression analysis, demographic and behavioral factors 
significantly associated with HIV prevalence in Sichuan Liangshan were shown in 
Table 3.18: minority versus Han-Chinese (OR 9.96; 95% CI 1.24-80.26; p<0.05), 
IDU versus Non-IDU (OR 1.94; 95% CI 1.21-3.11; p<0.01). See table 3.22. 
 
 
Table 3.22 Logistic regression analysis of sample characteristics associated with HIV+ 
in Sichuan Liangshan (HIV-1 prevalence 29.4%) 
95% C.I.  P OR 
Lower Upper
community vs. detoxification 
center 0.054 2.01 0.99 4.10 Sample source 
others vs. detoxification center 0.072 1.72 0.95 3.11 
Gender male vs. female 0.761 0.87 0.37 2.09 
Age <30 vs. >30 0.713 0.89 0.47 1.68 
Marital status live alone vs. live with partner 0.814 0.94 0.57 1.56 
Nation Minority vs. Han 0.031 9.96 1.24 80.26
Education >9 years vs. <9 years 0.431 0.76 0.38 1.52 
601-2000 vs. <600 0.073 2.00 0.94 4.26 
>2000 vs. <600 0.666 0.60 0.06 6.07 Monthly income 
missing1 vs. <600 0.507 0.83 0.49 1.43 
First drug use age <30 vs. >30 0.721 1.16 0.52 2.57 
IDU yes vs. no 0.006 1.94 1.21 3.11 
Commercial sex in 
last 12 months yes vs. no 0.871 1.07 0.49 2.32 
STD symptoms in last 
12 months yes vs. no 0.554 0.83 0.45 1.54 
1 25.3% were missing values in this category 
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Based on logistic regression analysis, demographic and behavioral factors 
significantly associated with HIV prevalence in Xinjiang Kashi were shown in Table 
3.23: female versus male (OR 6.34; 95% CI 1.30-30.82; p<0.05), age <30 versus >30 
(OR 5.71; 95% CI 1.50-21.70; p<0.05), live with partner versus live alone (OR 2.97; 
95% CI 1.17-7.53; p<0.05), IDU versus Non-IDU (OR 6.25; 95% CI 2.46-15.87; 
p<0.001), have had commercial sex in last 12 months versus no commercial sex in 
last 12 months (OR 5.08; 95% CI 1.06-24.46; p<0.05). See table 3.23. 
 
Table 3.23 Logistic regression analysis of sample characteristics associated with HIV+ 
in Xinjiang Kashi (HIV-1 prevalence 10.8%) 
95% C.I.  P OR 
Lower Upper
Sample source detoxification center vs. community 0.084 0.08 0.01 1.41 
Gender female vs. male 0.022 6.34 1.30 30.82
Age <30 vs. >30 0.011 5.71 1.50 21.70
Marital status live with partner vs. live alone 0.022 2.97 1.17 7.53 
Education >9 years vs. <9 years 0.837 0.91 0.36 2.29 
IDU yes vs. no <0.001 6.25 2.46 15.87
Commercial sex in last 
12 months yes vs. no 0.043 5.08 1.06 24.46
STD symptoms in last 
12 months yes vs. no 0.455 0.53 0.10 2.82 
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3.7 Sample Characters of Higher Syphilis Prevalence Sites 
 
 
In this study, the sentinel sites which the syphilis prevalence was over 5% were 
Guangxi Nanning 17.5%, Xinjiang Kashi 10.4%, Guangdong Dongguan 9.6%, 
respectively. 
 
The almost all samples  in Xinjiang Kashi (99.3%) and in Guangdong Dongguan 
(99.8%) were from detoxification center, in Guangxi Nanning over half of samples 
were from community (60.8%). Male accounted a enormously big part of samples in 
Guangdong Dongguan and Xinjiang Kashi, 89.2% and 96.6% respectively; whereas in 
Guangxi Nanning, male to female ratio is almost 1:1. More dug users in Guangdong 
Dongguan and Xinjiang Kashi were younger than 30, on the contrary, most drug users 
in Guangxi Nanning were elder than 30. Over 98% of drug users in Guangxi Nanning 
were local resident, in Xinjiang Kashi all samples were local resident; whereas, 
transient drug seurs in Guangdong Dongguan were 71.3%. Over 90% of drug users in 
Xinjiang Kashi were minorities, however, the proportion of Han-Chinese in Guangxi 
Nanning and Guangdong Dongguan were over 80%. Over 70% samples got more than 
9 years education in Guangxi Nanning, whereas, Over 50% samples got less than 9 
years education in Xinjiang Kashi. Most drug users use drug at younger than 30, 
97.6% drug users in Guangxi Nanning were IDUs, 66.6% drug users in Guangdong 
Dongguan were IDUs, only 17.6% samples were IDUs in Xinjiang Kashi. Most 
samples have had no commercial sex in last 12 months, and have had no STD 
symptoms in last 12 months. See Table  3.24. 
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Table 3.24 Characteristics of samples in three higher syphilis sites (Guangxi Nanning, 
Guangdong Dongguan, and Xinjiang Kashi) 
Variables 
Guangxi 
Nanning 
(N=291) % 
Guangdong 
Dongguan 
(N=407) % 
Xinjiang 
Kashi 
(N=297) %
detoxification center 39.2 99.8 99.3 
community 60.8 0.0 0.7 Sample source 
others 0.0 0.0 0.0 
male 50.9 89.2 96.6 Gender 
female 49.1 9.8 3.4 
<30 43.6 70.3 71.7 Age 
>30 56.4 29.7 28.3 
live alone 63.6 63.6 52.2 Marital status 
live with partner 36.4 35.4 47.8 
local 98.6 28.5 100 Resident place 
transient 1.4 71.3 0.0 
Han 82.7 86.2 1.7 Nation 
Minority 17.3 11.5 98.3 
<= 9 years 25.1 35.6 55.4 Education 
> 9 years 74.9 63.1 44.6 
<600 40.5 13.5 85.2 
601-2000 9.6 36.4 9.1 
>2000 3.4 27.8 1.3 
Monthly income 
missing 46.4 22.4 4.4 
<30 90.6 88.2 83.7 First drug use age
>30 9.4 11.5 16.3 
No 2.4 33.2 82.4 IDU 
Yes 97.6 66.6 17.6 
No 90.0 76.9 94.9 commercial sex in 
last 12 months Yes 10.0 23.1 5.1 
No 86.6 78.1 93.5 STD symptoms in 
last 12 months Yes 13.4 21.4 6.5 
 
 
 
 
Chapter III: Results 
 84
 
 
 
Based on logistic regression analysis, demographic and behavioral factors 
significantly associated with syphilis in Guangdong Dongguan were shown in Table 
3.25: female versus male (OR 4.52; 95% CI 1.81-11.28; p=0.001), live with partner 
versus live alone (OR 3.96; 95% CI 1.71-9.17; p=0.001), <= 9 years education versus 
> 9 years education (OR 3.12; 95% CI 1.41-6.89; p<0.01), IDU versus Non-IDU 
(OR 2.81; 95% CI 1.09-7.24; p<0.05). See table 3.25. 
 
Table 3.25 Logistic regression analysis of sample characteristics associated with 
syphilis in Guangdong Dongguan (syphilis prevalence 9.6%) 
95% C.I.  P OR 
Lower Upper
Gender female vs. male 0.001 4.52 1.81 11.28
Age <30 vs. >30 0.052 2.72 0.99 7.46 
Marital status live with partner vs. live alone 0.001 3.96 1.71 9.17 
Nation Han vs. Minority 0.122 5.21 0.64 42.12
Resident place local vs. transient 0.418 0.67 0.26 1.75 
Education <= 9 years vs. >9 years 0.005 3.12 1.41 6.89 
601-2000 vs. <600 0.420 1.82 0.42 7.86 
>2000 vs. <600 0.208 2.61 0.59 11.58Monthly income 
missing1 vs. <600 0.155 2.93 0.67 12.93
IDU yes vs. no 0.033 2.81 1.09 7.24 
Commercial sex in 
last 12 months yes vs. no 0.943 1.04 0.40 2.66 
STD symptoms in last 
12 months yes vs. no 0.219 1.73 0.72 4.15 
1 22.4% were missing values in this category 
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Based on logistic regression analysis, demographic and behavioral factors 
significantly associated with syphilis in Guangxi Nanning were shown in Table 3.26: 
female versus male (OR 8.50; 95% CI 2.51-28.78; p=0.001). See table 3.26. 
 
Table 3.26 Logistic regression analysis of sample characteristics associated with 
syphilis in Guangxi Nanning (syphilis prevalence 17.5%) 
 
95% C.I.  P OR 
Lower Upper
Sample source detoxification center vs. community 0.502 1.41 0.52 3.88 
Gender female vs. male 0.001 8.50 2.51 28.78
Age <30 vs. >30 0.717 0.88 0.44 1.77 
Marital status live with partner vs. live alone 0.892 1.05 0.50 2.20 
Nation Han vs. Minority 0.926 0.96 0.42 2.19 
Education <= 9 years vs. >9 years 0.073 2.12 0.93 4.82 
601-2000 vs. <600 0.994 1.01 0.32 3.18 
>2000 vs. <600 0.575 0.60 0.10 3.53 Monthly income 
Missing1 vs. <600 0.855 0.93 0.41 2.08 
IDU yes vs. no 0.230 0.33 0.05 2.02 
Commercial sex in last 
12 months yes vs. no 0.697 1.20 0.48 2.98 
STD symptoms in last 
12 months yes vs. no 0.115 2.30 0.82 6.50 
1 46.4% were missing values in this category 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter III: Results 
 86
Based on logistic regression analysis, demographic and behavioral factors 
significantly associated with syphilis in Xinjiang Kashi were shown in Table 3.27: 
female versus male (OR 7.44; 95% CI 1.40-39.57; p<0.05), live with partner versus 
live alone (OR 2.51; 95% CI 1.05-6.00; p<0.05), education equal or less than 9 years 
versus more than 9 years (OR 3.06; 95% CI 1.12-8.39; p<0.05). See table 3.27. 
 
Table 3.27 Logistic regression analysis of sample characteristics associated with 
syphilis in Xinjiang Kashi (syphilis prevalence 10.4%) 
95% C.I.  P OR 
Lower Upper
Sample source detoxification center vs. community 0.095 0.09 0.01 1.53 
Gender female vs. male 0.019 7.44 1.40 39.57
Age <30 vs. >30 0.131 2.19 0.79 6.02 
Marital status live with partner vs. live alone 0.038 2.51 1.05 6.00 
Education <= 9 years vs. >9 years 0.030 3.06 1.12 8.39 
IDU yes vs. no 0.323 1.73 0.58 5.10 
STD symptoms in 
last 12 months yes vs. no 0.601 0.61 0.10 3.91 
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“In a world that is divided along many lines, we now have a unique opportunity to 
bring us all together around a common challenge in ensuring that the millions of 
people who are infected and affected by HIV and Aids are not forgotten, we will not 
only make a difference to their lives, we will also make a difference to our lives as 
well. We owe this at least to humanity.“ 
 
 
--- Nelson Mandela,  
(former President of South Africa, The Nobel Peace Prize 1993) 
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4.1 HIV/AIDS Among Drug Users in China 
 
HIV/AIDS second generation surveillance is an annual routine work in China; target 
population groups include DU, FSW, STD clients, MSM, long distance truck drivers 
and young students. Cross-sectional survey is conducted with standardized 
questionnaire, it helps to trace the behaviour change over time, to describe the 
HIV/AIDS epidemic, the selection of sentinel sites is adjusted according to the 
national and local current situation of HIV epidemic (China CDC, 2006).  After 
more than 20 years since the first HIV case was diagnosed in China in 1985, IDU is 
still the major mode of HIV transmission in China, though HIV transmission 
through heterosexual transmission is increasing (China CDC, 2003, 2004, 2005). 
 
Worldwide, injecting drug use plays a role of HIV/AIDS transmission. HIV 
transmission among IDUs has always been a serious problem in America because of 
the risks posed by sharing injecting equipment. A study in 1988 found that one in 
four persons with AIDS in the United States had injected illicit drugs (NIDA, 1988). 
21.5% of adult HIV diagnoses in 2003 and 26% of cumulative infections through 
2004 were in people who had probably been infected by sharing needles or by being 
the sexual partner of an IDU (CDC, 2004).  In 2004, some 34% of women and 21% 
of men who were diagnosed with HIV were injecting drug users (CDC, 2004). Over 
70% of all HIV cases in Russia occur in IDUs, WHO estimates that between 1.5 and 
3.5 million Russians are IDUs, and the prevalence of HIV in the drug-using 
population reaches 65% in some Russian cities (WHO, 2005). In west Europe, the 
prevalence of HIV infection in IDU was 16% in France, and 31% in Spain in 1999 
(Semaille, 2003). 89% of all HIV/AIDS cases are found in IDU in Tajikistan. It is 
estimated that up to 1% of the population of countries in former Soviet Union is 
injecting drug users, placing these people and their sexual partners at high risk of 
HIV infection. Outbreaks of IDU-related HIV/AIDS infection are already being 
reported in several Central Asian republics, including Kyrgyzstan, Tajikistan and 
Uzbekistan (WHO, 2005). 
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IDU is the major mode of HIV-1 transmission in China, the HIV/AIDS second 
generation surveillance among drug users in 2005 showed HIV-1 antibody 
prevalence was 5.0%, HIV-1 antibody prevalence was 6.6% among IDU,  and 
prevalence of positive syphilis antibody status (active or former syphilis) was 2.8%. 
In several sentinel sites no HIV cases were recorded, whereas in others the 
prevalence was as high as 21.0% in Guangxi Nanning, 10.8% in Xinjiang Kashi, 
and 29.4% in Sichuan Liangshan. A site in Yunnan province was excluded because 
lack of key information of risk behaviour in this study, however, HIV-1 prevalence 
was 54% (54/100) in this site. The sites with higher HIV prevalence all located in 
west and south-west regions along the drug trafficking route. The risk of HIV 
infection was associated predominantly with minority status, lower education,  and 
injecting drug use/sharing needles.  
 
Risk behaviours among drug users in China are mainly due to injecting drug and 
needle-sharing, and unprotected sex among drug users and their partners (Zheng et 
al, 1994). Injection drug use is the primary mode of transmission of HIV 
transmission in China. The cumulative number of reported HIV positive cases from 
1985 to 2004 was 89,067, in which IDUs accounted for 41% (MOH, China/WHO, 
2004). By the end of 2002, HIV positive has been found among drug users in all 
mainland 31 provinces, autonomous regions and municipalities (UNAIDS, 2004). By 
the end of 2005, there were approximately 650,000 people living with HIV/AIDS in 
China; in which 288,000 were  drug users living with HIV/AIDS, accounting for 
44.3% of the total number of estimated HIV cases (MOH, 2006). 
 
The epidemic is characterized by a wide disparity between high and low prevalence 
regions. The prevalence rate among IDUs is quite higher in  the south-western and 
north-western areas which border Laos, Myanmar, and Afghanistan; in some regions 
of Xinjiang, Yunnan and Sichuan even over 50% (MOH, China/WHO, 2004).The 
major mode of HIV infection in the above four provinces with the highest reported 
cases of HIV/AIDS, including Yunnan, Xinjiang, Guangxi and Sichuan, is attributed 
to injecting drug use (MOH, China/WHO, 2004 & China CDC, 2003). In these 
regions, the proportion of minority population is much more higher than overall 
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8.4% minority of the entire population (Xiao, et al, 2007), 30% of reported 
HIV/AIDS cases were from ethnic minority group (Deng et al, 2007).    
 
In this study, the sentinel sites which the HIV-1 prevalence was over 5% in 
abovementioned higher  prevalence regions were Guangxi Nanning 21.0%, Xinjiang 
Kashi 10.8%, Sichuan Liangshan 29.4%, respectively; definitely higher than other 
drug user sentinel sites; based on logistic regression analysis, demographic and 
behavioral factors that significantly associated with HIV prevalence were shown 
below: minority versus Han-Chinese (OR 4.10; 95% CI 3.03-5.55; p<0.001), 
education <=9 years versus >9 years (OR 1.61; 95% CI 1.20-2.15; p=0.001), 
profession white collar versus blue collar (OR 1.69; 95% CI 1.25-2.27; p=0.001), 
injecting drugs without needle-sharing versus not injecting (OR 2.49; 95% CI 1.77-
3.52; p<0.001), injecting drugs with needle-sharing versus not injecting (OR 4.44; 
95% CI 3.19-6.19; p<0.001). The rate of needle sharing among IDUs may indirectly 
affect or reflect the HIV infection rates and trends of HIV prevalence among IDUs. 
 
Yunnan is the HIV/AIDS hardest hit province in China, more epidemiological and 
molecular studies have conducted in Yunnan to trace the epidemic,  Yunnan 
suffered first HIV epidemic in China, and accounted the biggest number of HIV 
infections in China (China CDC, 2003). In 2004, the HIV-1 prevalence among IDUs 
in Yunnan was between 21.2%-27.8%, in some IDU groups, the HIV-1 prevalence 
was even over 80% (Lu et al, 2004). By the end of 2004, Yunnan had cumulatively 
reported 28,391 HIV infections (MOH, China/WHO; 2004). Zhang et al. studied 
HIV-1 patients in Yunnan using immunoassays found  HIV-1 subtype 
C/CRF07_BC/CRF08_BC and CRF01_AE were codominant among IDU, the 
discovery of many sexually transmitted CRF01_AE cases was new and suggested 
that HIV-1 could be transmitted through “bridge population” into general 
population, this subtype may lead to a new epidemic in the general Chinese 
population (Zhang et al., 2006). Yu et al. found unprotected sex continued to occur 
at high rates among IDUs and their sex partners in Yunnan (Yu et al., 2003). The 
same phenomena  also found in another HIV-1 molecular epidemiological study by 
Zhang et al. in 2004 in Xinjiang found HIV-1 infected by homo- or heterosexual 
 90
Dissertation: national  HIV/AIDS second generation surveillance on drug users in China, 2005 
transmission multiple subtypes of HIV-1 which were related to strains dominated 
among IDUs suggested HIV-1 has spread into general population (Zhang et al., 
2004).   
 
High prevalence of HIV-1 among IDUs found by Zhang et al in a cohort study was 
71.9% (174/242), needle/syringe sharing was the major risk factor, most HIV-1 
infected IDUs were unemployed, single, aged 20-35 years, and Han-Chinese; all 
three sites from Yunnan (Gejiu, Kaiyuan and Yanshan) located along the drug 
trafficking route (Zhang et al, 2002). The National Narcotic Control Commission 
also reported in 2002 that the majority of drug users were young people with a low 
education level and limited job skills (NNCC, 2002). Liu et al conducted a cohort 
HIV-1 sero-incidence study among drug users in rural Guangxi found baseline HIV-
1 antibody prevalence was 25% (172/702), and risk factors were elder male drug 
users who injected drug and shared rinse water (Liu et al., 2006-b). Li et al found 
HIV prevalence among IDUs was 17.8% (56/314) in southern Sichuan, it was 
significantly associated with minority status and frequently needle-sharing (Yin et 
al, 2007). A community-based study among IDUs in Sichuan conducted by Choi et 
al found HIV risk behaviour was significantly associated with younger age and less 
family support for male IDUs; and for female IDUs, it was significantly associated 
with having an IDU sex partner and economic pressure; the probability of condom 
use by female IDUs who engaged in commercial sex was low (Choi et al, 2006). 
 
In this study, based on logistic regression analysis, no demographic and behavioral 
factors significantly associated with HIV-1 prevalence in Guangxi Nanning; 
demographic and behavioral factors significantly associated with HIV prevalence in 
Sichuan Liangshan were: minority versus Han-Chinese (OR 9.96; 95% CI 1.24-
80.26; p<0.05), IDU versus Non-IDU (OR 1.94; 95% CI 1.21-3.11; p<0.01); 
demographic and behaviral factors significantly associated with HIV prevalence in 
Xinjiang Kashi were: female versus male (OR 6.34; 95% CI 1.30-30.82; p<0.05), 
age <30 versus >30 (OR 5.71; 95% CI 1.50-21.70; p<0.05), live with partner versus 
live alone (OR 2.97; 95% CI 1.17-7.53; p<0.05), IDU versus Non-IDU (OR 6.25; 
95% CI 2.46-15.87; p<0.001), have had commercial sex in last 12 months versus no 
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commercial sex in last 12 months (OR 5.08; 95% CI 1.06-24.46; p<0.05). The 
findings in this study are also coincident with results from other studies, Injecting 
drug is the leading risk factor among drug users, and most drug users are young 
male minorities with lower education and lower socio-economical class, the 
proportion of female drug users who engaged in commercial sex is higher; at the 
same time, HIV infection among Han-Chinese drug users increases; all these factors 
speed the HIV transmission between the higher risk population groups and from the 
higher risk population groups to the general population. 
 
A molecular study by Piyasirisilp  et al in 2000 discovered that some subtypes BC 
and CRF of HIV-1 dominated among IDUs in Yunnan have spread through drug 
trafficking to the neighbouring provinces of Guangxi and to the west province of 
Xinjiang (Piyasirisilp et al, 2000). Co-circulating of multiple subtypes of HIV-1 in 
China implies the possibility of interclade recombination. Beryer et al also found 
HIV-1 subtypes B, C, and a B/C recombinant subtype spread from Yunnan to north 
and west, to Xinjiang (Beryer et al, 2000). The close relationship between viruses 
found in Yunnan, Guangxi and Xinjiang strongly showed HIV-1 epidemic among 
IDUs in China is likely to have a common origin. A study in Xinjiang showed HIV 
prevalence among drug users was 24.5%, and among IDUs was significantly higher 
(56.1%) (Ni et al, 2006). Zhang et al. found in a cohort study in Xinjiang baseline 
HIV-1 prevalence among high-risk IDUs was 29% (228/781), HIV infection among 
IDUs in Xinjiang spread repidly (Zhang et al., 2007).   HIV-1 has already spread far 
beyond the south border provinces of Yunnan and Guangxi into the distant 
northwest province of Xinjiang and neighboring province of Sichuan. These studies 
approved the hypothesis that the HIV-1 virus disseminated widely into many other 
provinces and population groups in China originated in Yunnan (See Figure 4.1). 
There are also several cohort studies tried to identify the HIV incidence among 
IDUs. HIV incidence density during 12-month follow-up period found in these 
studies was more than 2 per 100 person-years among IDUs, and the incidence 
density rose with the follow-up (Zheng et al, 1994; Lai et al, 2001; Ruan et al, 
2005). Like HIV prevalence studies among drug users, these results also 
demonstrate that HIV is spreading rapidly among IDUs. 
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Figure 4.1 HIV transmission among drug users in China 
Source: China CDC, MOH 
 
 
 
HIV/AIDS second generation surveillance is a cross-sectional survey. In order to 
guarantee the representativeness and avoid the potential arrest of the samples’ illegal 
behaviours in China, anonymity and confidentiality are assured among drug users 
surveyed in second generation surveillance (China CDC, 2006). Aside from recall 
bias, this study had several limitations. A site in Yunnan province was excluded 
because lack of key information of risk behaviour, HIV-1 sero-prevalence was 54% 
(54/100) in this site. Some studies have found drug users were more  likely to 
engage in high-risk sexual behaviors, and most female drug users engaged in 
commercial sex (Zhang et al., 2002; Lau et al, 2005; Yang et al., 2005; Qian et al., 
2005; Tucker et al., 2005; Chu & Levy, 2005).  A number of studies suggested that 
HIV infection spread from high risk groups into the general population mainly due 
to sexual transmission (Zhang et al., 1999; Zhang et al., 2001; Huang et al., 2004; 
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MOH, China/WHO, 2004; Hesketh et al., 2005; Zhu et al., 2005, Shao, 2006; Lonn 
et al, 2007).  
 
The prevalence of HIV infection in this study could underrepresented the current 
situation among drug users in China.  The number of female drug users in this study 
was relatively low (15.2%). With such a lower proportion of female drug users and 
no answer of key questions, analysis that evaluated the association between HIV 
positive and risk behaviours among female drug users could not be given. Therefore, 
any conclusions regarding female-related risk behaviours, based on the results in 
this study, should be cautious.  
 
A particular tragedy of the AIDS epidemic is that the spread of HIV goes largely 
undetected until it has already disseminated widely in vulnerable populations. In the 
absence of effective ART, full-blown AIDS generally occurs 9 to 10 years after new 
HIV infection. Early surveillance systems, based on case reporting of persons 
presenting with symptoms of HIV-1 infection or AIDS to hospitals and clinics, are 
very helpful, thus, even second generation surveillance provides more useful 
information to trace the HIV epidemic and risk behaviour changing, HIV/AIDS 
reporting is still a useful tool to supply more useful information.  
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4.2 HIV Transmission Through “Bridge Population” from Drug Users to 
General Population 
 
A bridge that can transmit the HIV virus from IDUs to non drug user population is 
risk sexual activity (Rhodes & Malotte, 1996). A majority of IDUs in China are 
young heterosexual men. These men have the potential to transmit HIV virus to their 
sexual partners: commercial sex workers, girl friends, wives, etc., many who do not 
have the awareness of condom use (Tucker et al, 2005). Male drug users have the 
characters of multiple heterosexual partners and low condom use rate in comparison 
to male who do not use drug.  In addition, commercial sex work is on the rise in 
numerous Chinese cities since economic reform launched in China, and the overlap 
between injectiing drug use and commercial sex is high, i.e. a big part of female 
IDUs practice commercial sex work, and many of them do so in order to get drugs; a 
big part of male IDUs pay for sex (CDC, 2001).  
 
HIV transmission from sex workers to their clients is quite common, and these IDU 
male clients may subsequently infect their non-IDU sex partners. Unprotected 
sexual behavior among IDUs and their sex partners may create “bridge population” 
from high to low risk populations (Klee, 1996). The mobility and changing behavior 
of male bridge population could accelerate HIV infection from higher risk groups to 
general population through heterosexual contact. Thus, IDUs and sex workers act as 
a bridge for sexual HIV transmission between IDUs and non-IDUs in China, 
speeding a more widespread epidemic, while HIV and STD prevalence are more 
traditional metrics for the heterosexual spread of HIV. “Bridge population” is 
worthy of further consideration to predict transition from a concentrated epidemic to 
generalized one. See Figure 4.2 
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Figure 4.2  Risk behaviours and the potential for HIV spread in China 
Source: China CDC, MOH 
 
 
A cohort study showed that HIV prevalence among spouses of HIV infected persons 
increased from 3.1% in 1990 to 12.3% in 1997. In 1998, the HIV infection rate was 
0.3 percent. In 1999, it went up to 1.1 percent (MOH, 2000-a). A molecular study 
showed IDUs and their sexual partners in Kunming Yunnan, Nanning Guangxi, and 
Yining and Urumqi in Xinjiang carry HIV-1 CRF07 and CRF08 subtypes, it 
demonstrated these strains of HIV-1 have spread into the general population (Zhang 
et al, 2004). In 2006, Zhang et al conducted a large scale prefecture by prefecture 
HIV-1 infection molecular study in Yunnan, HIV-1 subtypes 
C/CRF07_BC/CRF08_BC and CRF01_AE predominate in Yunnan, accounting for 
53% and 40.5% of HIV-1 infections, respectively. Because 85.4% of CRF01_AE 
infections were acquired through sexual contact, while 90.9% of IDUs had 
C/CRF07_BC/CRF08_BC viruses (Zhang et al, 2006); IDUs still are dominant of 
HIV infection, there is an increasing proportion of HIV-1 infections through sexual 
transmission.  
 
HIV infection among Han-Chinese has increased more quickly than among ethnic 
minorities recently; the infection among rural-to-urban migrant workers is also 
increasing that speeds the HIV spread from rural to urban areas; and in some areas 
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inYunnan, HIV prevalence among pregnant women also increased; all factors show 
that HIV transmission through heterosexual contact is increasing, and HIV infection 
is spreading from higher risk population groups to general population (Liao et al, 
1997; Hesketh et al, 2005; Zhang et al, 2006). 
 
Sexual risk behaviours may contribute to the HIV infection among female IDUs. 
IDU dominated HIV epidemic in the late 1980s and throughout the 1990s has been 
gradually replaced by those infected through heterosexual contact or other routes in 
Yunnan; in Dehong county, Yunnan province, HIV prevalence was over 1% in 
pregnant woman, HIV epidemic in Yunnan is already in a generalised phase (Cohen, 
2004). STD clients and female sex workers are the two major components. Result of 
a  surveillance survey among drug users in Xinjiang showed only 19.2% drug users 
used condom by latest sex with their sex partners (Xinjiang CDC, 2005). In this 
study, risk factors significantly associated with syphilis status in Xinjiang Kashi 
were female drug users who lived with partner with lower education, risk factors 
significantly associated with syphilis status in Guangdong Dongguan were lower 
educated female injecting drug users who lived with partner, female drug users were 
also a risk factor for syphilis infection in Guangxi Nanning; further research should 
also investigate the partner’s drug use behaviour (See Chapter III); it also indicated 
female IDUs who engaged in commercial sex could spread the HIV-1 virus 
transmission into general population.  
 
Yang et al carried a systematic review of behavioural studies about heterosexual 
transmission of HIV in China in 2005, they found circa 30%-75% drug users have 
had multiple sexual partner, condom use rate was low; the number of female drug 
users was rising, and most of them (52-98%) engaged in commercial sex (Yang et 
al, 2005). A community-based study among IDUs in Sichuan conducted by Choi et 
al found HIV risk behaviour was significantly associated with younger age and less 
family support for male IDUs; and for female IDUs, it was significantly associated 
with having an IDU sex partner and economic pressure; the probability of condom 
use by female IDUs who engaged in commercial sex was low (Choi et al, 2006). 
Female drug users who engaged in commercial sex to support their drug use may 
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have no sufficient power to insist on condom use of their clients (Ferry & Anderson, 
1992; Huang et al., 2004). All these factors indicate HIV infection could transmitted 
easily from higher risk population to general population. Not only drug users who 
have connection with general population form the bridge, female sex workers, 
young migrant population and MSM who also engaged in heterosexual intercourse 
are also components fuelling the epidemic to accelerate the transmission from high 
risk group to general population.   
 
In this study, factors significantly associated with syphilis infection were female 
IDUs with lower education and minority status. Lin et al in 2006 reviewed 
systematically sero-prevalence studies related to China’s syphilis epidemic found 
syphilis infection is increasing not only among higher risk groups but also among 
low risk groups, it suggested unprotected sex intercourse could accelerate HIV 
transmission from higher risk groups to general population (Lin et al, 2006). A cross 
sectional study on female sex workers conducted by Yuan et al in Xichang, Sichuan 
showed high syphilis prevalence was dominated among FSWs along a drug 
trafficking route who engaged in unprotected sex and injected drug; it indicated a 
potential rapid HIV transmission from injecting female sex workers to general 
population; urgent intervention should be issued to break the bridge (Ruan et al, 
2006). Another sero prevalence survey on female sex workers in Yunnan found 
9.5% syphilis positive and HIV prevalence was 10% (52/505), and all HIV positives 
were IDUs (Chen et al, 2005). Most FSWs were at young age with lower education 
and high mobility and low condom use rate, all these factor would fuel the HIV 
epidemic spread from high risk population to general population (Lau et al., 2002; 
Chen et al, 2005). Huang et al conducted a study focused on HIV knowledge among 
female sex workers addressed HIV prevention strategy must consider the socio-
cultural aspect to promote the condom use and safe sex (Huang et al, 2004).  
 
The government must increase support for safe needle exchange programs to reduce 
the spread of HIV among the IDU population, at the same time, the government 
needs also to put more focus on drug prevention programs. Future HIV prevention 
strategies targeting IDUs should include sexual risk reduction to reduce the potential 
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spread between the IDUs and non-IDU populations and promote condom use. 
Besides traditional STD/HIV prevention services, targeting high risk sex workers 
and clients is of great value to make prevention activities success. With such 
alarmingly high rates of HIV infection among the IDUs and syphilis infection 
among female sex workers, this problem cannot be ignored; and the control of the 
sexual transmission of HIV in China will have a significant impact on the war 
against HIV epidemic, especially with a extensive mobile population and 
disproportioned male female ratio in China.  
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4.3 Intervention Strategy on Drug Users in China 
 
As of today, there is still no cure or vaccination against HIV/AIDS, and HIV virus 
transmission is highly related to individual behavior, such as, injecting drug/sharing 
needles, MSM, unprotected sex; so that behaviral intervention becomes an effective 
and efficient approach to prevent HIV/AIDS transmission. Working specifically 
with IDUs can help to reduce their risk of infection of HIV. As we know, the most 
risk behaviors among IDUs are injecting drug and sharing inject euiqpments, i.e. 
syringe, cotton, and rinse water, it means the intervention programmes among IDUs 
should concentrate on harm reduction behavior, that is abandon injecting behavior 
or use cleaning apparatus.  
Drug use is illegal in China. All identified drug users will be registered by Public 
Security Bureau (NNCC, 2002). The Chinese government typically takes 
"crackdown" actions and tries to remove this behaviour. Now, the Chinese 
government actively seeks to collaborate with neighbouring countries to prevent 
drug smuggling across borders. Chinese mass media have increased anti-drug 
education to the general population. School’s curricula also cover the anti-drug 
education. Methadone maintenance therapy is the main action that Chinese 
government taking for drug users to abandon their risk behaviour, The National 
Working Group for Community based Methadone Maintenance Therapy was 
established collectively by the Ministry of Health, the Ministry of Public Security, 
and the State Food and Drug Administration Guidelines for methadone maintenance 
therapy and needle exchange programs were enacted in early 2004 (MOH, 2004a). 
Methadone, a synthesized narcotic which is far less noxious than heroin, is widely 
used internationally as a substitute drug to help drug users to abandon their 
addiction. By the end of 2004, there were 34 methadone maintenance therapy clinics 
and 90 clean needle exchange service points across the country (Qian et al, 2006). 
To the middle of 2006, over 300 methadone maintenance therapy clinics were 
established and covered 21 provinces (China CDC, 2006). By the end of 2006, the 
total number of methadone maintenance treatment clinics reached 320, the average 
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capacity of each clinic was 200 patients per day (Gill & Okie, 2007). However, 
methadone maintenance therapy is a long-term therapy. The most drug users who 
stop methadone maintenance therapy will reuse drug.  
If IDUs are provided with information and clean injecting syringes/needles then 
they can be promoted to take action to prevent HIV infection. IDU-related HIV 
transmission can be greatly reduced by the provision of clean needles, so called 
'needle exchange'. Needle exchange programmes specifically address the high risk 
behaviour of IDUs - sharing needles. This strategy is therefore referred to as 'harm 
reduction', since it does not attempt to prevent or stop their drug use behavior, 
merely reduce the harm –risk behavior it causes them. Because it does not try to 
break the dependence on drugs that most drug users have, this strategy is usually far 
more successful at preventing HIV transmission.  After a long time of HIV/AIDS 
campaign in the world, today, most IDUs know the risks of sharing injecting 
equipment that transmit HIV virus, and do not do so through choice, but through a 
lack of alternatives. When they are able to access clean equipment, they would do 
so.  
 
In China, cleaning needle is easy accessible in urban areas because it is sole legally 
in all licensed pharmacies and clinics. However, most drug users in China live in 
rural areas and most of them can not afford the price of frequent use of cleaning 
needles. Needle exchange program offers drug users an opportunity that they can get 
cleaning needles for free or in a low affordble price. Needle exchange schemes have 
been shown by a number of studies than significantly reduced HIV transmission 
amongst IDUs. In 2006, 12 provinces in east and south China that have severe drug 
problems have established around 100 needle exchange centres. Needle exchange, 
together with community outreach work to IDUs, has caused a decrease in heroin 
use and drug-related crimes among participants. By the end of 2006, over 10,000 
drug users in Guangxi joined the needle exchange programmes, the needle exchange 
programmes also launched in other provinces that HIV epidemic dominated by 
IDUs, such as Yunnan, Xinjiang, and Sichuan (China CDC, 2006a). Li et al 
reported 20% of all drug users in Liuzhou have receieved harm reduction service (Li 
et al., 2007). At the same time, program has also launced in rural areas where public 
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health infrastructure is not well-developed; other additional services, like condom 
distribution, VCT, ARV therapy, and drug user education are offered to drug users, 
too (Liu, 2006).  
This study provides useful information with respect to the HIV-1 prevalence, risk 
behaviours and demographic characteristics associated with HIV infection among 
drug users in China. Since the emergence of epidemic, China has launched  HIV 
prevention and harm reduction program. A comprehensive program to prevent the 
further transmission of HIV among drug users has been implemented that includes 
community based harm reduction programmes, mainly methadone maintenance 
treatment and needle-syringe programme.  
 
In 2003, China announced a national AIDS control policy, “Four Frees and One 
Care” (free treatment, free Voluntary Counselling and Testing (VCT), free 
Prevention of Mother to Child Transmission (PMCT) and free schooling for AIDS 
orphans, and provision of social relief for HIV patients) (MOH, China/WHO, 2004). 
Large-scale intensive education programmes should also be conducted in all drug 
detoxification centres. Efforts should include  a series of activities: safe sex 
education, AIDS counselling, harm reduction, and treatment of HIV infected (Zhang 
et al., 1999). There are some aspects must be still considered, drug users who 
enrolled in methadone treatment or needle exchange programs only accounted a 
small proportion of the whole population group, the follow-up or after-care of drug 
users who go through detoxification center should be strengthened (Liu et al., 2006). 
These efforts are likely to require an infrastructure that not only provides operational 
and financial support, but also creates an environment in which drug users feel 
comfortable and safe in seeking help and non-discrimination. 
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4.4 Use of Surveillance Data 
 
Surveillance data with good quality could be used to improve HIV/AIDS campaign 
program, to assess the effectiveness of prevention, to provide convictive evidence 
for policy maker, and  generate response from the whole society and affected 
community. According to the guidelines for effective use of data from HIV 
surveillance systems by UNAIDS, surveillance data could be used in three main 
areas: programme planning, programme monitoring and evaluation, and advocacy 
(UNAIDS/WHO, 2004). 
 
Since HIV/AIDS first emerged in China in 1985, Chinese HIV/AIDS surveillance 
system has improved from passive surveillance to active surveillance, the system is 
getting more mature and well-organized. Based on high quality data, effective and 
efficient prevention and intervention strategies have been conducting through the 
country. Besides second generation surveillance data, there are multiple data sources 
available in China now, it includes case reporting data, sentinel surveillance data, 
STI surveillance data, vital statistics, and data from prevention of MTCT and VCT 
and antiretroviral treatment (China CDC, 2006). A number of epidemiological 
studies funded by NGOs or international organizations also provide useful 
information. All these data could be integrated to understand the HIV epidemic 
dynamics, to make right decision on AIDS policy and intervention. 
 
surveillance report is published annually in China. The report covers not only the 
information about surveillance methodology, surveillance site selection, participants 
selection protocol, the types of test used, quality control procedure, sample size and 
results; but also about behavioural information (China CDC, 2005). As an official 
data source, it could be used as an effective communication means with other 
government organisations, the media society, donor organisations and other 
interested blocs (Pervilhac et al, 2005), it provides convictive data to evaluate the 
implementation of prevention and intervention activities. 
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Surveillance data could be used in different level in a country, at the national level, 
the magnitude of the epidemic and its distribution in different geographical areas 
and subpopulations could be assessed with the help of national surveillance data; at 
the regional and local level, surveillance data could be used to identify affected 
areas, to seek solutions and to design strategies appropriately to the varying 
epidemic. Epidemiological survey in 2003 showed HIV prevalence among former 
commercial plasma donors was 2.7%, most cases (40%) were in Henan province 
(MOH, 2004); by the end of 2005, it is estimated circa 69,000 infections in this 
group, accounting for 10.7% of the total number of estimated HIV cases. Henan, the 
center of HIV epidemic among former commercial plasma donors, with Hubei, 
Anhui, Hebei, and Shanxi provinces, accounted for 80.4% of infections in this group 
(MOH, 2006). Based on data collected through sentinel surveillance and other 
epidemiological studies, a national screening program was conducted in China, it 
suggested that the epidemic has been more localized among this group (Wu et al, 
2001), all illegal blood collection sites were closed, and Chinese government 
enacted blood regulation law to ban any kind of illegal blood collection. AIDS care 
and treatment program have launched since then. 
 
HIV/AIDS surveillance data is also a very important data source for estimating the 
number of people living with HIV/AIDS in a country, to assess the HIV/AIDS 
burden, to allocate the prevention resource and to plan the care and treatment. HIV 
sentinel surveillance data primarily are used to calculate HIV prevalence with help 
of other epidemiological studies, such as epidemiological surveys, and surveys 
among former commercial blood and plasma donors and other key population 
groups. The number of people living with HIV/AIDS is estimated biennially 
according to UNAIDS. In 2005, it was estimated 650,000 HIV cases in China. There 
were approximately 288,000 drug users living with HIV/AIDS, accounting for 
44.3% of the total number of estimated HIV cases. Seven provinces – Yunnan, 
Xinjiang, Guangxi, Guangdong, Guizhou, Sichuan, and Hunan – each have had 
more than 10,000 drug users infected with HIV, and these 7 provinces accounted for 
89.5% of the HIV/AIDS cases among drug users (MOH, 2006).  
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Surveillance system and surveillance data trace the HIV/AIDS epidemic, provide 
useful information for Chinese government and policy maker. Especially, second 
generation surveillance is an on-going cross-sectional survey, it combines HIV 
surveillance, STI surveillance, and behavioural surveillance. Before surveillance 
data are collected, investigator should have some idea of how they will be used in 
planning and evaluating programmes or in advocacy. For drug users, the risks of 
HIV virus transmission are sharing injecting equipment and unprotected sex (Zheng 
et al, 1998). When the surveillance conducts repeatedly, and supplys with other 
useful information, such as ethnographic and qualitative research, geographical 
information; epidemic trend could be projected from abovementioned data source 
(UNAIDS, 2004). Additionally, the data could give a living picture of behaviour 
changing, it is not only very useful to estimate the size of at-risk population, but also 
for implementing effective and efficient prevention and intervention programs, such 
as, cleaning needle program for IDUs, methadone maintenance treatment for drug 
users, and condom promotion program.  It is still a challenge to understand well 
HIV/AIDS epidemic from limited data source (Foulkes, 1998; Raab & Parpia, 
2001). 
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4.5 Limitation of HIV Surveillance and Limitation of This Study 
 
Quality of surveillance system 
Second generation HIV/AIDS surveillance was developed by UNAIDS based on 
first generation HIV/AIDS surveillance that only concentrated on HIV sero-
prevalence, it combines HIV sero-prevalence surveillance, STI surveillance, and 
behavioral surveillance (UNAIDS/WHO, 2000). HIV infection is definitely related 
with higher risk behaviour, for example, unprotected homosexual contact between 
gay, unprotected heterosexual contact, sharing contaminated injecting equipment 
among IDUs; thus, to know the risk behaviour among higher risk population groups 
and behaviour changing among them will help policy maker and public health 
officers to implement effective and efficient prevention and intervention strategy, to 
trace the epidemic more accurately; so that the quality of HIV/AIDS surveillance 
system is of great importance. 
 
Since 1999, China launched HIV/AIDS second generation surveillance based on the 
guideline from UNAIDS, HIV/AIDS second surveillance is a routine work in China 
in a yearly round,  it includes following population groups: drug users, FSWs, STD 
clients, MSM, long distance truck drivers and young students (China CDC, 2003).  
The goal of the HIV/AIDS second surveillance is to provide a comprehensive 
picture of the HIV/AIDS epidemic in order to support prevention intervention 
strategy; NCAIDS is responsible for the collection, analysis, and interpretation of 
surveillance data. 
 
The UNAIDS/WHO Working Group on Global HIV/AIDS and STI Surveillance 
has developed coding schemes to represent four dimensions related to the quality of 
surveillance systems: “ 
• Frequency and timeliness of data collection; 
• Appropriateness of populations under surveillance; 
• Consistency of the sites/locations and groups measured over time; and 
• Coverage/representativeness of the groups for the adult populations” (Garcia-
Calleja et al, 2004). 
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The coding schemes depend on the level of the HIV epidemic in a country. The 
levels are defined as generalized, concentrated and low. Generalized epidemic of 
HIV/AIDS means HIV prevalence is over 1% among antenatal clinic attendees, 
concentrated epidemic of HIV/AIDS means HIV prevalence is below 1% among 
pregnant women but over 5% among populations with high risk behaviours, for 
example, IDUs, female sex workers, MSM;  low epidemic of HIV/AIDS means HIV 
prevalence is below 5% among populations with high risk behaviour. As a whole, 
China is a low epidemic country, HIV prevalence is lower than 0.1% (China CDC, 
2005), however, China is the most populous country and third large country in the 
world, China is a country with big geographical and socio-economical disparity. For 
the HIV/AIDS epidemic, if we consider China as a whole is a low epidemic country, 
the HIV epidemic in China would be underestimated, because the HIV epidemic is 
really pressing in some regions, for example, in Yunnan province, the hardest hit 
region in China, the HIV prevalence among pregnant woman is already over 1% in 
some part of Yunnan, the HIV prevalence among drug users in Yunnan, Xinjiang, 
Guangxi and Sichuan is also in a critical level, so that more attentions should be 
paid in this regions, and consideration should be taken China as a whole. 
 
There are some principles that help to design the sentinel surveillance surveys: 
• The sample should be representative of the target population. Representative 
samples are those samples who not recruited in the survey has an equal or 
known probability with samples who recruited in the survey. This is the primary 
challenge of cross-sectional surveys, and most cross-sectional survey could not 
guarantee the representativeness of sample.  
• Persons in the sample should be only included once. It is another challenge in 
surveillance activities that ensures that samples are not included multiple times. 
This challenge could be greater when the anonymity and confidentiality are 
guaranteed for target samples whose behaviours are illegal or discriminated, 
such as drug users in this study. 
• The time to complete the survey should be short. Ideally, a cross-sectional 
survey represents a single moment in time, estimating, for example, point 
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prevalence. If the sample is collected over too long a time period, temporal 
changes may misrepresent estimates.  
 
Only with the surveillance sites in right places could identify the distribution and 
magnitude of the HIV/AIDS epidemic on drug users, i.e.  drug users engaging in 
risk behaviour must be included in the surveillance system. The most sites selected 
in urban areas because of the accessibility and resource availability, it could 
overlook the situation in rural areas. The sample of population group is another key 
point to compare infection and behaviour over time especially in different 
geographical regions; for example, if data of drug users from two sites are 
compared, recruiting settings should be identical, i.e. both are from community or 
detoxification center, otherwise, the outcome might be misleading. Sample size also 
should be considerate. Based on the local condition, sample size could not always be 
guaranteed to reach the needed number, any conclusion from the data outcome 
should be cautious, for example, higher HIV prevalence among a small sample size 
of drug users is unlikely to reflect the real situation, confidence interval of the 
prevalence should always be paid attention to see how reliable the outcome is.  
 
The main aim of surveillance is to track trends over time. This is only possible when 
surveillance data is comparable between periodical rounds, thus, surveillance sites 
must be maintained over time. Trend data should only present data from sites used 
continually over the time period. The test method of HIV should also be identical. 
All investigated questions should be clearly definite before conduct survey, for 
example, if one wanted to look forward at the potential spread of HIV among drug 
users at young age, a core indicator would be the proportion who are injecting drug 
users and sharing needles,  and the proportion with risk sex behaviours. But does 
“injecting” mean “ever injected” or “currently injecting”? How current is current? 
At what age counts man as “young”? What counts as risk sex behaviours?  Are these 
who pay for sex or whatever unprotected sex? Were these distinctions clear to the 
subjects? All equivocal questions must be explained before survey in order to 
minimize the misunderstanding.  
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Drug users are normally marginalized and discriminated in the society, random 
samples of drug users are hard to obtain in most time, making comparisons across 
time questionable. Even with good internal consistency, the validity of self-reported 
data on drug use behaviour and sexual behaviour is frequently on doubt. Any 
conclusions about small rises or falls in infection, and surprising findings in 
behavioural surveillance should be cautious and investigated further. Data limitation 
should be aware, and in HIV/AIDS surveillance, data do not need to be perfect; but 
they do need to be good enough to provide a reliable evidence of the major trends in 
HIV infection and related risk behaviour. 
 
In order to guarantee the quality of surveillance, all investigators who conduct 
interview were trained before the survey, they should be familiar with the 
questionnaire and command some interview skills in order to get more accurate 
information. They should respect target samples, be neutral, and non-prejudice. 
Investigators should also have ability to deal with any accidental situations and 
avoid any conflicts with subjects, after survey, questionnaire should be carefully 
rechecked and corrected if there are any missing values and mistakes, even so, it is 
inevitable that subjects reject to answer some sensitive questions or could not 
remember accurately what  happened in the past. 
China has established an effective and good organized surveillance system in many 
of most hard-hit south-western and western regions (MOH, 2006), however, 
surveillance system in low prevalence provinces is less comprehensive, and less 
information collected related to general population  trends. Integrated social, 
economic, and behavioral research that helps planning the AIDS response is still 
premature (Kaufman et al., 2006). These data could be meaningfully used for 
understanding the role of individual risk behaviors and sexual networks for the 
potential transmission, and to understand the social and economic factors could 
determine these behaviors, such as poverty and social marginalization. Information 
related to access to care, health seeking, and health systems requirements is very 
helpful to design effective prevention and treatment strategy.  
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Representativeness of sample  
Regions that HIV/AIDS epidemic dominates by  drug users locate along  south-
western and north-western areas which border Laos, Myanmar, and Afghanistan. 
This study also demonstrates that higher HIV/AIDS prevalence regions in 
abovementioned area. The issue of sample representativeness is decisive in cross 
sectional survey. Biases can arise when drug users selected in this study do not 
represent the general drug users in China, however, it is really difficult to reach the 
general representativeness among drug users in China which is the most populous 
country in the world and big geographical and socio-economical disparity between 
different regions.   
 
The representativeness criterion is best satisfied by making certain that sampling 
locations are selected properly and a sufficient number of samples are collected. For 
example, it is proved by a number of studies that HIV/AIDS prevalence among drug 
users in Xinjiang is really higher (Gill & Song, 2006), however, in this study, one 
site in Xinjiang there was no HIV positive found. A study in Xinjiang showed HIV 
prevalence among drug users was 24.5%, and among IDUs was significantly higher 
(56.1%) (Ni et al, 2006). Zhang et al. found in a cohort study in Xinjiang baseline 
HIV-1 prevalence among high-risk IDUs was 29% (228/781) (Zhang et al., 2007).   
A site in Yunnan province was excluded because lack of key information of risk 
behaviour, HIV-1 sero-prevalence was 54% (54/100) in this site. Yunnan suffered 
first HIV epidemic in China, and accounted the biggest number of HIV infection in 
China.  
 
The selection of sentinel sites should base on the local epidemic level, other useful 
data that obtained from HIV incidence studies, Cohort studies, or pilot studies 
conducted by other organisations could be used to guide the selection of sentinel 
sites, while sentinel surveillance only collect the HIV prevalence data, HIV 
incidence data could provide more useful information on current HIV new infection 
among selected populations and temporal changing of risk behaviours. In some 
hardest hit regions in China, for example, Yunnan, Guangxi, Xinjiang, and Sichuan, 
more sites could be selected according to the availability of local resource. 
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Selection bias is most important bias in surveillance. Selection bias can cause if the 
HIV-related behaviors in surveyed subjects are different from those who do not 
participate in the survey. Rejection to be surveyed among subjects is an important 
potential resource of selective bias. HIV-related behavioral surveillance usually 
involve in the subject’s privacy or even the illegal behaviors, and the rejection-
related bias can easily cause if the behaviors are different between subjects who 
reject survey and those who accept survey. Rejection bias may cause under-
estimation of risk behaviors.   
 
Recall bias means drug user who already test and know his HIV/AIDS status or 
who know his risk behaviour has a high probability to be infected with HIV virus 
might recall certain behaviors or ‘exposures’  different that other drug users, such as 
sharing needles, commercial sex. 
 
China lacks the resources to carry out extensive surveillance in the countryside. 
Additionally, current surveillance protocols primarily cover only specific high risk 
groups. HIV-1 prevalence but not incidence was tracked in HIV/AIDS surveillance 
system, HIV-1 prevalence is defined as the proportion of persons who are infected 
with HIV-1 at a given point in time. In contrast, HIV-1 incidence is defined as the 
rate at which new HIV-1 infections occur in a population in a given period of time. 
The measures of HIV-1 prevalence and incidence have different uses in public 
health. While HIV-1 prevalence is a measure of the relative burden of disease in a 
population, HIV incidence indicates the extent to which transmission of the virus is 
occurring. HIV incidence can be used to understand the current spread of infection, 
appropriately target prevention resources to those most vulnerable to HIV, monitor 
and evaluate prevention efforts, identify masked or missed sub-epidemics, and 
closely track the emergence of new sub-epidemics of HIV in the general population.  
 
Sample size needed in sentinel surveillance is 300-400, however, in this study only 
10 sentinel sites reached the needed sample size (300-400), they were Gansu 
Wuwei, Guangdong Dongguan, Guizhou Qianxinan, Guizhou Tongren, Hebei 
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Shijiazhuang, Hubei Xiaogan, Hubei Jingzhou, Qinghai Haixi, Sichuan Liangshan, 
and Chongqing. The rest sentinel sites did not recruit the needed samples. The 
proportion of missing values of some key variables was quite higher, especially the 
variables related to the sexual behaviours, any conclusions regarding to sexual risk 
behaviours should be viewed with caution based on the outcome of this study. It 
should be paid attention for the henceforth surveillance to recruit enough samples, 
increase the quality of data and do best to decrease the missing values. 
 
 
Other data sources (e.g. blood screening data, one-off studies) should be used to 
calibrate prevalence estimates. HIV case reports are mainly useful in the early stage 
of an epidemic or in low-level epidemics. Clearly defined national protocols for 
HIV testing and surveillance should be developed, taking into account ethical issues. 
Linked HIV testing requires informed consent and appropriate follow-up of HIV-
positive cases. Particular attention should be paid to ensuring the continuous 
monitoring of trends of HIV prevalence in selected populations. HIV/AIDS 
reporting system should also integrate into existing communicable disease reporting 
systems to make use of available facility and human resources and therefore reduce 
cost. 
 
Ideally, time changing of the number and distribution of HIV new infections reflects 
current epidemic, however, these data are hard to obtain under current surveillance 
system. Thus, epidemiologists have used HIV prevalence data from sentinel 
surveillance to monitor HIV infection (Lu, 2004).  HIV sentinel surveillance data 
were analysed to calculate the prevalence of HIV by person, place and time; in 
which changes in HIV prevalence over time are of greatest value. Even though, 
over- or under-estimate the true prevalence of HIV may be caused by sentinel 
surveillance data because of the selection bias. If sentinel surveillance is conducted 
consistently year by year, the changes over time may reflect the real change of HIV 
prevalence. 
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4.6 AIDS Policy in China 
 
AIDS prevention and AIDS policy are the core of the combat against HIV/AIDS 
epidemic, they tested government’s ability to provide leadership in formulating an 
appropriate public response to the crisis. 
 
China has banned all blood products from abroad in 1985 (Xinhua Agency, 1985). In 
May 1996, Red Cross and Red Crescent Societies of China, India, Indonesia, Laos, 
Malaysia, Myanmar, Nepal, the Philippines, Thailand and Vietnam met in Beijing to 
create a reproductive health and AIDS prevention manual (Xinhua Agency, 1996). 
This manual is the basis in training 10,000 young adults "who, in turn, will cascade 
key HIV/AIDS prevention messages to young people in China and the other 
participating countries. In addition to youth peer education, member countries will 
also focus particularly on strategies to reduce the spread of HIV/AIDS among 
women, who much rely on their partners to practice safe sex and are, therefore, 
increasingly vulnerable to the deadly virus. In December 1996, the State Council 
issued new regulations on China's blood supply (DPA, 1996). The new laws 
promote all Chinese between the ages of 18 and 55 should donate blood, and calls 
for stricter measures to protect the nation's blood supply. The new law would ban 
paid blood donations and punish blood dealers. China's first law regarding blood 
donation enacted in October 1998 (China Daily, 1998). The law “lays down the 
rights and duties of Chinese citizens relating to the donation and use of blood as 
well as standardizing the practices of blood collection and supply institutes”. 
 
In the war against HIV/AIDS, the establishment of China CDC AIDS/STD centre in 
1998 is one of the most positive activities (NCAIDS, 1998),  it directs the HIV/AIDS 
prevention programs at the national level and established the HIV/AIDS Control 
Centers in every province, it institutes national guideline of HIV/AIDS activities, 
provides technical support, develop HIV/AIDS test methods and vaccine, and co-
operates with international organisations and other NGOs and interested parties.  
(The structure of China CDC, please see Figure 4.3) 
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Figure 4.3 The Structure of Chinese Center for Disease Control and Prevention 
Source: MOH, China; China CDC 
 
 
On 12 November 1998,  China officially released its Medium and Long-term 
Strategic Plan of AIDS Prevention and Control (1998-2010) by State Council (State 
Council, 1998). The plan aims to keep the number of China's HIV infections to 
under 1.5 million by the year 2010. This plan was formulated to promote timely 
HIV/AIDS prevention and control work by governments and sectors at all levels, to 
ensure that various strategies and measures are implemented, to enhance the 
capacity of all societies and communities to resist the disease, and to mitigate the 
impact of HIV/AIDS to the health of China’s people and to China’s socio-economic 
development, on the basis of both international and Chinese domestic experience. 
The general goals of this plan are: to establish a government-led system of 
HIV/AIDS and STDs prevention and control in which many sectors work together 
and the entire society participates,  and to disseminate needed knowledge to the 
whole society for the prevention and control of HIV/AIDS and STDs. 
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In 1999, MOH announced a new regulation on the rights of patients who have been 
infected with HIV/AIDS (MOH, 2001a).  The new regulation ensures the following 
rights for HIV/AIDS patients: the identity or address of any HIV/AIDS patient 
should keep confidentiality; medical personnel must keep the patient's medical 
information confidential, and all samples should be sent to authorized laboratory for 
confirmation; medical documents belonging to HIV/AIDS patients are considered 
confidential and are only to be handled by assigned personnel; all charged public 
health departments provide treatment for HIV/AIDS patients; no medical facility 
can refuse medical treatment to HIV/AIDS patients; HIV carriers and their children 
should keep their right to work, study or participate in social activities; HIV carriers 
are banned to donate blood, organs or other body fluids. 
 
On June 25 2001, The MOH announced an updated China's Action Plan for 
Reducing and Preventing the Spread of HIV/AIDS (2001 - 2005) aimed at keeping 
HIV infections below 1.5 million by 2010 (MOH, 2001-c). According to the new 
plan, blood for clinical use would have to undergo complete HIV testing. To ensure 
the safety of the blood, more than 85 percent of blood for clinical use should be 
provided by non-profit blood centers, and the rest can be supplied by authorized 
hospitals for their own use.  The plan also calls for the use of the media to promote 
tolerance and reduce discrimination and fear of HIV/AIDS victims. 
 
In October 2002, China's State Council passed a resolution on improving healthcare 
in rural areas. The resolution aims to reach 90 percent of children in rural areas (to 
be) getting vaccination against common epidemic diseases by 2010. By then, 95 
percent of rural counties should implement "modern measures" against tuberculosis 
by 2010; 75 percent of townships will offer HIV carriers and AIDS patients 
appropriate healthcare. The Chinese government has initiated a treatment program 
which will provide up to 100 counties AIDS medication (MOH, 2003). 
 
 
 
 115
Chapter IV: Discussion 
 
On World  AIDS 2003, Chinese Government announced an epoch-making AIDS 
policy: “Four Frees and One Care” policy (MOH, 2004), it stated for: 
• Free ARV drugs for AIDS patients who live in rural areas or urban residents 
with low life standard;  
• Free Voluntary Counselling and Testing (VCT); 
• Free drugs to reduce or interrupt mother to child transmission of HIV 
(inclusive free testing of newborns); 
• Free education for AIDS orphans; 
• Care and financial assistance to the households of people living with 
HIV/AIDS. 
 
This policy is a remarkable milestone of Chinese AIDS policy, it showed the 
Chinese government has tried his best to organize all sectors and the whole society 
in the fighting against HIV/AIDS, its influence is far beyond the HIV/AIDS field, it 
will also pose positive effect on current public health reform in China.  
 
Free antiretroviral therapy has reached 20,453 AIDS patients in China by the end of 
2005 (Shao, 2006). The new policy integrates prevention and treatment, with the 
massive propaganda and media coverage, people living with HIV/AIDS and people 
at risk are now voluntarily seeking testing, they are more cooperative with health 
care workers now. There are still some issues have to be considered in order to 
implement this policy more successfully. Well trained public health personnel is a 
pivot, care should also be offered to rural areas where large amount estimated AIDS 
cases occurred,  patients who enrolled in to AVT should keep adherence in order to 
prevent drug resistance (Xing et al, 2005). 
 
Accompanying with the improvement of HIV/AIDS surveillance in China, the 
budget invested on HIV/AIDS prevention, intervention, care, and vaccine research 
has increased simultaneously. In 2001, the Chinese government allocated 1.8 
million USD for its national AIDS budget, AIDS funding in 2001 was 12.4 million 
USD (Xinhua Agency, 2001), the AIDS budget increased significantly to about USD 
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12 million in 2002 (Zhu, 2003). The Chinese government increases input for  
HIV/AIDS prevention and control, moreover, input for HIV/AIDS prevention and 
control also increased at provincial level. Based on data from 29 provinces, the total 
direct allocation was USD 7 million from the provincial government in 2002 
(UNGASS, 2002). In 2003,  Chinese government allocated 350 million USD to 
support every province to improve the basic infrastructure of provincial CDC  
(former provincial anti-epidemic station) (China Daily, 2003); in the same year, 
China MOH announced 1.2 billion USD would invest in the following three years to 
develop an emergency pubic health response system at the national, provincial and 
local levels (Cui, 2003), 272 million USD also invested to strengthen China's blood 
testing centers in the central and western regions where HIV epidemic once was 
prevalent among commercial plasma donors (Xinhua Agency, 2003a). 
 
The spread of HIV/AIDS is becoming more and more a serious social problem in 
China, many of Chinese people take an indifferent attitude towards or condemn 
AIDS patients (Sun et al., 2007). Because of low awareness of AIDS among the 
general public, discrimination against people with HIV/AIDS and their families is 
still a big problem in China (zhang et al., 1999). Stigma and discrimination are 
accompanying the epidemic since the first case emerged, HIV infection occurs 
mainly already social marginalized groups, e.g. drug users, FSWs, MSM; therefore, 
the stigma attached to HIV is added based on pre-existed stigma towards social 
marginalized groups (Green, 1996); Stigma and discrimination is also a main barrier 
of HIV/AIDS prevention in China (Williams, 2007), it is crucial to overcome stigma 
and discrimination to win the war against AIDS. Social and cultural discrimination 
prevents people from wanting to know more about HIV/AIDS, and makes it even 
hard to prevent  HIV transmission (Deng et al, 2007). Stigma and discrimination are 
also very dangerous in that they may push the HIV-affected group to be 
marginalized, and to commit criminality and destabilizes society (Holzmann et al., 
2003). However, denial, resistance and non-cooperation won’t get rid of the 
epidemic, it could follow by the nightmare of a full-blown health crisis (World 
Bank, 1997); government should do his best to disseminate the knowledge of 
HIV/AIDS to public, to design effective communication strategy to break the silence 
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of AIDS, establish supportive public policy and  overcome  stigma and 
discrimination (Singhal & Rogers, 2003).  
 
The 2003 Chinese “Four Frees and One Care” policy was a landmark in war against 
HIV/AIDS, it provides medical, social, moral and economic support for HIV 
infected and AIDS patients (MOH, 2004); obviously, to achieve this goal will 
require an infrastructure that not only provides operational and financial support, but 
also develops an environment in which drug users and other marginal population 
groups feel comfortable and safe in seeking help and non-discrimination (Shao, 
2006). 
 
In 2006, with the help of CDC, China CDC initiated test-run HIV-1 BED assay to 
estimate the HIV incidence among target population (China CDC, 2006b). HIV 
incidence reflects the extent of HIV infection is occurring.  HIV incidence can be 
used to appropriately allocate prevention resources to those most vulnerable to HIV 
transmission, it helps to identify and detect masked or missed sub-epidemics, 
monitor the new emergence of HIV sub-epidemics in the general population, and 
measure the effect of prevention programs (CDC, 2005).  
 
HIV incidence is the more accurate information to plan the  targeted HIV prevention 
to measure the impact of HIV prevention programs; however, it is hard to measure.  
With the expanding anti-retroviral treatment programs, interpretation of  HIV 
prevalence survey data will become more complex, HIV incidence estimates 
become more valuable as an additional data source (Hu et al., 2003; Lu et al., 2006). 
BED HIV-1 incidence assay has launched in high HIV-1 prevalence provinces; e.g. 
Yunnan, Xinjiang, Sichuan, Chongqing, Guangxi and Guangdong since 1996 
(China CDC, 2007).  It provided more useful information for understanding the 
changing of HIV epidemic and risk behaviours. 
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China has a strong centralism politics, HIV/AIDS program could only be successful 
with government support; Chinese government has strengthened HIV/AIDS control 
efforts, improved and perfected HIV/AIDS policy, increased AIDS funding, and 
closely collaborated with international organizations.  
 
Some actions must be done by Central Government, necessary laws and regulations 
should be promulgated to enhance administration, and a network should be formed 
to combine publicity and education, health access to all, monitoring administration 
and follow-up services. The Chinese Government needs more openness to develop a 
quality AIDS policies for acknowledging the seriousness and potential of the 
epidemic. The AIDS response at all levels needs to be widened, and involve 
multiple sectors beyond the purely medical sector. Government plays a important 
role in training medical personnel in order to remove the discrimination against 
HIV-infected patients. Improving AIDS awareness needs capacity building, training, 
information dissemination, and efforts at promoting life skills and healthy life styles 
among public. 
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After more than two decades of emerge of HIV/AIDS, it is not only considered as 
the worst public health disaster, but also as a social and economic crisis. HIV/AIDS 
has emphasized the interaction between human behavior, community, health and 
disease, it is an increasing challenge to countries all over the world, both directly as 
a public health issue and indirectly through the human capital and economic loss. 
China's HIV/AIDS epidemic is associated with illiteracy, poverty, population 
mobility, and gender inequality. The major mode of HIV transmission in China is 
injecting drug use. By the end of 2005, there were approximately 650,000 people 
living with HIV/AIDS in China; in which 288,000 were drug users living with 
HIV/AIDS, accounting for 44.3% of the total number of estimated HIV cases 
(MOH, 2006). 
Since the first emerge of HIV/AIDS, HIV surveillance has became a core function 
of national HIV/AIDS programmes (WHO, 1988). AIDS cases reporting has been 
used as the primary AIDS surveillance tool since the epidemic, currently, HIV 
sentinel surveillance is the main epidemiological tool used to monitor trends in HIV 
infection prevalence in various population groups in a country, since 1999, WHO 
and UNAIDS initialled  “second-generation” surveillance, it integrated biological 
surveillance — i.e. HIV sentinel surveillance, reporting of AIDS cases, and 
surveillance of sexually transmitted infections (STIs) — and behavioural 
surveillance, it is comprised the core component of current surveillance systems 
(UNAIDS/WHO, 2000).  
HIV surveillance system in China  mainly  includes HIV/AIDS case reporting 
system and HIV sentinel surveillance system, there are also a number of special 
studies focusing on HIV infection related behaviours as supplement (CDC, 
China/CDC; 2002). Since 1999, China began conducting second generation 
surveillance targeted high-risk groups, vulnerable groups and the general public, e.g. 
drug users, FSWs, STD clinic attendees, MSM, long distance truck drivers, and 
young students (NCAIDS, 2001). China now has in place a surveillance network that 
covers all 31 provinces, autonomous regions and municipalities. Much more 
information than in the past is now available on epidemiological trend and risk 
behaviour. 
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HIV transmission in China has been mainly due to misuse of injectable drugs. In 
2003, the number of registered drug users was 1.05 million of which 643,000 used 
heroin; in which 74 percent of drug users are under the age of 35 and 80 percent of 
detained female drug users were also engaged in commercial sex (Luo, 2004). By 
the end of 2004, there were totally 1.14 million registered drug users in China 
(NNCC, 2002, 2005; Liu et al, 2006-a; Chu & Levy, 2005). Risk behaviours among 
drug users are mainly due to injecting drug and needle-sharing, and unprotected sex 
among drug users and their partners (Zheng et al, 1994). Yunnan is one of the areas 
of China with alarmingly high rates of drug use. Yunnan also has one of the highest 
prevalence rates of HIV infection. Intravenous drug use and sharing of needles are 
the primary causes of HIV/AIDS transmissions in the region. A number of studies 
have found HIV infection spread from Yunnan to other parts of China (Zheng et al, 
1994; Beryer et al, 2000; Piyasirisilp et al, 2000; Lai et al, 2001; Ruan et al, 2005; 
Zhang et al., 2006). 
 
A big part of drug users in China are young heterosexual men. These men have the 
potential to transmit HIV-1 to their sexual partners: commercial sex workers, 
girlfriends, wives, etc., many who do not have the awareness of condom use (Tucker 
et al, 2005). Male drug users have the characters of multiple heterosexual partners 
and low condom use rate in comparison to male not use drug; and female drug users 
are high likely to engage commercial sex.  Thus, the connection of injecting drug 
and unprotected sex could form a “bridge” of HIV transmission from risk population 
to general population. Not only drug users who have connection with general 
population form the bridge, female sex workers, young migrant population and 
MSM who also engaged heterosexual intercourse are also components fuelling the 
epidemic to accelerate the transmission from high risk group to general population.   
 
In this study, factors that significantly associated with HIV prevalence are minority 
status, lower education, injecting drug and sharing needles; factors significantly 
associated with syphilis infection are female IDUs with lower education and 
minority status (See Chapter III). A comprehensive program to prevent the further 
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transmission of HIV among drug users has been implemented in China that includes 
community based harm reduction programs, mainly methadone maintenance 
treatment and needle-syringe program, and safe sex education and condom 
promotion programs. 
 
In order to use surveillance data effectively for programme planning, programme 
monitoring and evaluation, and advocacy; the quality of surveillance data must be 
guaranteed. Surveillance system should combine HIV surveillance, STI 
surveillance, and behavioural surveillance. Before surveillance data are collected, 
investigator should have some ideas of how they will be used in planning and 
evaluating programmes or in advocacy. Data collection is not merely for analysis, it 
is used for protection of people not infected, and care of people already infected. 
HIV/AIDS surveillance should have ability to assess the epidemic trends and 
monitor the effectiveness of prevention and care activities. Sites conduct 
surveillance on HIV prevalence in selected populations (e.g. sentinel site surveys) 
should be continued and improved. However, HIV case reporting data could not be 
neglected, it is also a core element of HIV surveillance. Confidentiality and 
anonymity should be guaranteed.  
 
Surveillance data could be used in different level in a country, at the national level, 
the magnitude of the epidemic and its distribution in different geographical areas 
and subpopulations could be assessed with the help of national surveillance data; at 
regional and local level, surveillance data could be used to identify affected areas, to 
seek solutions and to design strategies appropriate to the varying epidemic. 
 
HIV/AIDS surveillance should be flexible, needs and objectives could be changed 
according to the epidemic trend. At present, obtain more specific epidemiological 
data is important to understand well the effects of treatment, and to design better 
prevention and control interventions in risk population and in general population. 
Second generation surveillance system have made progress in China, not only in 
tracing the HIV epidemic trend, but also  tracing sexually transmitted infection (e.g. 
syphilis)  risk behaviours. Data of diseases associated with HIV/AIDS, particularly 
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tuberculosis and other opportunistic infections should also be collected 
systematically. China has planed to integrate HIV/AIDS surveillance system with 
STD surveillance system to allow for better interpretation and prediction of trends. 
Surveillance reports created by computing, interpreting and analyzing data collected 
from the HIV surveillance system; STD surveillance, HIV/AIDS reporting, 
behavioral surveillance and other epidemiological research published by China CDC 
AIDS/STD center quarterly and annually (China CDC, 2005). An effective 
surveillance system can orient the national AIDS strategy, trace HIV/AIDS trends, 
and provide early-warning the pubic of any coming epidemic. 
 
Since 2003, free anti-retroviral therapy has provided under “Four Frees and One 
care” policy, the anti-retroviral therapy is developed and monitored and documented  
by national HIV/AIDS clinical team. By the end of 2006, there were more than 
30,640 patients have been treated in mainland China (Wu et al, 2007). Consideration 
of side effect and drug resistance, China has established viral load and resistance 
monitoring system and trained clinicians and health care professionals to understand 
the drug resistance and appropriate drug regimens (Zhang et al., 2006a; Shao 
2006a). In March 2006, the first legislation directly related to HIV/AIDS was issued 
by State Council of China: The AIDS Prevention and Control Regulations (State 
Council, 2006). It was an decisive measure that Chinese government has recognized 
that HIV/AIDS is not only a pure public health issue, its impact will impair 
economic and social development, all sectors that related to the prevention and 
control of HIV/AIDS must integrate. A national HIV/AIDS prevention and control 
committee has set up headed by vice-prime minister; and each province has set up 
its subsidiary office correspondingly.  
 
The epidemic is growing in different parts of China, it is getting even more 
fugacious, thus, the surveillance system should emphasize on support for decision 
making, not merely data collection; surveillance activities should be adjusted to the 
needs of the community. Underreporting of HIV infection and imbalance between 
urban and rural areas are the two major barriers on AIDS epidemiological analysis 
and implementation of prevention strategy. Rural areas are lack of resources to carry 
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out extensive surveillance, and the infrastructure in rural areas is weak. 
Additionally, current surveillance protocols primarily cover mainly specific high 
risk groups and in specific regions. More efforts are needed to promote an 
integration of the whole society to create an environment in which drug users and 
other marginalized population groups feel comfortable and safe in seeking help,  
community settings should provide resources for information, social interactive 
support, crisis resolution, and social integration and non-discrimination (Trickett, 
2005). It is of great importance that intervention and prevention strategy for a target 
population group must be based on the unique risk circumstances of this group, 
though standard principles have been issued for effective risk reduction counselling 
(Kerry 1995). 
HIV/AIDS as a national development threat, is not purely a medical and health 
problem, it requires a multidisciplinary approach for its prevention and care. AIDS 
is not simply a public health problem. It is  rather a complex social problem. The 
whole society should and must get involved and share responsibility for  actively 
working together to solve this problem. Chinese Government must not miss any 
opportunity to implement all HIV prevention and control policies and measures to  
reduce the impact  that HIV causes to the people and society.  
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Appendix 
Questionnaire for drug users 
Analysed variables 
 
 A01 Surveillance sites  
            Province (autonomy region, metropolitan)        City        ________District (County) 
A06 Source of sample  
① Detox center      ② Community     ③ （ Other Please, n ）otice __________               
A07 Blood taking    ①Yes        ②No（ ）skip to signature  
A08 Result of HIV test   First  ELISA  ①Positive     ②Negative 
         Second ELISA  ①Positive     ②Negative 
A09Result of syphilis test   RPR    ①Positive     ②Negative 
 
Interviewer                   Supervisor                 Charge person at surveillance site                
 
 
Hallo, my name is ……, I am working for……, we are conducting a survey now, to 
know about the knowledge and behavior about some health issues, please do not worry, this 
survey is anonym, we will keep confidentiality about your answers. Your honest answers to 
these questions will help us better understand what people think, say and do about certain 
kinds of behaviors. We would greatly appreciate your help in responding to this survey. The 
survey will take about 10 minutes, we could offer your some help about health issues (e.g. 
you can ask us some questions about health, we will try our best to explain). We hope you 
will support us. Thank you! 
 
Have you been interviewed in the past few weeks [or other appropriate time period] for this 
study? IF THE RESPONDENT HAS BEEN INTERVIEWED BEFORE DURING THIS 
ROUND, DO NOT INTERVIEW THIS PERSON AGAIN. 
 
B01 Gender             ① male  ② female 
B02 Birth year                Year 
B03 Marital status ① not married     ② married     ③ co-habit          ④ divorce/widow 
 141
B04 Resident place  ① local resident      ② transient （ resident Please notice         
Province）_____ 
B05 Nation ______                
 
B06 Education  ① illiteracy    ② primary school    ③ middle school   
                                               ④ high school     ⑤ college or above 
B07 Profession  ① Student  ② Teacher  ③ Nursemaid  ④  food industry  
                                                ⑤ commercial service  ⑥ medical staff ⑦ industrial worker 
                                                ⑧ mobile worker  ⑨ peasant  ⑩ farmer  (11) fisher/seaman 
                                                 (12) white collar  (13) pensioner (14) house worker/no job 
                                               (15) （ ）other please, notice ______           
 
C01 Can a person who infected HIV looks health?       
① Yes  ② No  ③ Not know 
C02 Can a person infects HIV through transfusion HIV infected blood or blood product? 
 ① Yes  ② No  ③ Not know 
C03 Can a person infects HIV if he/she shares needles with HIV infected person? 
  ① Yes  ② No  ③ Not know 
C04 Can the risk of transmission HIV decreases if condom is used properly by sex at every 
time?   
① Yes  ② No  ③ Not know 
C05 Can the risk of transmission HIV decrease if you have a non-infect fix sex partner? 
  ① Yes  ② No  ③ Not know 
C06 Can a HIV infected pregnant woman transmit HIV virus to her unborn child? 
  ① Yes  ② No  ③ Not know 
C07 Can a person get HIV infection if he/she shares meat with HIV infected person? 
   ① Yes  ② No  ③ Not know 
C08 Can mosquito bite transmit HIV virus?  
       ① Yes  ② No  ③ Not know 
C09 In the last year, have you ever tested for HIV?       
① Yes    ② No（ ）Skip to D01   ③Not know 
（ ）C10 Do you know the test result? Do not need tell me the result  
    ① Yes      ② No 
 
D01 At what age did you use drug first time? 
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         ①       age ② reject 
D03 Did you ever inject drug? 
    ① Yes    ② No（ ）skip to D11  ③ Reject 
 
D04 At what age did you inject drug for first time? 
      ①        age    ② Reject 
 
D05 Have you ever injected drug in last one month?    
① Yes       ② No   ③ Reject 
（for drug user in detox center, last one month means one month before going into detox 
）center  
D06 Did you ever share needles with other person?    
① Yes  ② No（ ）skip to D10   ③ Reject 
D07 Did you share needles with other person by last time injection? 
 ① Yes  ② No  ③ Reject 
D08 Did you share needles with other person by injection in last one month? 
   ① Yes  ② No  ③ Reject 
（for drug user in detox center, last one month means one month before going into detox 
）center  
D09 How often did you share needles with others when you injected drug in last 6 months? 
 
① Never  ② Occasionally  ③ every time  ④ Reject 
？D11 Have you ever been in detox center （for drug user already in detox center, please 
choose ①）   
①Yes ② No ③ Reject 
 
 
 
E01 Have you had sex in last month?       
① Yes  ② No（ ）skip to E03  ③ Reject 
E02 Did you use condom by last sex?     
① Yes  ② No  ③ Reject 
 
 
G01In last one year, have you got commercial sex through paying or offer drug? 
① Yes       ② No（ ）skip to H01       ③ Reject 
G02 In last one year, how many commercial sex partners have you had through paying or 
offer drug?  
①       person  ②can not remember ③ Reject  
G03 Did you use condom by last commercial sex?  
① Yes  ② No   ③ Reject 
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G04 How often did you use condom with such commercial sex partner in last one year? 
① Never  ② Occasionally  ③ every time  ④ Reject 
 
H01 In last one year, have you provided sex service in order to get pay or drug?  
① Yes   ② No（ ）skip to I01  ③ Reject 
H02 In last one year, how many commercial sex partners have you had in order to get pay or 
drug? 
①       person  ②can not remember ③ Reject  
H03 Did you use condom with last commercial sex partner?  
① Yes  ② No   ③ Reject 
H04 How often did you use condom with such commercial sex partner in last one year? 
① Never  ② Occasionally  ③ every time  ④ Reject 
 
J01 In the last year, have you got following symptoms: emiction ache/burn, urethra/vagina 
secretion abnormal, genitals derma trauma/hyperplasia? 
  ① Yes  ② No（ ）skip to K01   ③ Reject 
J02 How did you handle it if you had above symptoms? （ ）multiple choice possible  
① to STD clinic  ② to general hospital  ③ to private clinic  ④ 
bought medicine by self         ⑤ did nothing  ⑥ to woman health hospital 
 ⑦ （ other please, notice）           ⑧ Reject 
 
 
In last year, have you ever got following HIV prevention services? 
 
K01Needle exchange/clean needle distribution 
① Yes  ② No 
K02 Methadone 
① Yes  ② No 
K03Partner education 
① Yes  ② No 
K04 Condom distribution          
① Yes  ② No 
K05 HIV counseling and test 
① Yes  ② No 
K06 AIDS/STD brochures 
① Yes  ② No 
 
 
 
E ，nd of interview thanks for your co-operation. 
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Summaries 
 
 
 
National HIV/AIDS second generation surveillance on drug users in 2005 in 
China 
1. Abstract 
 
Aim: To determine prevalence of HIV-1, risk behaviours and demographic 
characteristics associated with HIV-1 infection among drug users in China based on 
the national second-generation surveillance on drug users in 2005. 
 
Methods:  National HIV/AIDS second-generation surveillance is a routine work in 
China; the data on drug users in 2005 were analysed; HIV-1 antibody status was 
obtained from blood tests; demographic and behavioural data were collected through 
standardized interviews. In total, 6539 records from 21 surveillance sites were 
obtained.  After data cleaning, a total of 5890 records were included in the analysis. 
Logistic regression was used to analyse independent association between HIV-1 status 
and risk behaviours.  
 
Results: HIV-1 antibody prevalence was 5.0%, with large regional differences. 52.7% 
drug users in this study once injected drug, HIV-1 antibody prevalence was 6.6% 
among injecting drug users. Syphilis antibody prevalence was 2.8%. Based on logistic 
regression analysis, demographic and behavioral factors significantly associated with 
HIV prevalence were: minority versus Han-Chinese (OR 4.10; 95% CI 3.03-5.55; 
p<0.001), education <=9 years versus >9 years (OR 1.61; 95% CI 1.20-2.15; p=0.001), 
injecting drugs without needle-sharing versus not injecting (OR 2.49; 95% CI 1.77-
3.52; p<0.001), injecting drugs with needle-sharing versus not injecting (OR 4.44; 
95% CI 3.19-6.19; p<0.001). 
  
Conclusion:  Prevalence of HIV-1 infection among drug users in China is relatively 
high (5%) and the risk of HIV-1 infection is associated predominantly with minority 
status, education equal or smaller than 9 years, and injecting drug use. Special 
interventions among drug users in China are warranted.  
 
Keywords: HIV/AIDS, drug user, IDU, China 
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2. Summary 
 
Introduction 
 
Injecting drug use (IDU) is the major mode of HIV transmission in China (China 
CDC, 2003). Historically, drug abuse in China referred only to the smoking of opium. 
In late 1980s, heroin abuse first emerged as a problem in China’s border regions with 
the opium-growing countries (Zhang & Ma, 2002; UNAIDS, 2000). The progression 
from non-injecting to injecting drug-use is now increasingly common (UNAIDS, 
2000). Drug use is illegal in China, all identified drug users are registered by Public 
Security Bureau. By the end of 2004, there were cumulative 1.14 million registered 
drug users in China (Liu et al., 2006-a), However, the real number of drug users in 
China could be much higher, since drug users may try to avoid registration which is 
potentially associated with being arrested. A study in central China found that 45%-
92% of all drug users in 4 investigated cities injected drugs at least once (Cheng et al, 
2003). Widespread drug injection was an early source of HIV infection in China 
especially in the southern border provinces. The rapid increase in heroin injecting in 
this population appears to have triggered an explosive HIV epidemic (Xiao et al, 
2007). Up to the end of 2004 injecting drug users (IDUs) accounted for about 70% of 
total cumulative reported HIV infections in China (China CDC, 2005). The number of 
provinces that have reported HIV infections among IDUs increased from one 
province in 1994 to 21 provinces in 1999 (China CDC, 2003). By the end of 2005, 
there were approximately 650,000 people currently living with HIV/AIDS in China, 
including approximately 288,000 drug users (both IDUs and non-IDUs), accounting 
for 44.3% of the total number of estimated HIV cases. Outbreaks of HIV infections 
have been reported among IDUs in Yunnan, Xinjiang, Guangxi, Sichuan, and 
Guangdong provinces and autonomous regions (China CDC, 2005). HIV prevalence 
among IDUs has reached 20%-30% in some areas in these provinces, and even 
reached 60%-80% in Ruili, Yunnan Province and in Yining, Xinjiang Autonomous 
Region. Seven provinces – Yunnan, Xinjiang, Guangxi, Guangdong, Guizhou, 
Sichuan, and Hunan – each have more than 10,000 drug users infected with HIV, and 
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these 7 provinces account for 89.5% of the HIV/AIDS cases among drug users in 
China (WHO, UNAIDS; 2006). 
 
Frequent risk behaviours for HIV infections among IDUs are needle-sharing, and 
unprotected sex (Zheng et al, 1994). Despite information campaigns large numbers of 
IDUs in China continue to share equipment (73% in Hunan, 81% in Jiangxi and 100% 
in Xinjiang) (China CDC, 2004/MAP, 2005). Also unprotected sex is common and 
the increasing  of HIV prevalence among commercial sex workers, many of whom 
inject drugs, may lead to spread of HIV into the general population (Zhang & Ma, 
2002).  
 
HIV surveillance system in China includes HIV/AIDS case reporting system and HIV 
sentinel surveillance system, there are also a number of special epidemiological 
studies focusing on HIV related behaviours as supplement (China, CDC/CDC; 2002). 
HIV/AIDS case reporting was set up at the national level in 1985 (Yuan & Li; 1997). 
HIV/AIDS case reporting is a passive HIV surveillance tool, all identified HIV 
infection and AIDS cases are reported to China CDC through net-based direct 
reporting system with an individual code to avoid multiple registration, and a 
nationally standardized form is used for HIV/AIDS case reporting, this form includes 
demographic information such as gender, age, resident place and nation; and 
HIV/AIDS related co-infection and syndromes.   
 
The passive reporting is supplemented by HIV surveillance which is targeted towards 
selected population groups, which was launched in China  since 1995 (Xinhua News 
Agency, 2003). China CDC and provincial CDCs are responsible for national and 
provincial sentinel surveillance, respectively. In 1999, the second generation 
surveillance was initiated. HIV/AIDS second generation surveillance combines HIV 
sero-prevalence surveillance and behavioural surveillance, in difference to standard 
sentinel surveillance which focuses on HIV sero-prevalence data only. Up to the end 
of 2005, there were total 105 comprehensive (second generation surveillance) sentinel 
sites in China focusing on drug users, female sex workers, STD clinic clients, MSM, 
male long distance truck drivers and students (China CDC, 2005). The number of 
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sites collecting data each year is selected based on local HIV epidemic level and 
resource availability. Priority should be given to keep the sustainability of sentinel site, 
it means the same sites should be selected inner province, and new sites should be 
added. Provinces that HIV prevalence among drug users over 5% should set at least 1 
surveillance site, sites in provinces that HIV prevalence among drug users below 5%  
or HIV positive was not found could also be selected to compare the difference of 
demographic characteristics and risk behaviors in different sites. Factors like local 
socio-economical level, local medical resource, and floating population should also be 
considered when decide to set surveillance sites.  
 
The aims of our analysis are to describe the results of second generation surveillance 
among drug users in China conducted in 2005, to assess the prevalence of the HIV 
infection, risk behaviours and their relationship to each other accounting for regional 
differences.  
 
Method 
 
Study sample 
 
In 2005, according to the HIV prevalence obtained from HIV/AIDS case reporting 
system and other epidemiological studies in every province associated local resource 
in different regions, 22 drug user sentinel sites from 14 provinces were selected in 
2005. Each site was requested to provide between 300 and 400 participants. In order 
to avoid prosecution by law and increase participation, anonymity and confidentiality 
were guaranteed to the drug users when they participated in the surveillance. The 
participants can be recruited from community where most drug users reside and use 
drugs, from detoxification centres and from other places like bars, street outreach 
which different from drug user communities etc. The sampling methods that used for 
recruiting drug users could be convenience sampling method and snowball sampling 
method. Convenience sampling method means investigators interview with key 
informants, local surveillance department, Public Security Bureau and community 
members that who know the places where local drug users reside and use drugs. If the 
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drug user found by this way rejects to be investigated, next drug user could be 
recruited and so on until the expected sample size is reached. Snowball method is that 
investigators should find a key informant or a drug user recognized by local 
surveillance department and this informant or drug user gives the names, address, and 
other contact information of second drug user (or second group of drug users) for 
investigation, who provides the names, address, and other contact information of third 
drug user (or third group of drug users) in the same way, and so on to increase 
samples through snowball sampling process until the expected number of sample size 
is reached. The blood specimen was collected on-site and tested in provincial CDC.  
 
Drug users from community have the better representativeness, because drug users in 
community are random distributed, but there are difficulties to recruit enough subjects 
because of their hidden behaviours. Drug users at detoxification centers are easily to 
recruit and cooperate but have a problem in representativeness. Each sentinel site 
should be based on their local situation to try the community-based surveillance.  
 
Data collection period was from July to September 2005, but could be prolonged in 
the case sites were not able to collect the requested number of cases. If so, the needed 
size of samples was still not reached, then local investigators could contact China 
CDC who decided to end the sampling process. During the surveillance period, 
questionnaire survey was conducted and serum specimen were collected from all 
samples who participated survey. HIV antibody status was obtained from blood tests; 
demographic and behavioural data were collected through standardized interviews.  
 
Two ELISA assays were used for testing HIV antibodies. In  blood specimens with 
positive result in  the first ELISA assay, a second (different) ELISA assay was 
performed. Specimens with positive results in both ELISA assays were considered 
positive for HIV test.  
 
First HIV ELISA  test: ELISA reagent: (Wantai Biotech, Beijing, China) 
Second HIV ELISA test: ELISA reagent: (Vironostika HIV Uniform II Ag/Ab. Akzo 
Organon Teknika, Netherlands). 
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 Variables used in this study included sample source, gender, age, marital status, 
resident place, nation, education background, profession, monthly income, age at first 
drug use age, use of injecting drug and  needles sharing, number of commercial sex 
partners in last 12 months, and STD symptoms in last 12 months. 
 
Age at the time of survey was recoded into two categories: less than 30 years and 
more. Marital status originally included 4 categories: single, married, cohabiting, and 
divorce/widowed; but of the purpose of the analysis was collapsed into 2 categories: 
living alone (single and divorce/widowed) and living with partner (married and 
cohabited). Resident status included 2 categories, local resident and transient resident. 
There are totally 56 nations in China, all non-Han samples were categorized to 
minority category. Education background originally included 5 categories: illiteracy, 
primary school, middle school, high school, and college or above; for the purpose of 
analysis it was collapsed into 2 categories: equal or less than 9 years of education 
(illiteracy, primary school, middle school), and more than 9 years education (high 
school and college or above). There were originally 15 profession categories: 1 
Student, 2 Teacher, 3 home maid, 4 service industry personnel, 5 shop assistant, 6 
medical staff, 7 worker, 8 migrant worker, 9 peasant, 10 farmer, 11 fisher, 12 officer, 
13 pensioner, 14 home worker, 15 other; for the purpose of the analysis they were 
collapsed into 2 categories: white collar (student, teacher, medical staff, officer, 
pensioner) and blue collar (all rest categories). Monthly income was subdivided into 
four categories according to the socio-economical situation in China: equal or less 
than 600 RMB (Chinese Currency, 1$=7.73RMB; 600 RMB is general considered as 
minimal life standard in China, however, there is a big socio-economical disparity in 
different regions), 601-2000 RMB and more than 2000 RMB per month). In one third 
of the sample income information was missing and the respondents were classified 
into missing category. Age at the time of first drug use was recoded into two 
categories according to the frequencies: younger than 30 and older than 30. 
Information about injecting drug use and needle sharing was investigated by several 
questions, with different time intervals. We used only the information on ever use of 
injecting drug and ever needle sharing and coded it into a single category. 
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Respondents were asked whether they had any commercial sex partners in the last 12 
months. If yes they were asked about their number. Respondents were also asked 
about any of following symptoms of sexually transmitted infections in the last 12 
months as ache/burn during miction, abnormal urethral or vaginal secretion, genital 
warts. 
 
Data analysis 
There were totally 6539 samples from 21 surveillance sites which conducted survey, 
one site in Kunming, Yunnan province was excluded for lack of information about 
risk behaviour.  
 
First, data cleaning was conducted, in which 649 samples were deleted. In 621 cases 
no blood test was performed (blood samples were either insufficient for conducting 
HIV test, blood taking was not successful or the participants rejected). In one case 
first HIV test was negative and the second positive, but second test should be 
performed only if the first test was positive. In 26 cases age of the first drug use was 
below 10 and additionally in one case the age was reported as 13 years. All other 
participants reported first age use starting from 14 to 60, we therefore decided to 
consider the 27 cases as coding errors.  
 
After data cleaning, a total of 5890 records were included in the analysis. SPSS 
software (version 14.0 for Windows; SPSS Inc., Chicago, IL) is used to analyse the 
dataset, χ2 statistics with P-values were used to compare HIV prevalence associated 
with demographics, drug use and sexual risk behaviours. Logistic regression was used 
to analyse independent association between HIV status and risk behaviours. 
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Results 
 
Characteristics of the sample 
Among the 21 survey sites, there were 14 sites with more than 200 records available 
(Sichuan Dazhou, Zhejiang Hangzhou, Guangxi Nanning, Xinjiang Kashi, Hubei 
Xiaogan, Gansu Wuwei, Hebei Shijiazhuang, Guizhou Qianxinan, Chongqing, 
Guizhou Tongren, Guangdong Dongguan, Hubei Jingzhou, Sichuan Liangshan, and 
Qinghai Haixi), for 5 other sites there were 100-200 records (Anhui Huainan, Anhui 
Maanshan, Qinghai Haidong, Sichuan Leshan, and Gansu Dingxi) and for two sites 
(Liaoning Fushun and Xinjiang Yili) less than 100 records.  
 
About half of respondents originated from detoxification centres, one third from 
community, and the remaining from other surveillance places. The sample was 
predominantly male with 5.6:1 male-to-female ratio. Age range was between 14 and 
78 years, with a median of 30 years. About half of the respondents were living alone, 
the second half was either married or living with a steady partner. Most drug users 
were local residents (had local permanent resident permission) and two thirds were 
Han Chinese. Two thirds had education of more than 9 years (which includes high 
school and above) and also two thirds were blue collar workers.  
  
80% of the participants initiated drug use before age of 30 years, here again several 
responses were missing. About half of the sample did never inject drugs (thus being 
drug users but not injecting drug users). Among the IDUs 44.1% ever shared needles.  
 
87% had no commercial sex partners in last 12 months before the time of interview, 
2% had at least one sex partner, with a large variation, but for 11% the information 
was missing. Among persons who had commercial sex, 36.8% used condom by latest 
commercial sex. 14% of participants experienced any STD symptoms in the last 12 
months before the interview. 
 
The overall HIV-1 antibody prevalence was 5.0%; it was 6.6% among IDUs and 3.5% 
among non-injecting drug users. Several sites showed no HIV-1 cases in the sentinel 
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samples, but in some regions the prevalence was as high as 10 to 30% (Guangxi 
Nanning 21.0%, Xinjiang Kashi 10.8%, Sichuan Liangshan 29.4%). The proportion of 
IDUs among the sentinel sites was very different, the proportion of IDUs as a whole 
accounted for 52.7%, needle-sharing rate among IDUs was also quite  higher, almost 
50% IDU once shared needles; in five sites that HIV-1 prevalence over 5%, 97.6% 
drug users in Guangxi Nanning were IDUs, 91.0% drug users in Chongqing were 
IDUs, 66.7% drug users in Guangdong Dongguan were IDUs whereas only 36.2% 
and 17.6% drug users were IDUs in Sichuan Liangshan and Xinjiang Kashi, 
respectively. Even in sites that no HIV positive was found, there was a big difference 
of the proportion of IDU among drug users, e.g. Non IDUs accounted for 97.9% in 
Gansu Dingxi, 98.3% in Gansu Wuwei, and 94.4% in Qinghai Haixi, respectively;  
whereas, IDUs accounted for 66.9% in Hebei Shijiazhuang, 96.4% in Liaoning Fuhun, 
and 81.6% in Xinjiang Yili, respectively. The big part of samples (87.3%) have had 
not any commercial sex partners in last 12 months,  However the missing values 
account for 11.2%, in some sentinel sites, the missing values are even over 20%, 
analysis related to the commercial sex behaviours should be cautious for higher 
proportion of missing.  
 
Bivariate analysis showed several associations between the investigated variables and 
HIV-1 antibody status. HIV prevalence was significantly associated with the source of 
the sample (p<0.01), younger age (p<0.05), being resident versus transient (p<0.001), 
being minority versus Han-Chinese (p<0.001), higher versus lower education 
(p<0.001), blue collar versus white collar (p<0.001), age of first drug use (p=0.05), 
injecting drugs, and sharing needles (p<0.001). 
 
Based on logistic regression analysis, demographic and behavioral factors 
significantly associated with HIV prevalence were: minority versus Han-Chinese (OR 
4.10; 95% CI 3.03-5.55; p<0.001), education <=9 years versus >9 years (OR 1.61; 
95% CI 1.20-2.15; p=0.001), injecting drugs without needle-sharing versus not 
injecting (OR 2.49; 95% CI 1.77-3.52; p<0.001), injecting drugs with needle-sharing 
versus not injecting (OR 4.44; 95% CI 3.19-6.19; p<0.001). 
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Discussion 
 
The HIV/AIDS second generation surveillance data from 2005 showed HIV-1 
antibody prevalence of 5.0% among drug users and 6.6% among IDUs. The data 
displayed also considerable differences in prevalence of HIV and risk behaviours 
between investigated regions. In several sentinel sites no HIV cases were recorded, 
whereas in others the prevalence was as high as 21% (Guangxi Nanning), 10.8% 
(Xinjiang Kashi), and 29.4% (Sichuan Liangshan).  
 
HIV/AIDS second generation surveillance is a cross-sectional survey. In order to 
guarantee the representativeness  and avoid the potential arrest of the samples’ illegal 
behaviours in China, anonymity and confidentiality are assured among drug users 
surveyed in second generation surveillance (China CDC, 2006). In most cases the 
sample size was less than was planned, and missing values impacted the analysis 
outcome, it should be paid attention for the henceforth surveillance to recruit enough 
samples, increase the quality of data and do best to decrease the missing values. Still,  
this study had several limitations.  
 
Regions that HIV/AIDS epidemic dominate by  drug users locate along  south-
western and north-western areas which border Laos, Myanmar, and Afghanistan. This 
study also demonstrated that higher HIV/AIDS prevalence regions locate in 
abovementioned areas. The issue of sample representativeness is decisive in cross 
sectional survey. Biases can arise when drug users selected in this study do not 
represent the general drug users in China, however, it is really difficult to reach the 
representativeness among drug users in China which is the most populous country in 
the world and big geographical and socio-economical disparity between different 
regions.  The representativeness criterion is best satisfied by making certain that 
sampling locations are selected properly and a sufficient number of samples are 
collected. For example, it is proved by a number of studies that HIV/AIDS prevalence 
among drug users in Xinjiang is really higher (Gill & Song, 2006), however, in this 
study, one site in Xinjiang there was no HIV positive found. A study in Xinjiang 
showed HIV prevalence among drug users was 24.5%, and among IDU was 
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significantly higher (56.1%) (Ni et al, 2006). Zhang et al. found in a cohort study in 
Xinjiang baseline HIV-1 prevalence among high-risk IDUs was 29% (228/781) 
(Zhang et al., 2007).   
 
A site in Yunnan province was excluded because lack of key information of risk 
behaviour, HIV-1 sero-prevalence was 54% (54/100) in this site. Yunnan suffered 
first HIV epidemic in China, and accounted the biggest number of HIV infections in 
China. In 2004, the HIV-1 prevalence among IDUs in Yunnan was between 21.2%-
27.8%. By the end of 2004, Yunnan had cumulatively reported 28,391 HIV infections 
(MOH, China/WHO; 2004).  Selection bias is most important bias in surveillance. 
Selection bias can cause if the HIV-related behaviors in surveyed subjects are 
different from those who do not participate in the survey. Rejection to be surveyed 
among subjects is an important potential resource of selective bias. HIV-related 
behavioral surveillance usually involves in the subject’s privacy or even the illegal 
behaviours, and the rejection-related bias can easily cause if the behaviours are 
different between subjects who reject survey and those who accept survey. Rejection 
bias may cause under-estimation of risk behaviours. The prevalence of HIV infection 
in this study could underrepresented the current situation among drug users in China.   
 
Risk behaviours among drug users in China are mainly due to injecting drug and 
needle-sharing, and unprotected sex among drug users and their sex partners (Zheng 
et al, 1994). Injecting drug use is the primary mode of transmission of HIV 
transmission in China. The cumulative number of reported HIV positive cases from 
1985 to 2004 was 89,067, in which IDUs accounted for 41% (MOH, China/WHO, 
2004). The epidemic is characterised by a wide disparity between high and low 
prevalence regions. The prevalence rate among IDUs is quite higher in  the south-
western and north-western areas which border Laos, Myanmar, and Afghanistan. In 
some regions of Xinjiang, Yunan and Sichuan even over 50% (MOH, China/WHO, 
2004).The major mode of HIV infection in the above four provinces with the highest 
reported cases of HIV/AIDS, including Yunnan, Xinjiang, Guangxi and Sichuan, is 
attributed to injecting drug use (MOH, China/WHO, 2004 & China CDC, 2003). In 
these regions, the proportion of minority population is much more higher than overall 
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8.4% minority of the entire population (Xiao, et al, 2007). In this study, the sentinel 
sites which the HIV-1 prevalence was over 5% in abovementioned higher  prevalence 
regions were Guangxi Nanning 21.0%, Xinjiang Kashi 10.8%, Sichuan Liangshan 
29.4%, respectively; definitely higher than other drug user sentinel sites.  
 
High prevalence of HIV-1 among IDUs found by Zhang et al in a cohort study was 
71.9% (174/242), needle/syringe sharing was the major risk factor, all three sites from 
Yunnan located along the drug trafficking route. Liu et al conducted a cohort HIV 
sero-incidence study among drug users in Guangxi found baseline HIV antibody 
prevalence was 25% (172/702), and risk factors were elder male drug users who 
injected drug and shared rinse water (Liu et al., 2006-b). A molecular study by 
Piyasirisilp  et al in 2000 discovered that some subtypes BC and CRF of HIV-1 
dominated among IDUs in Yunnan have spread through drug trafficking to the 
neighbouring provinces of Guangxi and to the west province of Xinjiang (Piyasirisilp 
et al, 2000). Beryer et al also found HIV-1 subtypes B, C, and a B/C recombinant 
subtype spread from Yunnan to north and west, to Xinjiang (Beryer et al, 2000).  
Zhang et al. studied HIV-1 patients in Yunnan using immunoassays found  HIV-1 
subtype C/CRF07_BC/CRF08_BC and CRF01_AE were codominant among IDU, the 
discovery of many sexually transmitted CRF01_AE cases was new and suggests that 
HIV-1 could be transmitted through “bridge population” into general population, this 
subtype may lead to a new epidemic in the general Chinese population (Zhang et al., 
2006). Yu et al. found unprotected sex continued to occur at high rates among IDUs 
and their sex partners in Yunnan (Yu et al., 2003). The same phenomena  also found 
in another HIV-1 molecular epidemiological study by Zhang et al. in 2004 in Xinjiang 
found HIV-1 infected by homo- or heterosexual transmission multiple subtypes of 
HIV-1 which were related to strains dominated among IDUs suggested HIV-1 has 
spread into general population (Zhang et al., 2004).  Some other studies have found 
drug users were more  likely to engage in high-risk sexual behaviours, and most 
female drug users engaged in commercial sex (Zhang et al., 2002; Yang et al., 2004; 
Qian et al., 2005; Tucker et al., 2005; Chu & Levy, 2005).  In Dehong county, 
Yunnan privince, HIV prevalence was over 1% in pregnant woman, HIV epidemic in 
Yunnan is already in a generalised phase (Cohen, 2004). A number of studies suggest 
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that HIV infection spread from high risk groups into the general population mainly 
due to sexual transmission (Zhang et al., 1999; Zhang et al., 2001; Huang et al., 2004; 
MOH, China/WHO, 2004; Hesketh et al., 2005; Zhu et al., 2005, Shao, 2006; Lonn et 
al, 2007).  
 
This study provided useful information with respect to the HIV-1 prevalence, risk 
behaviours and demographic characteristics associated with HIV infection among 
drug users in China. However, any conclusions regarding to sexual risk behaviours 
should be viewed with caution based on the outcome of this study, because the 
proportion of missing values of sexual behaviour variables as a whole and in some 
sites was higher. Since the emergence of epidemic, China has launched  HIV 
prevention and harm reduction program. A comprehensive program to prevent the 
further transmission of HIV among drug users has been implemented that includes 
community based harm reduction programmes, mainly methadone maintenance 
treatment and needle-syringe programme. In 2003, China announced a national AIDS 
control policy, “Four Frees and One Care” (free treatment, free Voluntary 
Counselling and Testing (VCT), free Prevention of Mother to Child Transmission 
(PMCT) and free education for AIDS orphans, and provision of social relief and care 
for HIV patients) (MOH, China/WHO, 2004). These efforts are likely to require an 
infrastructure that not only provides operational and financial support, but also creates 
an environment in which drug users feel comfortable and safe in seeking help and 
non-discrimination. 
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